Did you know that headache attributed to IIH has no specific clinical phenotype?
It can closely resemble chronic migraine or chronic tension-type headache. Moreover, primary headache disorders may coexist with IIH.
The ICHD-3 criteria require:
- A new headache or significant worsening of a pre-existing headache.
- Confirmed IIH and elevated CSF pressure.
- Evidence supporting a temporal or clinical relationship between IIH and headache.
- No better alternative ICHD-3 diagnosis.
An important clinical consideration: IIH should be diagnosed with caution in patients without papilloedema. In these cases, alternative explanations, including medication-overuse headache, must be carefully considered.
**The key message:** identifying IIH is not simply about recognizing a headache pattern. It requires integrating clinical findings, ophthalmological assessment, neuroimaging and CSF pressure measurements.
#migraine #headachedisorders #ichd3matters
International Headache Society
The International Headache Society (IHS) is a London-based charity membership organisation that was founded in 1981 for those with a professional commitment to helping people affected by headache disorders and facial pains. In 1994, the IHS was incorporated in England and Wales as a Company Limited by Guarantee and then registered as a charity in 1995. The current President is Professor Cristina Tassorelli, who is a full professor and Chair of Neurology, Director of the Neurology Residency Program and Director of the Department of Brain and Behavioral Sciences at the University of Pavia. More on Wikipedia
-
International Headache Society
@ihs_official
-
International Headache Society
@ihs_official
New in Cephalalgia!
•
Long-term treatment of atogepant for the preventive treatment of migraine was safe and well tolerated. Overall safety results across 156 weeks were consistent with the known safety profile of atogepant; no new safety signals were observed.
•
Efficacy and functional outcomes showed improvement from lead-in study baseline at weeks 13–16 and were consistent through 156 weeks.
journals.sagepub.com/doi/10.1177/03331024261500983
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In this real-world case series, gepants were associated with clinically meaningful reductions in attack frequency in patients with active cluster headache bouts, with good short-term tolerability.
journals.sagepub.com/doi/10.1177/03331024261495544
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Atogepant showed rapid reductions in headache burden within one week in episodic cluster headache. Improvements across outcomes support its potential as an early preventive option in real-world practice.
journals.sagepub.com/doi/10.1177/03331024261495542
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Management must move beyond reducing attack frequency to standardizing measures that capture and treat the full spectrum of pain-free disability.
journals.sagepub.com/doi/10.1177/03331024261502429
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Rimegepant provides 2-hour pain freedom in nearly half of treated migraine attacks, with a consistent response across repeated attacks in a meaningful proportion of individuals.
journals.sagepub.com/doi/10.1177/03331024261484897
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Post-hoc analyses in 234 women with suspected/confirmed hypertensive disorders of pregnancy (HDP) showed no association between migraine and sFlt-1, PlGF, or their ratio within HDP groups, yet differences were seen in the overall population
journals.sagepub.com/doi/10.1177/03331024261492308
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📣 Deadline extended: Complimentary registrations for IHS members!
The ACEFAPERU Headache Summit 2026 will take place online on 26–28 November 2026.
ACEFAPERU is offering complimentary registrations to IHS members, allocated on a first-come, first-served basis, with priority given to junior members.
📅 Extended application deadline: 20 November 2026
📧 To apply, email: ihsoffice@i-h-s.org
To learn more, please go to: ihs-headache.org/en/events/acefaperu-headache-summit-2026/ -
International Headache Society
@ihs_official
New in Cephalalgia!
A 10-year study developed and externally validated the Migraine Risk Stratification Score (MRSS) to stratify cryptogenic ischemic stroke (CIS) risk in patients with migraine and right-to-left shunt, with particular value for identifying individuals at low risk.
journals.sagepub.com/doi/10.1177/03331024261499744
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Across all countries, substantial humanistic and economic burden was reported in individuals with migraine and comorbid depression compared with individuals with migraine alone, emphasizing the need for comprehensive management and preventive strategies to cohesively address both conditions
journals.sagepub.com/doi/10.1177/03331024261477399
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
🧠 How much can we learn about a headache simply by asking the right questions?
When it comes to headache disorders, a good clinical history is often our most powerful diagnostic tool.
But effective history-taking is more than ticking boxes. It requires active listening, empathy, structured questioning, and clinical reasoning.
📢 A new article published in Cephalalgia Reports by the International Headache Society Education Committee presents a practical approach to optimising headache history-taking:
1️⃣ Listen and connect: Build rapport, ask open-ended questions, and understand the patient's experience.
2️⃣ Characterise the headache: Explore the onset, timing, pain characteristics, associated symptoms, triggers, and impact on daily life.
3️⃣ Check for red flags: Identify warning signs of secondary headaches using tools such as SNNOOP10 and careful assessment of temporal patterns.
4️⃣ Explain and plan: Communicate the diagnosis, address patient concerns, and develop a shared management plan.
💡 The key message?
Headache diagnosis is not just about recognising symptoms. It is about understanding the person experiencing them.
And while digital tools and AI may support clinical assessment, they cannot replace the art of listening.
📖 Read the full paper:
Souza MNP, et al. Optimizing headache history-taking: A structured approach from the International Headache Society Education Committee. Cephalalgia Reports. 2026;9.
🔗 doi.org/10.1177/25158163261486759
💬 For clinicians: What is the one question you never forget to ask when taking a headache history?
#cephalalgiareports #headachemedicine #migraine #neurology #headacheeducation #internationalheadachesociety #medicaleducation -
International Headache Society
@ihs_official
New in Cephalalgia!
Some other headache was unaccounted for in these studies; moreover, it was common: the Turkish study, with 7,088 participants, estimated its 1-year prevalence as 29.2%.6 The study authors labelled it “undifferentiated headache” (UdH) (in terminological alignment with A3.6 Undifferentiated
trigeminal autonomic cephalalgia in ICHD-3).
journals.sagepub.com/doi/10.1177/03331024261501136
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The evidence cited in the letter supports giving UdH greater attention in future population studies and burden estimates. At the same time, its clinical course and the benefits of any specific intervention require further study.
The authors therefore regard UdH as an important research and public health consideration, without assuming that every child with brief or mild
headache requires treatment.
journals.sagepub.com/doi/10.1177/03331024261501141
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The authors encourage colleagues within the international orofacial pain
and oral medicine communities, to evaluate our proposed criteria through independent validation studies and multicenter collaborative research.
journals.sagepub.com/doi/10.1177/03331024261493168
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This Letter discusses how discordant negative-control outcomes should be interpreted when assessing residual bias in the cerebrovascular safety evaluation of CGRP monoclonal antibodies.
journals.sagepub.com/doi/10.1177/03331024261493119
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Both negative-control findings should inform interpretation, without treating the fracture result as confirmation of exchangeability or
the UTI result as a quantitative measure of bias in the primary outcome.
journals.sagepub.com/doi/10.1177/03331024261493112
#migraine #headache #brain #pain #neurology #neuroscience
@BradleyOngMD -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Headache disorders are a leading cause of disability, yet publicly funded headache clinical trials in Australia are remarkably scarce. This new paper highlights the gap and the opportunity for change.
Article highlights
•
No funded clinical trials were identified for migraine or tension-type headache, despite their substantial burden.
•
A review of NHMRC and MRFF funding in Australia identified only one funded headache disorder clinical trial since 2013, focused on cluster headache.
•
Increased investment in headache clinical trials, workforce development, and national research infrastructure could help accelerate evidence generation and improve patient outcomes.
journals.sagepub.com/doi/10.1177/25158163261501562
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📣 10 Complimentary Registrations for IHS Members!
The ACEFAPERU Headache Summit 2026 will be held online on 26–28 November 2026.
ACEFAPERU is offering 10 complimentary registrations to IHS members. Places are available on a first-come, first-served basis, with priority given to junior members.
📅 Application deadline: 16 November 2026
📧 To apply, email: ihsoffice@i-h-s.org
Learn more: ihs-headache.org/en/events/acefaperu-headache-summit-2026/ -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Can rheumatoid meningitis mask itself as a simple worsening of pre-existing migraine with aura? Yes, even without focal signs! Read how calculating the serum anti-CCP antibody (ACPA) index via the Reiber equation cracked this diagnostic puzzle.
journals.sagepub.com/doi/10.1177/25158163261503143
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠🏆
Submissions are now open!
Cephalalgia invites researchers worldwide to submit their original research for the Jes Olesen Awards, recognising excellence and innovation in headache medicine.
🏆 Two prestigious awards:
🔬 Jes Olesen Basic Science Award
🩺 Jes Olesen Clinical Science Award
Each award includes:
💶 €10,000 prize
🌍 Recognition through Cephalalgia and IHS platforms
🎤 Opportunity to present at a major scientific meeting
✅ Eligibility:
• Original research papers only
• First author must be under 45 years of age at submission
• One submission per participant
📅 Submission deadline: 28 February 2027
📄 All submissions will undergo Cephalalgia's standard peer-review process, with winners selected from accepted papers by an expert panel.
The awards are generously funded by Professor Jes Olesen through JO Health to support and inspire the next generation of headache researchers.
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
More details: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Don't miss this opportunity to have your research recognised!
#jesolesenawards #cephalalgia #ihs #headacheresearch #headachemedicine #callforpapers #headache -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A letter to the editor from Uzun and Sahin responding to the recent case series by Abdalla et al. on lamotrigine in migraine with aura.
journals.sagepub.com/doi/10.1177/25158163261504730
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Meet the IHC2027 Local Congress Chair, Dimos Mitsikostas, as he welcomes the global headache community to Athens:
In September 2027, Athens will welcome the global headache community for IHC2027. A city renowned for its history, culture, hospitality, and spirit of discovery, Athens provides the perfect setting to connect with colleagues, exchange ideas, build collaborations, and experience the very best of the international headache community.
We look forward to welcoming you to Athens and sharing an unforgettable IHC2027 together.
📍 Athens, Greece
📅 8–11 September 2027
Where science meets history. Where colleagues become friends. Where the global headache community comes together.
#ihc2027 #internationalheadachecongress #internationalheadachesociety #headache #migraine #athens -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A first-ever migraine aura was followed by a small cerebellar ischemic lesion in a patient with a patent foramen ovale, supporting a possible link between paradoxical microembolism, cortical spreading depression, and focal ischemia.
journals.sagepub.com/doi/10.1177/25158163261500746
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A 69-year-old man with chronic cluster headache enjoyed a notable reduction in attack frequency with memantine 20 mg twice daily. Off-label use of memantine in cluster headache should be considered in select patients.
journals.sagepub.com/doi/10.1177/25158163261500757
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In 1M+ headache-diary days, weather was a real but tiny correlate of headache reports — no reproducible "weather-sensitive" subgroup could be identified, no match to patients' own triggers, and near-chance day-level prediction.
journals.sagepub.com/doi/10.1177/25158163261498893
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Meet the IHC2027 Scientific Programme Chairs: Anna Andreou and Scott Yuan! Here, they share their vision for the congress:
“As Scientific Programme Chairs, we are working to develop a congress that reflects both the extraordinary progress being made across headache medicine and the challenges that still lie ahead. ‘Science that Inspires. Care that Transforms. Policy that Impacts,’ is the vision at the heart of the scientific programme for IHC2027.”
Join us at the International Headache Congress!
📅 9–11 September 2027
📍 Athens, Greece
#ihc2027 #headachemedicine #internationalheadachesociety -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The first study in the world comparing pharmacopuncture, a type of acupuncture technique, to standard oral medication (propranolol) as prophylaxis treatment for migraine.
.............
GB20 pharmacopuncture with 2% lidocaine produced reductions in migraine frequency, disability and bothersome symptoms in the same direction as propranolol, without evidence of a statistically significant between-group difference.
•
GB20 pharmacopuncture with 2% lidocaine warrants further evaluation as a possible option for patients intolerant of or contraindicated for propranolol prophylaxis.
journals.sagepub.com/doi/10.1177/25158163261496909
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This paper compared the ICHD-3 and DC/TMD diagnostic systems for headache attributed to temporomandibular disorder in the OPPERA-II cohort and found that the two approaches identify overlapping but clinically distinct headache presentations.
journals.sagepub.com/doi/10.1177/25158163261497660
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Adjunctive masseter botox may improve outcomes in patients with chronic migraine and muscular temporomandibular disorder.
journals.sagepub.com/doi/10.1177/25158163261498886
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In patients with refractory migraine, evolving systemic features may provide an important clue to an underlying neuroendocrine disorder.
journals.sagepub.com/doi/10.1177/25158163261496890
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This systematic review examined EEG findings in migraine with brainstem aura. EEG was usually normal, while generalized rhythmic delta activity was the most frequently reported abnormal pattern in patients with decreased level of consciousness.
journals.sagepub.com/doi/10.1177/25158163261493456
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Secondary headaches can signal serious disease. The authors reviewed warning signs (“red flags”) and organised them into a structured framework (DIPIH-T) to help clinicians decide when further testing is needed.
journals.sagepub.com/doi/10.1177/25158163261488715
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Secondary headaches can signal serious disease. The authors reviewed warning signs (“red flags”) and organised them into a structured framework (DIPIH-T) to help clinicians decide when further testing is needed.
.......
•
Secondary headaches often present with symptoms that are uncommon in primary headaches (red flags) and should prompt further diagnostic evaluation.
•
Red-flag information can be organized into different domains reflecting underlying pathological processes.
•
The proposed DIPIH-T framework groups warning signs into neurological dysfunction, inflammation/infection, precipitating factors, intracranial pressure abnormalities, hormonal dysfunction, and temporal features.
•
This structured approach may help clinicians recognize potentially dangerous headaches and guide decisions about further investigations.
journals.sagepub.com/doi/10.1177/25158163261488715
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Masterclass in Headache
No treatment for new daily persisten headache (NDPH) has been well established. Although NDPH is rare in both general and clinic-based populations, and more frequent in adolescents than in adults,
it is usually disabling and highly refractory.
Link to the 'Masterclass in Headache' paper:
journals.sagepub.com/doi/10.1177/25158163261503151
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The purpose of this letter to the editor was to draw attention to the fact that Peru has two established headache organizations, rather than to explain their full activities.
journals.sagepub.com/doi/epub/10.1177/25158163261491881
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
These updates complement the valuable regional perspective provided by Velez-Jimenez et al. and offer international readers a more contemporary and nuanced view of the progress and remaining challenges in headache care in Peru.
journals.sagepub.com/doi/10.1177/25158163261491909
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The clinical significance of pain behaviors in chronic headache patients is unclear. Headache specialists place less weight on these compared to other neurologists who may withhold treatment if headache behaviors are not displayed.
Highlights
•
Online survey of general neurologists and headache specialists about whether pain behaviors in patients with chronic headache influence clinical management.
•
Although the clinical significance of these behaviors is unclear, headache specialists appeared to place less weight on them.
•
Practical implication: clinicians should not dismiss reports of chronic headache, even when observed pain behaviors are absent.
journals.sagepub.com/doi/10.1177/25158163261485447
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A structured, patient-centred headache history improves diagnostic accuracy and safety. This framework integrates ICHD-3–based diagnosis with assessment of red flags, MOH risk, and disability measures to guide practical, real-world care.
journals.sagepub.com/doi/10.1177/25158163261486759
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Alterations in the interstitial microenvironment across headache phases and clinical phenotypes in migraine: A multimodal diffusion MRI study”, which has been selected as the Editor’s Choice for the October issue of Cephalalgia.
.................
Migraine-related alterations in the interstitial microenvironment vary with headache phase and disease burden
•
Individuals with migraine experiencing headache and with higher disease burden showed reduced extracellular volume fraction and increased intracellular volume fraction, suggesting a microenvironment that may influence interstitial fluid dynamics and glymphatic activity.
•
Observed alterations involved major white matter tracts implicated in multisensory processing and migraine pathophysiology.
•
Diffusion-derived alterations vary with headache phase and disease burden rather than representing a static trait.
journals.sagepub.com/doi/10.1177/03331024261470368
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🏆 Jes Olesen Awards – Winners Announcement & Award Lectures!
The wait is almost over!
Join us at the European Headache Congress (EHC) for the announcement of the inaugural Jes Olesen Award winners and their award lectures!
Celebrating excellence in Basic Science and Clinical Science research, these prestigious awards recognise outstanding contributions to the advancement of headache medicine.
📅 11 December 2026
🕔 17:45–18:45, Berlin
📍 Plenary Hall | EHC
Each award carries a €10,000 prize, generously funded by Professor Jes Olesen through JO Health.
We look forward to celebrating the winners and hearing about their exceptional research!
#jesolesenawards #cephalalgia #ehc2026 #headacheresearch #headachemedicine -
International Headache Society
@ihs_official
New in Cephalalgia!
The chronicization process in migraine patients involves changes in the structure, function, iron content, and clearance function of multiple nuclei.
•
Migraine was associated with subcortical dysfunction, including selective subcortical functional and glymphatic changes.
•
These abnormalities provide new insight into chronic migraine pathophysiology.
journals.sagepub.com/doi/10.1177/03331024261485487
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
3,000 migraine papers. 1 in 5 open with the same tired 'common, prevalent, disabling' line. This Cephalalgia letter says: it's not plagiarism, it's just boring, and asks authors (and reviewers) to try harder.
journals.sagepub.com/doi/10.1177/03331024261489743
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
From Aristotle’s metaphysics to IHS higher standards: shifting migraine prevention from relative response to residual disease control, requiring real-world evidence, education, and routine clinical implementation.
journals.sagepub.com/doi/10.1177/03331024261489742
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍🧠 IHC2027 | The Global Headache Community Comes Together in Athens!
📅 8–11 September 2027
📍 Athens, Greece
The journey towards the International Headache Congress 2027 (IHC2027) has begun!
We are delighted to share a special message from our Congress Chairs, Prof. Mario Peres and Prof. Messoud Ashina, as we look ahead to one of the most anticipated international gatherings in headache medicine.
"As Congress Chairs, it is our great pleasure to welcome the global headache community on the journey to the International Headache Congress 2027 in Athens.
IHC2027 will be more than a scientific meeting. It will be an opportunity to connect across disciplines, share new ideas, build collaborations, and accelerate progress for the millions of people affected by headache disorders worldwide.
Thank you for being part of this journey. We look forward to learning, debating, and advancing the field together.
See you in Athens in September 2027.
The IHC2027 Congress Chairs
Mario Peres and Messoud Ashina"
✨ Save the dates and join us in Athens!
ihc2027.org
Stay connected for upcoming announcements on the scientific programme, distinguished speakers, abstract submissions, and more.
#ihc2027 #internationalheadachecongress #headachemedicine #headacheresearch #athens2027 #globalheadachecommunity #migraine #neurology -
International Headache Society
@ihs_official
New in Cephalalgia!
Al-Sayegh et al. reported that CGRP-targeted therapies consistently reduced depressive and anxiety symptoms in migraine patients across 12 studies (n=2,796), likely secondary to migraine control rather than direct psychotropic effects.
....
Placebo-controlled evidence did not confirm a direct psychotropic effect, suggesting improvements may be mediated through effective migraine control.
•
The predominance of open-label designs underscores the need for randomised controlled trials with prespecified psychiatric endpoints.
journals.sagepub.com/doi/10.1177/03331024261484898
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In TTH, tension is not stress or muscle tension. A single word shapes how doctors talk about the condition, how patients understand their own bodies, and how easily they fall into the hands of unproven or costly treatments. Time to change!
journals.sagepub.com/doi/10.1177/03331024261476229
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Developed and externally validated the Migraine Analgesic Usage (MAU) Index, a simple triage score using acute medication days and Migraine Treatment Optimization Questionnaire 6-item version (MTOQ-6) to identify high multidimensional migraine burden. It supports Green/Yellow/Red clinical prioritisation.
journals.sagepub.com/doi/10.1177/03331024261478621
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Escalation to eptinezumab 300 mg was associated with improved population-averaged outcomes in this selected cohort of difficult-to-treat partial responders to 100 mg, supporting, as such, dose escalation over switching therapy.
•
Escalation converted partial 100 mg responders: 57.9% and 64.9% achieved ≥ 50% MHD reduction after first and second 300 mg cycles.
•
After two 300 mg cycles, MHD decreased from 17 to 5, and MIDAS scores dropped from 93 to 39.
•
Greater 100 mg MHD reduction and no prior erenumab exposure independently predicted ≥ 50% response, supporting escalation before switching treatment.
journals.sagepub.com/doi/10.1177/03331024261498883
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine-related alterations in the interstitial microenvironment vary with headache phase and disease burden
•
Individuals with migraine experiencing headache and with higher disease burden showed reduced extracellular volume fraction and increased intracellular volume fraction, suggesting a microenvironment that may influence interstitial fluid dynamics and glymphatic activity.
•
Observed alterations involved major white matter tracts implicated in multisensory processing and migraine pathophysiology.
•
Diffusion-derived alterations vary with headache phase and disease burden rather than representing a static trait.
journals.sagepub.com/doi/10.1177/03331024261470368
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
A structured two-tier headache curriculum defines core competencies for general neurologists and advanced skills for specialists—aligning education with ICHD-3, modern therapeutics, and multidisciplinary care to improve headache diagnosis.
journals.sagepub.com/doi/10.1177/03331024261485181
#migraine #headache #brain #pain #neurology #neuroscience
@amrhasanneuro -
International Headache Society
@ihs_official
New in Cephalalgia!
Comment from the authors:
"We therefore view the contribution by Wasserman and
colleagues not as an alternative to our proposal, but as an important extension that illustrates the breadth of hypotheses
that can be systematically explored within a shared descriptive framework"
journals.sagepub.com/doi/10.1177/03331024261479677
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Musella et al. propose a multidimensional Oral Dysaesthetic and Perceptual Disorder (ODPD) framework for burning mouth syndrome and call for psychiatric input. This reply: the perceptual dimension is exactly where that input is needed — psychoanalytic, interoceptive & Complex Regional Pain Syndrome (CRPS) accounts converge.
journals.sagepub.com/doi/10.1177/03331024261479682
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📅 Save the date for IHC 2027 in Athens! 🇬🇷
Join the international headache community on 9–11 September 2027 for the latest advances in headache research and clinical care, while experiencing the rich history and culture of Athens.
Mark your calendar and join us in Athens for the International Headache Congress!
#ihc2027 #internationalheadachecongress #headache #athens -
International Headache Society
@ihs_official
#sundayquiz
The answer is C: 13.3.1 Nervus intermedius neuralgia
According to ICHD-3rd, it is a rare disorder characterized by brief paroxysms of pain felt deeply in the auditory canal, sometimes radiating to the parieto-occipital region. In the vast majority of cases, vascular compression is found at operation, occasionally with a thickened arachnoidea, but it may develop without apparent cause or as a complication of herpes zoster or, very rarely, multiple sclerosis or tumour.
It is provoked by stimulation of a trigger area in the posterior wall of the auditory canal and/or periauricular region.
#ichd-matter #headache #awareness #sundayquiz -
International Headache Society
@ihs_official
Headache medicine is full of questions. Are we always asking the right ones?
How do we recognise the less obvious presentations? Navigate diagnostic pitfalls? Make better treatment decisions?
A new educational initiative is coming to Cephalalgia Reports: Masterclass in Headache — a series featuring contributions from leading experts in the field, bringing practical, evidence-informed insights to clinicians who want to improve the way they diagnose and manage headache disorders.
Our introductory editorial has just been published. This is only the beginning.
📖 Read the editorial:
journals.sagepub.com/doi/10.1177/25158163261497651
More knowledge. More practical insights. Better headache care.
#headache #migraine #ihs #cephalalgiareports #masterclassinheadache -
International Headache Society
@ihs_official
🌍 Today is World Menopause Day 2026!
This year’s theme is “Chronic Pain at Midlife.”
Together with the International Menopause Society, the IHS highlights the importance of understanding migraine during menopause and ensuring women receive the support and care they need.
#worldmenopauseday #chronicpainatmidlife -
International Headache Society
@ihs_official
#sundayquiz
A male patient presented with recurrent attacks of deeply sited sever shooting pain in the auditory canal lasting between 15 and 45 seconds and provoked by lightly touching of the posterior wall of the external auditory canal.
Which type of headache according to the ICHD-3rd?
A. Glossopharyngeal neuralgia
B. Classical trigeminal neuralgia
C. Nervus intermedius neuralgia
D. Post-herpetic neuralgia of the facial nerve
#ihs #ichd #education #awareness -
International Headache Society
@ihs_official
Tomorrow is World Menopause Day 2026!
This year’s theme is “Chronic Pain at Midlife.”
Reported estimates of migraine prevalence during menopause range from 10% to 29% across studies, highlighting the importance of recognizing migraine as part of women’s midlife health.
The International Headache Society, together with the International Menopause Society, is raising awareness and promoting better recognition and care for women living with migraine.
🗓️ Save the date: Sunday, 18 October 2026.
Reference: Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F, Carolei A, Sacco S. Migraine in menopausal women: a systematic review. Int J Womens Health. 2015 Aug 20;7:773-82. doi: 10.2147/IJWH.S70073.
#worldmenopauseday #chronicpainatmidlife #ihs #ims #migraine #womenshealth -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The Arabic Migraine Attacks–Subjective Cognitive Impairments (Mig-SCog) demonstrated good internal consistency and acceptable construct validity in Arabic-speaking individuals with migraine. Its correlations with HIT-6, MoCA, and monthly migraine days support its utility as a screening tool.
journals.sagepub.com/doi/10.1177/25158163261486045
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In adults with episodic migraine, higher retrospective premonitory symptom burden was associated with greater cephalic and extracephalic allodynia, but not clinically meaningful HIT-6 change.
journals.sagepub.com/doi/10.1177/25158163261484899
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Lamotrigine should be considered with caution as a preventive treatment for migraine with aura.
Lamotrigine showed minimal effectiveness for preventing migraine with aura, with only one responder out of 52 patients.
•
No improvements in aura symptoms were reported across the cohort.
•
Nearly one quarter discontinued treatment due to adverse effects.
journals.sagepub.com/doi/10.1177/25158163261486689
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#throwbackthursday
IHC 2025 in Brazil: These moments remind us that progress in headache medicine is built not only on scientific exchange, but also on meaningful connections and a shared vision for the future. 💙
Are you planning to attend the next IHC on September 9–11, 2027, in Athens, Greece? Share it with us in the comments! 💬
#internationalheadachecongress #headache
#ihc2025 in Brazil -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Trigeminal autonomic cephalalgias (TACs) are severe headaches that sometimes do not respond to medication. This study reviewed surgical options and found that microvascular decompression can provide lasting relief, especially when imaging shows nerve compression.
journals.sagepub.com/doi/10.1177/25158163261478501
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Aerobic training increased resting-state alpha wave activity than Biofeedback and Placebo. Sleep quality and quality of life improved significantly, with large effect sizes. Pain reduction did not differ significantly between groups.
journals.sagepub.com/doi/10.1177/25158163261481054
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Atraumatic-first lumbar puncture was associated with a low post-dural puncture headache (PDPH) incidence of 4.1% in 344 neurological outpatients undergoing diagnostic LP at a tertiary neurological outpatient clinic. Younger age, but not sex, BMI or puncture attempts, predicted PDPH. Findings support routine atraumatic-first LP.
journals.sagepub.com/doi/10.1177/25158163261480327
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
An interesting case presented with both intracranial hyper and hypotension, associated with cerebellar tonsillar displacement as a navigator.
Tonsillar displacement can be associated with both intracranial hypertension and hypotension. This phenomenon should be understood as a dynamic process instead of a fixed or unidirectional force.
•
It is crucial to understand the pathophysiology of CSF dynamics and to recognize the imaging findings.
•
Careful clinical and imaging surveillance are essential for managing patients with conditions related to intracranial pressure.
journals.sagepub.com/doi/10.1177/25158163261478626
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment.
journals.sagepub.com/doi/10.1177/25158163261478222
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Protocol for a systematic review/meta-analysis assessing whether migraine—especially with aura—is associated with increased white matter hyperintensity burden on MRI, addressing conflicting evidence using rigorous, population-based methods.
journals.sagepub.com/doi/10.1177/25158163261472105
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Can pitolisant, a selective H3 receptor inverse agonist, trigger migraine-like attacks in women with migraine without aura?
This randomized, double-blind, placebo-controlled crossover study in 14 women will provide novel insights into the involvement of the H3 receptor in migraine pathophysiology and clarify whether selective modulation of this receptor is sufficient to provoke migraine-like attacks.
journals.sagepub.com/doi/10.1177/25158163261474461
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Migraine-related healthcare interaction status was associated with substance-use indicators among U.S. college students engaged in care.
•
No treatment after appointment/discussion or being told no treatment was necessary showed elevated substance-use odds.
•
Depression, anxiety, or PTSD explained only a modest portion of selected associations.
•
Findings are hypothesis-generating, not evidence of treatment adequacy or mechanistic mediation.
journals.sagepub.com/doi/10.1177/25158163261474168
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A systematic review of 17 studies with 1857 pediatric patients with status migrainosus highlights literature gaps and brings attention to an under-recognized condition.
.............................
Status migrainosus in pediatric populations is under-recognized, mostly affecting adolescent girls.
•
Evidence on pediatric status migrainosus is limited to observational, non-comparative, predominantly retrospective studies; no randomized trials were identified.
•
Stress, chronic migraine, and psychiatric comorbidities are reported associated factors.
•
Nerve blocks showed a trend toward short-term pain control in observational, non-randomized studies.
•
Pediatric-focused, standardized, acute management protocols from clinical trials are urgently needed.
journals.sagepub.com/doi/10.1177/25158163261469216
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠🏆
Submissions are now open!
Cephalalgia invites researchers worldwide to submit their original research for the Jes Olesen Awards, recognising excellence and innovation in headache medicine.
🏆 Two prestigious awards:
🔬 Jes Olesen Basic Science Award
🩺 Jes Olesen Clinical Science Award
Each award includes:
💶 €10,000 prize
🌍 Recognition through Cephalalgia and IHS platforms
🎤 Opportunity to present at a major scientific meeting
✅ Eligibility:
• Original research papers only
• First author must be under 45 years of age at submission
• One submission per participant
📅 Submission deadline: 28 February 2027
📄 All submissions will undergo Cephalalgia's standard peer-review process, with winners selected from accepted papers by an expert panel.
The awards are generously funded by Professor Jes Olesen through JO Health to support and inspire the next generation of headache researchers.
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
More details: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Don't miss this opportunity to have your research recognised!
#jesolesenawards #cephalalgia #ihs #headacheresearch #headachemedicine #callforpapers #headache -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This paper reports that intravenous dihydroergotamine (DHE) given as a five-day infusion is an effective, well tolerated approach to the management of intractable primary headache disorders.
journals.sagepub.com/doi/10.1177/25158163261470348
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
New research is testing whether blocking 10 nerves of the scalp instead of 2 stops migraine faster and prevents them for longer. It could change how episodic migraine is treated.
journals.sagepub.com/doi/10.1177/25158163261471133
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The findings of this study highlight the need for consensus-based guidelines, specialized physiotherapy training, and stronger multidisciplinary collaboration in headache care.
......................
Exercises and manual therapy were the most frequently advised physiotherapy modalities, with neck pain and musculoskeletal findings being the main drivers for referral.
•
Referral patterns differed by country income level, with high-income countries more often using defined criteria than lower-to-upper-middle-income countries.
•
These findings highlight the need for consensus-based guidelines, specialized physiotherapy training, and stronger multidisciplinary collaboration in headache care.
journals.sagepub.com/doi/10.1177/25158163261469410
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
"Reply to Letter to the Editor. The authors provided responses to clarify the methodological considerations and clinical framework
underlying our case series and satisfactorily address the points raised by Viceconti et al."
journals.sagepub.com/doi/10.1177/25158163261477300
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Letter to the Editor highlighting methodological and clinical concerns in a study on individualized physiotherapy for migraine: unclear diagnosis, incomplete outcomes, missing medication data, and potential interpretation bias.
journals.sagepub.com/doi/10.1177/25158163261477293
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The available literature consistently suggests that gender-affirming hormone therapy can trigger or exacerbate migraine through hormonal pathways. The authors propose that Migraine Triggered or exacerbated by gender-affirming hormone therapy could be included in the ICHD-4.
journals.sagepub.com/doi/10.1177/25158163261472312
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌟 The theme of World Menopause Day 2026 is Chronic Pain at Midlife.
The International Headache Society (IHS) and the International Menopause Society are raising awareness of chronic pain conditions, including headache disorders, and highlighting the importance of recognition and evidence-based care.
Join us in starting conversations, sharing information, and supporting women living with chronic pain, including headache and migraine.
🗓️ Save the date: Sunday, 18 October 2026.
#worldmenopauseday #chronicpainatmidlife #ihs #ims #migraine #womenshealth -
International Headache Society
@ihs_official
🏆 Jes Olesen Awards – Winners Announcement & Award Lectures!
The wait is almost over!
Join us at the European Headache Congress (EHC) for the announcement of the inaugural Jes Olesen Award winners and their award lectures!
Celebrating excellence in Basic Science and Clinical Science research, these prestigious awards recognise outstanding contributions to the advancement of headache medicine.
📅 11 December 2026
🕔 17:45–18:45, Berlin
📍 Plenary Hall | EHC
Each award carries a €10,000 prize, generously funded by Professor Jes Olesen through JO Health.
We look forward to celebrating the winners and hearing about their exceptional research!
#jesolesenawards #cephalalgia #ehc2026 #headacheresearch #headachemedicine -
International Headache Society
@ihs_official
New in Cephalalgia!
In Visual Snow Syndrome, persistent visual symptoms occur despite normal cerebral imaging. This EEG- based study reveals altered interaction between cardiac-related brain activity and visual prediction-error responses.
journals.sagepub.com/doi/10.1177/03331024261480300
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
App-based self-administered biofeedback therapy was associated with a reduction in migraine frequency in adults with episodic migraine. Higher adherence was associated with a greater reduction in migraine days
journals.sagepub.com/doi/10.1177/03331024261480724
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Headache is common in patients with joint hypermobility but often overlooked. This review highlights links with migraine and secondary causes such as intracranial hypotension and craniocervical instability.
..................
Joint hypermobility is frequently underrecognized in patients with headache.
•
Migraine is the predominant primary headache phenotype, but secondary headache disorders should be systematically considered.
•
Headache assessment should incorporate musculoskeletal, autonomic, and systemic evaluation.
•
Management should be individualized, integrating standard headache care with management of hypermobility-related comorbidities and secondary headache disorders.
journals.sagepub.com/doi/10.1177/03331024261477381
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Which receptor lets Substance P and PACAP activate dural mast cells in migraine? Not NK1R or PAC1, both essentially absent. Only MRGPRX2 is expressed, pointing to a single convergent target for future headache therapies.
journals.sagepub.com/doi/10.1177/03331024261480167
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
New in Cephalalgia!
FDG-PET/MRI revealed distinct reward- and cerebellar-network alterations in chronic migraine with medication overuse patients with poor 1-year outcomes. Network-level metabolic covariance was closely linked to dependence severity.
.............
Patients with poor outcomes showed hypermetabolism in reward-related regions and the cerebellum when compared with healthy controls (HC), and in the cerebellum when compared with good-outcome patients.
•
Cerebellar metabolic covariance with the putamen and occipital cortex was associated with dependence severity and long-term outcomes.
•
Findings support early, comprehensive interventions targeting both headache burden and maladaptive neurobehavioral processes in Chronic migraine with medication overuse (CMwMO).
journals.sagepub.com/doi/10.1177/03331024261476230
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We’re delighted to share that the paper “EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication”, has been selected as essential reading by our Editor-in-Chief, Prof. Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
............................
This new scoring system highlighted the importance of treatment reliability, pain intensity, and frequency in categorizing patients into a simple migraine severity grouping. The European Migraine and Headache Alliance–Migraine Scoring System (EMHA-MSS) could facilitate tailored management and longitudinal monitoring, potentially improving alignment with sufferers’ perceptions and enhancing patient-physician communication and understanding.
journals.sagepub.com/doi/10.1177/03331024261471185
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
According to this systematic review, current evidence on blood PACAP-38 levels in migraine remains inconsistent and inconclusive. At present, circulating PACAP-38 cannot be considered a reliable clinical biomarker for migraine.
journals.sagepub.com/doi/10.1177/03331024261468031
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Migraine attack prediction using wearable biosensor data” which has been selected as the Editor’s Choice for the September issue of Cephalalgia.
.........................
This study supports the feasibility of migraine attack prediction using continuous physiological data from a wrist-worn biosensor analysed with personalised machine learning approaches.
journals.sagepub.com/doi/10.1177/03331024261492220
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
journals.sagepub.com/doi/10.1177/03331024261474833
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
A randomized, placebo-controlled trial prospectively stratified by baseline severity and treatment timing would be better positioned to determine whether earlier rimegepant administration truly improves acute vestibular outcomes.
journals.sagepub.com/doi/10.1177/03331024261474832
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In a population-based cohort of 675 adults with migraine and 232 controls, domestic labor patterns differed by sex.
•
Females with migraine reported greater involvement in female-dominated household tasks, whereas males showed increased participation in distinct domains.
•
Migraine severity correlated with task-specific partner reliance, particularly among females.
•
·Domestic labor emerges as an overlooked dimension of migraine-related disability.
journals.sagepub.com/doi/10.1177/03331024261464573
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The EMHA-MSS is a novel scale to evaluate the severity of migraine reported by patients.
•
This new scoring system classifies patients with migraine based on the frequency of migraine, treatment effectiveness, pain intensity, and attack intensity.
•
The scores obtained in the EMHA-MSS may be used to foster patient-clinician conversations and shared understanding.
journals.sagepub.com/doi/10.1177/03331024261471185
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Reply to: Tariq N, Awais Amir, M. Letter to Editor: Methodological considerations regarding smoking, psychological distress, and medication-overuse headache
journals.sagepub.com/doi/10.1177/03331024261471846
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This letter critiques three methodological limitations in Hussein et al.'s cross-sectional study on smoking and medication-overuse headache: causal ambiguity, unvalidated instruments, and regression circularity.
journals.sagepub.com/doi/10.1177/03331024261471862
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Low unprompted recognition of prodromal symptoms suggests subjective awareness is unreliable, highlighting the need for objective prodrome detection.
•
Selected personalised machine learning configurations using wearable physiological signals achieved good or excellent migraine prediction in approximately two-thirds of participants.
•
Generalised model transferability was limited, with above-chance prediction in only one-third of participants, supporting the need for individual calibration.
journals.sagepub.com/doi/10.1177/03331024261492220
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📅 What’s coming up in headache medicine?
Looking to stay up to date with the latest developments in headache research, clinical practice and education?
The International Headache Society (IHS) maintains a calendar of national, regional and international events in headache medicine and related fields. 🌍🧠
Whether you're interested in clinical education, basic science, clinical research, pain medicine or multidisciplinary care, there are opportunities to connect with colleagues and learn from the international headache community.
👉 Explore the IHS event calendar: ihs-headache.org/en/events/
#headache #neurology -
International Headache Society
@ihs_official
🎓 Looking to learn more about headache medicine?
The International Headache Society (IHS) offers a growing collection of webinars covering both clinical and scientific topics in headache medicine, presented by experts from around the world. 🌍🧠
Many webinars include live Q&A sessions, providing an opportunity to engage directly with experts and discuss clinical and scientific questions.
Whether you're a neurologist, headache specialist, trainee, researcher, or simply interested in headache medicine, the IHS Learning Centre is worth exploring. 📚
👉 Explore the IHS webinar library: ihs-headache.org/en/learning-centre/resources/categories/… -
International Headache Society
@ihs_official
🫀 When a headache may be coming from the heart
Headache is usually thought of as a neurological symptom, but in rare cases, it can be a manifestation of acute myocardial ischaemia.
This is known as cardiac cephalalgia, a secondary headache disorder recognized in the International Classification of Headache Disorders (ICHD-3).
🔹 The headache can resemble migraine, including moderate-to-severe pain and nausea
🔹 It is often, but not always, triggered or aggravated by physical exertion
🔹 It develops in temporal relation to myocardial ischaemia and improves as the ischaemia resolves
🔹 Unlike typical migraine, it is characteristically not accompanied by photophobia or phonophobia
🔹 Nitroglycerine may relieve the headache, but can also itself trigger migraine-like headache
Cardiac cephalalgia can be difficult to distinguish from migraine, particularly when headache and nausea are the predominant symptoms. Correct recognition is important because treatments used for migraine, such as triptans, can be contraindicated in ischaemic heart disease.
Read more about cardiac cephalalgia here: ichd-3.org/10-headache-attributed-to-disorder-of-homoeost…
#neurology #headache #ichd3 -
International Headache Society
@ihs_official
The IHS–PHS Master School took place in Bacolod City, Philippines, on 25–26 September 2026, reflecting the shared commitment of the International Headache Society and the Philippine Headache Society to advancing headache education and improving patient care.
Thank you to the organisers, faculty, and participants for supporting this important educational initiative. Together, we can strengthen headache care through education and international collaboration! 💙
#ihs #philippineheadachesociety #ihsmasterschool -
International Headache Society
@ihs_official
On the final day of Migraine Awareness Week 2026, we’re delighted to celebrate a milestone: the IHS Facebook community has reached 18,000 followers 🎉🎉
Thank you for helping us raise awareness and support people living with migraine.
#migraineawarenessweek #migraine #ihs #headache #18kfollowers -
International Headache Society
@ihs_official
During Migraine Awareness Week, we’re also happy to celebrate the Mid-Autumn Festival today. Let’s enjoy time with family and care for those around us.
Happy Mid-Autumn Festival from IHS!
#midautumnfestival #migraineawarenessweek -
International Headache Society
@ihs_official
Migraine Awareness Week | 21–27 September 2026
Migraine really is “that bad.” Believe us.
Migraine can mean missing work, or working through an attack while struggling to concentrate and keep up. A 2021 scoping review by Begasse de Dhaem et al., published in Cephalalgia, found that workplace migraine education and management programs were associated with improved productivity.
Understanding migraine at work can help people get the support they need.
To learn more, please go to: doi.org/10.1177/0333102420977852
#migraineawarenessweek #migraine #believeus -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional challenges, healthcare disparities, and opportunities to advance migraine care.
In this interview, Ildefonso Rodríguez-Leyva discusses migraine care in Latin America, drawing on insights from the Latin American Headache Association (ASOLAC). The discussion explores barriers to accessing effective migraine treatments despite broad healthcare coverage and highlights priorities for improving headache care across the region.
Key takeaway:
💬 "The paradox: High healthcare coverage does not mean high healthcare access. That's the paradox at the heart of migraine care in Latin America and it's costing millions of people effective treatment for one of the world's most disabling conditions."
— Ildefonso Rodríguez-Leyva
🎥 Watch the author interview: www.youtube.com/watch?v=hkzEKVwS7ao
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163261456215
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #latinamerica #asolac #globalhealth #healthequity #headachecare #healthcareaccess -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional advances, ongoing challenges, and opportunities to improve migraine care.
In this interview, Sucharita Ray discusses migraine care in India and Sri Lanka, exploring current practice standards, recent progress in healthcare access, and the opportunities and challenges that lie ahead for migraine management in South Asia.
Key takeaway:
💬 "From National Health Insurance to Universal Health policy, migraine care in India and Sri Lanka has soared to newer heights. But challenges remain amid opportunities in the vast landscape of South Asian healthcare."
— Sucharita Ray
🎥 Watch the author interview: www.youtube.com/watch?v=EiZVRXFj36c
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163261456124
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #india #srilanka #southasia #globalhealth #healthequity #headachecare -
International Headache Society
@ihs_official
Migraine Awareness Week 2026 takes place from 21 to 27 September.
This year’s theme is: “Migraine really is ‘that bad’. Believe us.”
Migraine is a disabling neurological disease that can affect every aspect of life, including education, relationships, family life, work, and everyday experiences.
Help us challenge misconceptions, raise awareness, and end the stigma by sharing this message.
#migraineawarenessweek #migraine -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together high-quality articles from different regions of the world, highlighting local challenges, advances, and opportunities to improve migraine care.
In this interview, Avidesh Panday discusses the article Management of Migraine in the Caribbean, exploring the current state of migraine care in the region, barriers to diagnosis and treatment, and the importance of education, advocacy, and professional collaboration.
Key takeaway:
💬 "Migraine care in the Caribbean can be improved through the formation of a unified and dedicated Headache Society aimed at improving health provider education as well as patient advocacy and education."
— Avidesh Panday
🎥 Watch the author interview: www.youtube.com/watch?v=fqVxzr7aeX8
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251415565
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #caribbean #globalhealth #healthequity #medicaleducation #headachecare -
International Headache Society
@ihs_official
We’re delighted to share that the paper “Migraine and headache in children and adolescents: A 2026 evidence-based factsheet”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
.......
Pediatric headache is a growing global public health challenge. This factsheet reveals that 60% of children and adolescents worldwide experience headaches, and migraine is already among the leading causes of disability.
journals.sagepub.com/doi/10.1177/03331024261463173
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together perspectives from across the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care and reduce health inequalities.
In this interview, Oxana Grosu discusses the current state of migraine care in the Eastern Europe region, highlighting barriers to care, gaps in access to evidence-based treatments, and the importance of education and regional collaboration in advancing headache care.
Key takeaway:
💬 "Migraine is not just a clinical condition, it is a health system challenge. By strengthening education, improving access to evidence-based treatments, and fostering regional collaboration, we can reduce inequalities and advance equitable migraine care across Eastern Europe."
— Oxana Grosu
🎥 Watch the author interview: www.youtube.com/watch?v=exmBU5ctj2U
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251414020
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #easterneurope #globalhealth #healthequity #medicaleducation #headachecare -
International Headache Society
@ihs_official
#throwbackthursday
Do you remember the inspiring science and unforgettable moments we shared at #ihc2023 in Seoul?
What is your favorite memory from the congress? Share it with us in the comments! 💬
#internationalheadachecongress #headache #seoul -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Increased markers of heavy metal exposure and DNA methylation in cluster headache”, which has been selected as the Editor’s Choice for the August issue of Cephalalgia.
.......................................
This study shows that there is indirect evidence indicating heavy metal exposure in relation to cluster headache, as well as a tendency for alterations in global DNA methylation. These results support the hypothesis that heavy metal exposure from smoking contributes towards the pathophysiology of cluster headache.
journals.sagepub.com/doi/10.1177/03331024261480707
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from around the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care.
In this interview, Mona Nada discusses migraine care in the Middle East and North Africa (MENA) region, with a particular focus on North Africa. The discussion explores current challenges in headache care, barriers to accessing evidence-based treatments, and the importance of education, collaboration, and sustainable healthcare development across the region.
Key takeaway:
💬 "Migraine care in North Africa needs to move from recognition to action. By strengthening education, expanding access to evidence-based care, and fostering regional collaboration, we can build more equitable and sustainable headache care for our communities."
— Mona Nada
🎥 Watch the author interview: www.youtube.com/watch?v=iKXl9amw8hA
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251403011
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #mena #northafrica #globalhealth #healthequity #medicaleducation #headachecare -
International Headache Society
@ihs_official
New in Cephalalgia!
This study shows that there is indirect evidence indicating heavy metal exposure in relation to cluster headache, as well as a tendency for alterations in global DNA methylation. These results support the hypothesis that heavy metal exposure from smoking contributes towards the pathophysiology of cluster headache.
journals.sagepub.com/doi/10.1177/03331024261480707
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together perspectives from around the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care.
In this interview, Freda Dodd-Glover discusses migraine care in the Sub-Saharan Africa region, highlighting the importance of education, strengthening primary healthcare systems, expanding access to evidence-based treatments, and fostering locally led research to improve outcomes for people living with migraine.
Key takeaway:
💬 "The future of migraine care in Africa begins with education, strengthened primary healthcare, equitable access to evidence-based treatments, locally led research, and digital innovation powered by partnerships that ensure no person with migraine is left behind."
— Freda Dodd-Glover
🎥 Watch the author interview: www.youtube.com/watch?v=goki0oCW3og
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251402983
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together insights from different regions to explore the real-world challenges and opportunities in migraine diagnosis, treatment, and care delivery.
In this interview, the author discusses findings from an Australian hospital headache clinic, highlighting the substantial delays that many people with migraine continue to experience before receiving an accurate diagnosis and appropriate preventive treatment.
Key takeaway:
💬 "Despite significant advances in migraine therapies and science, patients with migraine still routinely face significant delays in reaching the diagnosis and being commenced on appropriate preventive therapies."
— Usman Ashraf
🎥 Watch the author interview: www.youtube.com/watch?v=UqhTwwHPoto
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251398869
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #australia #healthcareaccess #globalhealth #healthequity -
International Headache Society
@ihs_official
12,000 Instagram followers — and growing! 🚀
The International Headache Society community has reached 12K followers — and we couldn’t be more excited!
12,000 people.🌍
One global community.
One shared commitment: advancing headache science and improving care for people living with headache disorders.
From groundbreaking research to clinical education, from trainees taking their first steps in headache medicine to experts pushing the field forward — we’re stronger together.
💙 Thank you for following.
💙 Thank you for engaging.
💙 Thank you for sharing our mission.
Here’s to the next chapter of discovery, collaboration, and progress in headache medicine.
Let’s keep moving the field forward. Together.
#internationalheadachesociety #ihs #headacheresearch #neurology -
International Headache Society
@ihs_official
New in Cephalalgia!
🧠 This AI model distinguishes primary from secondary headaches in 1,219 patients (AUC=0.905). Trigger & symptom burden, not pain intensity, drive diagnosis. SHAP & LIME make every prediction explainable.
journals.sagepub.com/doi/10.1177/03331024261479693
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection showcases innovative initiatives, regional experiences, and practical approaches to improving headache and migraine care across diverse healthcare settings worldwide.
In this interview, the authors discuss the Regional Outreach Programme of the International Headache Society in Sub-Saharan Africa, highlighting how education, collaboration, and local partnerships are helping to strengthen headache care capacity and improve access to training and expertise across the region.
Key takeaway:
💬 "Sustainable healthcare starts with shared knowledge. Through strategic education initiatives and collaborative regional partnerships, we are equipping local healthcare communities in Sub-Saharan Africa to transform headache management from the ground up."
— Daniele Martinelli
🎥 Watch the author interview: www.youtube.com/watch?v=duMfC6pPO60
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251396915
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #headachemedicine #migraineresearch #subsaharanafrica #globalneurology #healthequity #medicaleducation -
International Headache Society
@ihs_official
Less than one year to go!
The countdown to IHC 2027 in Athens has begun!
From 9 to 11 September 2027, the global headache community will come together for three inspiring days of science, collaboration, and progress.
Save the date and join us in Athens 🇬🇷
#ihc2027 #internationalheadachecongress #headache #athens -
International Headache Society
@ihs_official
#throwbackthursday 🌎
One year ago today, IHC 2025 began in São Paulo, marking a historic milestone as the first International Headache Congress ever held in South America and bringing the global headache community together under the theme “Headache Care for All: Embracing the Challenge.”
What is your favourite memory from IHC 2025?
#ihc2025 #internationalheadachecongress #brazil -
International Headache Society
@ihs_official
Another fake email is circulating to IHS members, pretending to be from the IHS President, Mario Peres, asking for assistance with a board matter.
The Subject line is: IHS
From: Mario F P Peres <presidenntboard@gmail.com>
Please ignore this and do not click on any links or respond.
Remember: IHS will never ask you to send money on behalf of the society. Please always check the email address to ensure the email is valid.
Thank you -
International Headache Society
@ihs_official
New in Cephalalgia!
•
Photophobia during a migraine attack is not directly correlated with variations in retinal or cortical electrophysiological responses.
•
During a migraine attack, activity in photoreceptors sensitive to the short-wavelength light spectrum can vary.
•
During a migraine attack, photophobia is associated with increased phase (e.g., latency) of cortical responses, suggesting cortico-subcortical integration mechanisms involving thalamo-trigeminovascular convergence onto the sensory cortices.
journals.sagepub.com/doi/10.1177/03331024261476232
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional challenges, advances, and opportunities to improve migraine care.
In this interview, the authors discuss the current state of migraine care in Kuwait and the Gulf region, including progress made in recent years and the ongoing need for improved education, awareness, and evidence-based management.
Key takeaway:
💬 "Migraine care in Kuwait and the Gulf region has improved over the past years but still needs to be optimized. Primary care physicians need to be educated and migraine management guidelines are crucial."
— Jasem Al-Hashel
🎥 Watch the author interview: youtu.be/DLmi1IqJZ2M
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251374141
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #kuwait #gulfregion #healthequity -
International Headache Society
@ihs_official
New in Cephalalgia!
There are no data available on fremanezumab as a migraine preventive treatment in a Chinese population.
This Phase 3, double-blind trial with an open-label extension demonstrates the robust efficacy and safety of fremanezumab, compared with placebo, in Chinese adults living with migraine.
journals.sagepub.com/doi/10.1177/03331024261462833
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together high-quality articles from across the globe, exploring how migraine services are organised and delivered in different countries and regions, and highlighting opportunities to improve care worldwide.
In this interview, guest editor Francesca Puledda discusses the value of learning from diverse healthcare systems and sharing experiences across regions to better understand the challenges and strengths of migraine care globally.
Key takeaway:
💬 "The collection brings together contributions from around the world, exploring how migraine services are organised and delivered across different countries and regions. By highlighting local healthcare systems, barriers to care, health inequities, and different approaches, these conversations provide valuable insights into both the strengths and the challenges of migraine care worldwide."
— Francesca Puledda
🎥 Watch the interview: www.youtube.com/watch?v=RcbXYFbgxVA
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity #ihsheadache -
International Headache Society
@ihs_official
Burning Mouth Syndrome (BMS) is characterized by an intraoral burning or dysaesthetic sensation that occurs daily for more than 2 hours per day, for more than 3 months, without clinically evident causative lesions.
According to ICHD-3, BMS requires:
A 🔹Oral pain fulfilling criteria B and C
B 🔹Recurring daily for >2 hours/day for >3 months
C 🔹Pain has both of the following characteristics:
burning quality
felt superficially in the oral mucosa
D🔹Oral mucosa is of normal appearance and clinical examination, including sensory testing, is normal
E 🔹Not better accounted for by another ICHD-3 diagnosis.
The pain is usually bilateral, and the tip of the tongue is the most common site.
Other symptoms may include:
💧 Subjective dry mouth
👅 Dysaesthesia
🍽️ Altered taste
💬 Have you seen patients presenting with these symptoms in your practice? Share your clinical experience in the comments!
#ichd3matters #ichd3 #internationalheadachesociety #burningmouthsyndrome -
International Headache Society
@ihs_official
New in Cephalalgia!
Pediatric headache is a growing global public health challenge. This factsheet reveals that 60% of children and adolescents worldwide experience headaches, and migraine is already among the leading causes of disability.
doi.org/10.1177/03331024261463173
#migraine #headache #brain #pain #neurology #neuroscience
@deryauluduz -
International Headache Society
@ihs_official
New in Cephalalgia!
Cerebrospinal fluid (CSF) in 36 Visual Snow Syndrome (VSS) patients showed no meaningful differences vs matched controls. Routine lumbar puncture and autoimmun antibody screening may not be routinely indicated in patients with typical VSS and no clinical red flags.
journals.sagepub.com/doi/10.1177/03331024261469080
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). Through contributions from experts across different regions, the collection highlights how migraine care is shaped by local healthcare systems, resources, and cultural contexts, while identifying opportunities to improve care globally.
In this interview, guest editor Tesha Monteith discusses the importance of sharing regional experiences and fostering international collaboration to advance equitable migraine care worldwide.
Key takeaway:
💬 "Migraine is universal, but its care is shaped by regional realities. Sharing experiences across regions fosters collaboration and advances equitable migraine care worldwide."
— Tesha Monteith
🎥 Watch the interview: www.youtube.com/watch?v=vbItbLHEMS0
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity #ihsheadache -
International Headache Society
@ihs_official
📢 IHS Webinar | Digital home follow-up for headache
Join us on 10 September at 15:00 BST for our upcoming webinar:
💻 Digital home follow-up for headache – Battling an increasing demand
🎙️ Maria Bengtson Argren, MD
Digital home follow-up: structure and platform
🎙️ Bendik S. Winsvold, MD, PhD
Digital home follow-up: experiences and key take-aways
Our speakers will share practical insights into the structure, implementation, and experience of digital home follow-up for people with headache disorders, and discuss how digital solutions may help meet the increasing demand for headache care.
📅 10 September
🕒 15:00 BST
Registration link:
us02web.zoom.us/webinar/register/WN_HzkpbukhTb-IuYmOtxbhgA
#headache #digitalhealth #neurology #headachemedicine #webinar #ihs -
International Headache Society
@ihs_official
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). This collection brings together perspectives from around the globe to explore how migraine is understood, diagnosed, and treated across diverse healthcare systems, while highlighting opportunities to advance equitable care worldwide.
In this special interview, the guest editors discuss the vision behind the collection and why sharing experiences from different countries and regions is essential for improving migraine care globally.
Key takeaway:
💬 "Migraine Care Around the World is more than a collection of articles. It is a global portrait of how migraine is understood, treated, and too often neglected across different health systems and cultures. By bringing these realities together, we hope to make inequalities visible, share solutions, and inspire a more equitable future in which every person with migraine, wherever they live, has access to informed and effective care."
— Mario Peres
🎥 Watch the interview: www.youtube.com/watch?v=wvWtglAA6QM
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity -
International Headache Society
@ihs_official
📢 IHS Webinar | Digital home follow-up for headache
Join us on 10 September at 15:00 BST for our upcoming webinar:
💻 Digital home follow-up for headache – Battling an increasing demand
🎙️ Maria Bengtson Ågren, MD
Digital home follow-up: structure and platform
🎙️ Bendik S. Winsvold, MD, PhD
Digital home follow-up: experiences and key take-aways
Our speakers will share practical insights into the structure, implementation, and experience of digital home follow-up for people with headache disorders, and discuss how digital solutions may help meet the increasing demand for headache care.
📅 10 September
🕒 15:00 BST
Registration link:
us02web.zoom.us/webinar/register/WN_HzkpbukhTb-IuYmOtxbhgA
#headache #digitalhealth #neurology #headachemedicine #webinar #ihs -
International Headache Society
@ihs_official
New in Cephalalgia!
Cephalalgia Reports lets the headache community see the whole of its shared problem. What remains is to move from describing it to acting on it, so that where someone happens to live no longer decides whether their migraine is recognized.
journals.sagepub.com/doi/10.1177/03331024261474132
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Discover Migraine Care Around the World | Topical Collection & Author Interview Series
🌍 Migraine Care Around the World
How is migraine care delivered across different countries, healthcare systems, and cultures? What challenges remain, and what solutions are emerging to improve care for people living with migraine worldwide?
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). This collection brings together high-quality articles from experts across the globe, exploring regional perspectives on migraine care, health system challenges, inequalities in access, education, advocacy, and innovative approaches to improving patient outcomes.
To complement the collection, we have launched a series of exclusive author and guest editor interviews, providing insights from contributors representing:
📍 Caribbean
📍 Sub-Saharan Africa
📍 North Africa and the MENA region
📍 Eastern Europe
📍 India and Sri Lanka
📍 Kuwait and the Gulf Region
📍 Latin America
📍 Australia
These conversations highlight the realities of migraine care in different regions while sharing lessons that can help advance equitable and effective headache care worldwide.
🎥 Watch the interviews: ihs-headache.org/en/resources/cephalalgia/topical-collect…
📄 Explore the topical collection: journals.sagepub.com/topic/collections-rep/rep-1-migraine…
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #globalhealth #healthequity #medicaleducation #headachecare #ihsheadache #migraineadvocacy -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
📣 IHC 2027: See you in Athens!
The International Headache Congress will take place in Athens, Greece, from 9–11 September 2027.
Register your interest to stay up to date with the latest information on registration, programme details, abstract submissions, speaker announcements, and other congress news.
We look forward to welcoming the global headache community to Athens in 2027! 👉
ihc2027.org
#ihc2027 #internationalheadachecongress #internationalheadachesociety #headache #migraine #athens -
International Headache Society
@ihs_official
We are pleased to announce the IHS 2026 Fellowship recipients.
Kadir Oğuzhan Soylu (Türkiye) will conduct his research at Leiden University Medical Center, the Netherlands, in collaboration with Else Tolner and Arn van den Maagdenberg.
Rune Häckert Christensen (Denmark) will be hosted by Beth Israel Deaconess Medical Center, Boston, USA, with Rami Burstein as his research mentor.
We look forward to seeing how their work advances our understanding of migraine and headache mechanisms. Congratulations to both researchers! 👏
To learn more, please go to: ihs-headache.org/en/news/ihs-fellowship-2026-meet-the-rec… -
International Headache Society
@ihs_official
Headache care has no borders. Neither should collaboration. 🌍
The African Headache Network (AHEAD) connects healthcare professionals across Africa to strengthen understanding of headache disorders, support research and education, and advocate for equitable access to headache treatment across the continent.
Interested in joining?
Membership is open to healthcare professionals working in Africa with a special interest in headache, and applications are available in English, French and Portuguese.
💡 Many healthcare professionals across Africa may also be eligible for free or discounted IHS membership.
🔗 Discover AHEAD and become part of this growing headache community:
ihs-headache.org/en/about-ihs/affiliate-member-societies/…
#ihs #headache #ahead #africanheadachenetwork #globalhealth #healthequity -
International Headache Society
@ihs_official
Missed it live? You can now watch the full webinar on demand 🎥
Based on the recently published IHS Child and Adolescent Committee position paper in Cephalalgia, this webinar explores how we can support a smoother, more effective transition from paediatric to adult headache care.
Hosted by Committee Chair Andrew Hershey, with presentations from:
• Vincenzo Guidetti – Migraine: One disease from youth to adult
• Ishaq Abu-Arafeh – Preparation and timing of the transition
• Juliana Vanderpluym – Receiving patients and continuity of care
• Jacques Bruijn – Possibilities for improvement through digital innovation
You can find this and other IHS webinars in the IHS Learning Centre:
ihs-headache.org/en/learning-centre/resources/categories/…
Or watch on the IHS YouTube channel:
youtu.be/lSTKeYbhLgM
#ihs #headache #paediatricheadache #headacheeducation #learnwithihs -
International Headache Society
@ihs_official
Do you know that ICHD 3 also includes Neck-tongue syndrome?
It is characterised by sudden, unilateral sharp or stabbing pain in the upper neck and/or occipital region, precipitated by sudden turning of the neck and accompanied by abnormal sensation and/or posture of the ipsilateral tongue.
Attacks are brief, lasting from seconds to several minutes, and may occur with or without simultaneous dysaesthesia.
Sometimes the most unexpected symptom is the most useful diagnostic clue! 🧠👅
#ichd3matters #ihs #headache #learnwithihs #notjustaheadache -
International Headache Society
@ihs_official
🧠 IHS Psychology SIG – 3rd Open Meeting
Join us for updates on current projects, future initiatives, and opportunities to get involved.
📅 20 August | 18:30 CEST
💻 Online via Microsoft Teams
👉 To learn more, please go to:
ihs-headache.org/en/news/ihs-psychology-sig-3rd-open-meet…
Everyone interested in the psychological aspects of headache is welcome!
#ihs #headache #psychology -
International Headache Society
@ihs_official
New in Cephalalgia!
In a study by Petersen et al., preventive treatment patterns in cluster headache were explored. Treatment was limited by insufficient efficacy and tolerability, but verapamil was effective long term in intial responders.
journals.sagepub.com/doi/10.1177/03331024261456265
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Cervical strengthening and stabilization may be a helpful adjunct for select patients with migraine, especially those with neck pain. Evidence is promising, but stronger trials are needed to clarify dosing, safety, and ideal candidates
journals.sagepub.com/doi/10.1177/03331024261471179
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study suggests a potential mismatch between perceived urgency and actual risk, highlighting the need to consider sex-specific factors in emergency headache care.
journals.sagepub.com/doi/10.1177/03331024261462493
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The authors thank Suga et al. for their constructive comments, support expanding BMS criteria to include dysaesthetic pain, and clarify that ODPD is a complementary phenotyping framework to improve classification, research, and patient care.
journals.sagepub.com/doi/10.1177/03331024261470425
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study reveals significant alterations in the periaqueductal grey matter in chronic migraine patients compared to controls, highlighting its potential as a reliable ultrasound marker.
journals.sagepub.com/doi/10.1177/03331024261467732
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
New study investigates endocannabinoids in migraine and reveals a significant link between CSF levels of the endocannabinoid 2-AG and depression, offering new insights into the neurochemical basis of comorbid migraine and depression.
journals.sagepub.com/doi/10.1177/03331024261451250
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Save the date | II Einstein International Symposium on Headaches
The International Headache Society is pleased to share the upcoming II Einstein International Symposium on Headaches, taking place on 18–19 September 2026.
Organised by Einstein Hospital Israelita, the symposium will bring together clinicians, researchers and healthcare professionals with an interest in headache and migraine medicine for two days dedicated to education, scientific exchange and advances in the field.
📅 18–19 September 2026
🔗 Programme, further information and registration:
ensino.einstein.br/evento_simposio_cefaleias_p5459/p
Follow @faculdadeeinstein for updates.
#headache #migraine #headachemedicine #neurology #headacheresearch #medicaleducation #internationalheadachesociety #ihs -
International Headache Society
@ihs_official
New in Cephalalgia!
The triglyceride-glucose (TyG) index was associated with 50% response status after adjustment.
•
The TG/HDL-C ratio, TyG-BMI, and metabolic score for IR (METS-IR) were not significant in the final adjusted model.
•
Further validation is needed to assess the prognostic relevance of these indices in MOH.
journals.sagepub.com/doi/10.1177/03331024261464213
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This letter discusses that diagnostic criteria for burning mouth syndrome should balance accuracy with clinical inclusiveness. Also, the authors caution against making bilaterality and a ≥6-hour daily duration mandatory without broader external validation.
journals.sagepub.com/doi/10.1177/03331024261467715
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz
The answer for sunday quiz is: Epicrania fugax
It is a rare primary headache disorder according to the #ichd-3 described as brief paroxysmal head pain, with stabbing quality, describing a linear or zig-zag trajectory across the surface of one hemicranium commencing and terminating in the distributions of different nerves, lasting 1-10 seconds.
To read more data about this type of headache: ichd-3.org/appendix/a4-other-primary-headache-disorders/a… #ihs #ichd-3 -
International Headache Society
@ihs_official
New in Cephalalgia!
CGRP monoclonal antibodies were associated with improvement in HIT-6 scores in adolescents with migraine.
•
Early clinically meaningful improvement was observed within about 3 months.
•
CGRP mAbs in adolescents with migraine may support participation in school and social activities during adolescence.
journals.sagepub.com/doi/10.1177/03331024261461634
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In vivo confocal microscopy reveals progressive corneal nerve degeneration and neuroinflammation in trigeminal neuralgia, highlighting its potential as a non-invasive biomarker for disease severity and progression.
journals.sagepub.com/doi/10.1177/03331024261466134
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz
A very brief pain across the scalp in a zigzag pattern in one hemicranium, lasting only 1 to 10 seconds! What type of headache do you think this patient is experiencing? 🤔
A. Epicrania fugax
B. Nummular headache
C. SUNCT
D. Primary cough headache
#ihs #headache # Awareness #education -
International Headache Society
@ihs_official
New in Cephalalgia!
Evidence suggests that candesartan should have a stronger place in migraine prevention. Its success highlights the need for regular guideline updates, standardized trial outcomes, and deeper research into repurposed treatments.
journals.sagepub.com/doi/10.1177/03331024261471180
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine is associated with significantly reduced thalamic glutathione (GSH) levels, resulting in decreased GSH/glutamate (Glu) ratios that indicate diminished antioxidant buffering capacity.
•
This metabolic alteration is present in both migraine with and without aura but not in tension-type headache, supporting distinct pathophysiological mechanisms.
•
Tissue-corrected thalamic metabolic profiling may help clarify migraine vulnerability and guide therapeutic strategies targeting oxidative stress.
journals.sagepub.com/doi/10.1177/03331024261462792
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
•
Migraine in children causes significant disability, yet preventive drug efficacy and safety remain a matter of debate.
•
Meta-analysis of 40 studies (2742 patients) found that 30% experienced adverse effects, mainly drowsiness, anorexia, fatigue and paraesthesia.
•
Safety data is crucial for clinicians to weigh risk/benefit, given the low efficacy of current prophylactic treatments.
journals.sagepub.com/doi/10.1177/03331024261441586
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Now available in Cephalalgia! 🧠
The abstracts from the 2026 China Headache Congress (Xi'an, China, 15–17 May 2026) have now been published in Cephalalgia.
Congratulations to all authors and presenters on their contributions to advancing headache research.
Read the published abstracts and stay up to date with the latest developments in the field.
journals.sagepub.com/doi/10.1177/03331024261461082
#cephalalgia #chinaheadachecongress #headacheresearch #migraine #neurology #headachemedicine #medicalresearch #ihs -
International Headache Society
@ihs_official
Have you heard about Visual Snow Syndrome?🤓
Looking back at one of the fascinating topics discussed at the International Headache congress 2025 in São Paulo- Brazil—Visual Snow Syndrome by Dr Francesca Puledda.
#throwbackthursday #visualsnowsyndrome #ihs #ihc -
International Headache Society
@ihs_official
⚠️ Fraudulent Email Alert
Another fake email is circulating among IHS members, falsely claiming to be from IHS President Mario Peres and requesting assistance with a board matter.
Subject: IHS
Sender: presidentboardforumassociation@gmail.com
Please ignore this email. Do not reply, click any links, or provide personal or financial information. -
International Headache Society
@ihs_official
Can a headache last only seconds… yet be excruciating?
Some attacks strike suddenly, last just 1–600 seconds, recur many times a day, and are accompanied by striking autonomic symptoms such as:
💧 Tearing
🔴 Red eye
👃 Nasal congestion or runny nose
👁️ Drooping eyelid or a small pupil
These are the hallmark features of Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA)—a rare but highly disabling group of trigeminal autonomic cephalalgias that is often misdiagnosed.
According to ICHD-3 Classification 3.3.1 Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) are attacks of moderate or severe, strictly unilateral head pain lasting seconds to minutes, occurring at least once a day and usually associated with prominent lacrimation and redness of the ipsilateral eye.ichd-3.org/3-trigeminal-autonomic-cephalalgias/3-3-short-…
Have you encountered a patient with attacks like these?
#ichd3matters #sunha #sunct #suna #trigeminalautonomiccephalalgias #neurology #headachemedicine #internationalheadachesociety #ihs -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Seung Ae Kim
👩🏫 Mentor: Teshamae Monteith
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Seung Ae will work closely with Teshamae, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Seung Ae and thanking Teshamae for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study” which has been selected as the Editor’s Choice for the July issue of Cephalalgia.
..................................
Article highlights
•
Machine learning models can predict treatment response to migraine preventives with modest accuracy.
•
Inclusion of genotype data in the models did not improve performance, however, this could be a result of the low sample size.
•
Predictions of triptan retention were unreliable.
journals.sagepub.com/doi/10.1177/03331024261467723
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This new study uses machine learning to predict individual responses to migraine drugs. Clinical data provided modest accuracy, while genetic data contributed little. Hormones, lipids and blood pressure look most informative.
journals.sagepub.com/doi/10.1177/03331024261467723
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
First real-world study of rimegepant as preventive treatment (n=150), including prior anti-CGRP mAb exposure. Effective at 3 months, well tolerated, and associated with improved mood symptoms, even in highly treatment-resistant patients
journals.sagepub.com/doi/10.1177/03331024261462836
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Nevra Öksüz Gürlen
👨🏫 Mentor: Andrew Hershey
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Nevra will work closely with Andrew, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Nevra and thanking Andrew for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Seventy-six Special Interest Group-registered physiotherapists practicing as headache experts in 24 countries, provided insights into their approaches for cervicogenic headaches, migraine, tension-type headaches and temporomandibular disorders.
•
Regardless of headache type, education, manual therapy and exercise were used. There was little distinction reported regarding the approaches for the different headache types.
•
Self-referral was the most common pathway into physiotherapy.
journals.sagepub.com/doi/10.1177/25158163261469090
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study looked at treatments used for new daily persistent headache in youth, finding that earlier treatment may improve outcomes, and transitional therapies benefit most patients but should be followed with preventive therapies.
journals.sagepub.com/doi/10.1177/03331024261426562
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Yan Zhou
👨🏫 Mentor: Gianluca Coppola
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Yan will work closely with Gianluca, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Yan and thanking Gianluca for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
•
Therapeutic patient education (TPE) is a structured programme empowering migraine patients toward self-management and behavioural change.
•
Evidence shows TPE with standard treatments outperforms standard treatments alone, with in-person group sessions proving superior to digital or written formats.
•
Effective delivery of TPE does not require headache experts; trained nurses, medical students and lay migraineurs can successfully facilitate it.
journals.sagepub.com/doi/10.1177/25158163261467653
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🚨 We’re looking for new Associate Editors!
Cephalalgia Reports, the official open-access journal of the International Headache Society (IHS), is inviting applications for Associate Editors to join its international Editorial Board.
This is an exciting opportunity to:
🧠 Help shape the future of headache and facial pain research
📚 Contribute to a rigorous and constructive peer-review process
🌍 Join a diverse, international editorial team
🤝 Work alongside leading researchers and clinicians from around the world
We particularly encourage applications from colleagues representing diverse geographical regions, disciplines, career stages, and backgrounds, reflecting the global headache community.
📅 Application deadline: 23 August 2026
🔗 Read the full call and application details here:
ihs-headache.org/en/news/call-f…
Please help us spread the word by sharing this opportunity with colleagues who may be interested.
#cephalalgiareports #internationalheadachesociety #headacheresearch #neurology #academicpublishing #peerreview #openaccess #research #editorialboard #facialpainThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in Cephalalgia!
This Letter discusses how chronic idiopathic oral symptoms should be classified in future headache and orofacial pain taxonomies. It supports the proposal of oral dysaesthetic and perceptual disorder as a useful descriptive framework
journals.sagepub.com/doi/10.1177/03331024261464166
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Migraine affects approximately 9.3% of Latin Americans
•
Migraine remains underdiagnosed and undertreated across Latin America.
•
Specialist care is concentrated in urban areas, with rural waits up to five years.
•
Triptan and anti-CGRP access is limited mainly to the private sector in most countries.
•
Medical schools offer only 2–4 h of headache education on average.
•
Regional telemedicine and unified advocacy could bridge major care gaps.
journals.sagepub.com/doi/10.1177/25158163261456215
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Sophie M. Yener
👨🏫 Mentor: Erling Tronvik
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Sophie will work closely with Erling, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Sophie and thanking Erling for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Mohamed I. Mohamed
👩🏫 Mentor: Simona Sacco
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Mohamed will work closely with Simona, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Mohamed and thanking Simona for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Merve Ceren Akgör
👩🏫 Mentor: Francesca Puledda
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Merve Ceren will work closely with Francesca, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Merve Ceren and thanking Francesca for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Carlo Piero Lastarria Pérez
👩🏫 Mentor: Mi Ji Lee
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Carlo Piero will work closely with Mi Ji, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Carlo Piero and thanking Mi Ji for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
📚 Looking for reliable, evidence-based resources on headache disorders?
Whether you're a clinician, researcher, student, or simply interested in headache medicine, the International Headache Society (IHS) offers a wealth of freely available resources to support learning and clinical practice.
🔹 ICHD-3 - The international standard for classifying headache disorders
🔹 Clinical guidelines - Evidence-based recommendations for diagnosis, treatment, and clinical trials
🔹 Awareness campaigns - Educational materials on migraine, tension-type headache, cluster headache, medication-overuse headache, and more
🔹 Educational content - Webinars, podcasts, videos, and interviews with leading headache experts
🔹 Research opportunities - Information on grants, fellowships, and training programmes for early-career researchers and clinicians
Whether you're refreshing your knowledge, looking up a rare headache disorder, or searching for the latest international guidelines, the IHS Resources page is an excellent place to start.
Explore the resources here:
ihs-headache.org/en/resources/ -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Stefano Di Antonio
👨🏫 Mentor: Sait Ashina
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Stefano will work closely with Sait, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Stefano and thanking Sait for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Lukasz Kolakowski
👨🏫 Mentor: Kuan-Po Peng
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Lukasz will work closely with Kuan-Po, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Lukasz and thanking Kuan-Po for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
🧠 22 July is World Brain Day
Headache disorders, particularly migraine, remain a major global health challenge. Together, migraine and tension-type headache affect approximately 2.9 billion people worldwide, representing 34.6% of the global population.
This immense burden underscores the urgent need to raise awareness, strengthen prevention, and promote equitable access to effective treatment and care.
This World Brain Day, we highlight the 2026 theme:
“Brain Health: Access for All.”
#worldbrainday #brainhealth #accessforall #headache #migraine #internationalheadachesociety -
International Headache Society
@ihs_official
☀️🌊 Summer means travel and for many, that also means exploring the underwater world. But did you know that diving can trigger a specific type of headache recognized in the International Classification of Headache Disorders (ICHD-3)?
🤿 Diving headache typically:
- Occurs during dives deeper than 10 metres
- Often becomes more intense during ascent or after resurfacing
- Is usually linked to carbon dioxide (CO₂) build-up rather than decompression illness
- May be accompanied by light-headedness, confusion, shortness of breath, flushing, or poor coordination
Why does it happen?
One important cause is hypercapnia (elevated CO₂ levels). This can occur if a diver unintentionally breathes too shallowly, holds their breath intermittently ("skip breathing"), or doesn't ventilate adequately during strenuous swimming. Elevated CO₂ can cause increased intercranial pressure and blood vessels in the brain to dilate, which can lead to headache.
Enjoy your summer adventures - and dive safely! 🌴🐠
ichd-3.org/10-headache-attributed-to-disorder-of-homoeost… -
International Headache Society
@ihs_official
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce one of our mentor–mentee pairs for the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Chisato Iba
👩🏫 Mentor: Patricia Pozo-Rosich
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Chisato will work closely with Patricia, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Chisato and thanking Patricia for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
International Headache Society
@ihs_official
We are delighted to announce the outstanding mentors who will guide the "Cephalalgia Reviewer Academy" for the 2026–2027 course year.
Our mentors are internationally recognised experts in headache research and peer review, generously volunteering their time, experience, and expertise to support the next generation of reviewers.
Through structured mentorship, supervised peer-review practice, and personalised feedback, they will play a pivotal role in helping our Fellows develop the skills required to become confident, high-quality peer reviewers.
We sincerely thank our mentors for their commitment to fostering excellence in scientific publishing and strengthening the future of headache research.
Please join us in welcoming our 2026–2027 Cephalalgia Reviewer Academy mentors!
#cephalalgia #cephalalgiareports #peerreview #mentorship #headacheresearch #scientificpublishing #researchintegrity #academicmedicine #medicaleducation #neurology -
International Headache Society
@ihs_official
📅 Save the Date: IHC 2027 in Athens!
The International Headache Congress will take place in Athens, Greece, from 9–11 September 2027. Register your interest to receive the latest updates on registration, programme details, abstract submissions, speaker announcements and other congress news.
Register your interest today and join us in Athens 👉
ihc2027.org
#ihc2027 #internationalheadachecongress #internationalheadachesociety #headache #migraine #athens -
International Headache Society
@ihs_official
#throwbackthursday
Do you remember the first IHS/EHF Headache Research Academy in Baku, Azerbaijan?
Share your favourite memories and the key lessons you took away from the Academy!
#ihs #azerbaijan #baku #research -
International Headache Society
@ihs_official
📢 Welcoming our new Associate Editor!
We are delighted to welcome Prof. Zheman Xiao as the newest Associate Editor for Cephalalgia and Cephalalgia Reports.
Prof. Zheman Xiao's expertise and contributions to headache medicine will be a valuable addition to our editorial team. We look forward to working together to advance high-quality research and support the global headache community.
Please join us in welcoming Prof. Zheman Xiao to the editorial board.
#cephalalgia #cephalalgiareports #headacheresearch #migraineresearch #neurology #scientificpublishing #headachemedicine
@Simona_Sacco_ -
International Headache Society
@ihs_official
We are excited to share the news that we have selected eleven new Fellows for the Cephalalgia Reviewer Academy for the 2026-2027 course year.
The Cephalalgia Reviewer Academy is a unique, structured, and mentored training programme hosted by Cephalalgia and Cephalalgia Reports. It is specifically designed to support and develop the next generation of expert peer reviewers in headache research.
The program provides our Fellows with:
- Structured peer-review training
- One-on-one mentorship and supervised practice
- Formal certification upon completion
We are looking forward to working with this talented group as they contribute to the future of headache research excellence.
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin” which has been selected as the Editor’s Choice for the June issue of Cephalalgia.
..................................
Effective migraine treatment, with monoclonal antibodies or botulinum toxin, improves performance in some cognitive tasks
journals.sagepub.com/doi/10.1177/03331024261458424
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎓 Join IHS's upcoming webinar: Transition of Headache Care from Childhood to Adulthood
Based on the recently published IHS Child and Adolescent Committee position paper in Cephalalgia, this webinar will be hosted by Committee Chair Andrew Hershey.
Presentations:
👉 Vincenzo Guidetti – Migraine: One disease from youth to adult
👉 Ishaq Abu-Arafeh – Preparation and timing of the transition
👉 Juliana VanderPluym – Receiving patients and continuity of care
👉 Jacques Bruijn – Possibilities for improvement through digital innovation
📅 Thursday 30 July
🕖 19:00 BST | 20:00 CEST | 14:00 EST
📝 Find out more and register via the IHS Learning Centre:
ihs-headache.org/en/learning-centre/resources/categories/…
#headachemedicine #migraine #headache -
International Headache Society
@ihs_official
🎥 Expand your knowledge with our latest IHS webinar, now available on demand.
Learn from international experts as they discuss the latest evidence on headache management during pregnancy and lactation.
Programme:
👉 Welcome and introductions – Marcio Nattan (IHS Education Committee Co-Chair) & Francesca Puledda
👉 Acute treatment of headache in pregnancy – Shazia Afridi (UK)
👉 Prophylactic treatment of primary headaches in pregnancy and lactation – Anne MacGregor (UK)
Whether you're caring for women during pregnancy, planning treatment, or looking to update your clinical knowledge, this webinar provides practical, evidence-based insights from international experts.
🎓 Watch the webinar now on the IHS Learning Centre:
ihs-headache.org/en/learning-centre/resources/ihs-webinar…
#headachemedicine #pregnancy #lactation -
International Headache Society
@ihs_official
🎥 Missed our latest IHS webinars? You can now watch them on demand!
Catch up on the latest advances in cluster headache with this expert-led IHS webinar, now available on the IHS Learning Centre Webinar Page.
Programme:
👉 Welcome and introductions – Mona Nada & Mario Peres (IHS President)
👉 Updates in the pathogenesis of cluster headache – Rolf Fronczek (Netherlands)
👉 Preventive treatment updates – Nunu Lund (Sweden)
👉 Acute treatment updates – Mark Burish (USA)
👉 The potential role of gepants as a preventive treatment for cluster headache – Soo-Jin Cho (Korea)
Don't miss this opportunity to hear from international experts discussing the latest developments in the understanding and management of cluster headache.
🎓 Watch the webinar now on the IHS Learning Centre:
ihs-headache.org/en/learning-centre/resources/ihs-webinar…
#ihsheadache #clusterheadache #webinar -
International Headache Society
@ihs_official
🍷 Did you know that ICHD-3 includes diagnostic criteria for immediate alcohol-induced headache?
According to ICHD-3, this type of headache develops within 3 hours of alcohol intake and resolves within 72 hours after alcohol consumption has ceased.
Typical features may include at least one of the following:
• Bilateral pain
• Pulsating quality
• Worsening with physical activity
To learn more, please go to: ichd-3.org/8-headache-attributed-to-a-substance-or-its-wi…
#ihs #ichd3matters #headacheeducation #migraine #headachemedicine -
International Headache Society
@ihs_official
✨ Reflecting on a massive milestone in São Paulo! 🇧🇷
Looking back at this incredible group photo from the 10th International Headache Academy (iHEAD), held right before the 22nd International Headache Congress! 🧠💡
This landmark event brought
107 delegates from 45 countries to South America for an intensive 2-day course, where 16 leading headache specialists inspired them.
🎓 A major thank-you to our iHEAD Chair, Professor Patricia Pozo-Rosich, for developing such an impactful educational agenda!
🏥 A huge thank you to the Albert Einstein Hospital for hosting us, to Mario Peres for arranging the venue, and to Marcio Nattan for his invaluable local support!
Over the past decade, iHEAD has proudly educated nearly 550 young clinicians and researchers from 69 countries.
Thank you to everyone for shaping the future of global headache care! 🌍
👇 Tag yourself or a colleague if you spot them in the crowd!
#ihs #ihead2025 #headachemedicine #medicaleducation -
International Headache Society
@ihs_official
🏛️ Save the Date for IHC 2027 in Athens, Greece! 🏛️
We are thrilled to officially invite you to the International Headache Congress, taking place from 9–11 September 2027 in one of the world’s most historic cities.
Under the banner of "Science that Inspires, Care that Transforms, Policy that Impacts," #ihc2027 will bring together global leaders to advance the future of headache medicine across our five core pillars:
🔬 Science
💡 Innovation
🏥 Clinical Practice
🎓 Education
🌍 Global Advocacy
✨ Be part of the conversation that shapes the future of patient care. Register your interest today to receive official updates, abstract deadlines, and registration alerts. ihc2027.org #ihc2027 #headacheresearch #savethedate #athens2027 -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
🩸 For this week's #ichd3matters spotlight, we look at the Appendix of the ICHD-3 to highlight a highly specific, hormone-driven condition:
Pure Menstrual Migraine without Aura.
Many women experience migraines throughout their life course—from adolescence into adulthood—but for those with this specific diagnosis, attacks are strictly synchronized with the hormonal shifts of the menstrual cycle.
📋 Attacks fulfill the criteria for 1.1 Migraine without aura.
Occurring exclusively on day 1 ± 2 (ie, days −2 to +3) of menstruation in at least two out of three menstrual cycles and at no other times of the cycle
This strict pattern is present in at least two out of three menstrual cycles, with absolutely no attacks occurring at any other time of the cycle.
#ichd3matters #ihs #learnwithihs #menstrualmigraine #womenshealth -
International Headache Society
@ihs_official
For #migraineawarenessmonth, we are pleased to share this video from Dr. Yi Liu, Tri-Service General Hospital, Taiwan.
In this video, Dr. Liu introduces recent advances in CGRP-targeted therapies for migraine, including monoclonal antibodies and gepants, and explains their mechanisms of action and potential impact on patients with migraine.
#migraineawareness #migraine #cgrp #treatmentThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in @JCephalalgia! @IHSHeadache "A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US"
journals.sagepub.com/doi/10.1177/03331024261447187 -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Vitamin D deficiency is independently associated with migraine chronification and increased musculoskeletal tenderness, suggesting a potential musculoskeletal–sensitization contribution to migraine progression.
journals.sagepub.com/doi/10.1177/25158163261456250
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Answer to Sunday Quiz for #migraineawarenessmonth 🧠
According to ICHD-3, “episodic syndromes that may be associated with migraine” include cyclical vomiting syndrome, abdominal migraine, benign paroxysmal vertigo, and benign paroxysmal torticollis.
However, benign paroxysmal positional vertigo (BPPV) is not included in this category.
Correct answer: C
#migraine #headache #sundayquiz #ichd3matters -
International Headache Society
@ihs_official
We are pleased to share an Arabic-language video for Migraine Awareness Month 2026, recorded by Professor Mona Nada, consultant neurologist and professor of neurology at Cairo University.
#migraineawarenessmonth #migraineawareness #ihs #headachemedicine -
International Headache Society
@ihs_official
Sunday Quiz for #migraineawarenessmonth
According to ICHD-3, which of the following is NOT included as an “episodic syndrome that may be associated with migraine”?
A. Cyclical vomiting syndrome
B. Benign paroxysmal vertigo
C. Benign paroxysmal positional vertigo
D. Benign paroxysmal torticollis
#migraine #headache #sundayquiz -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The real-world INFUSE study is evaluating the effectiveness of IV eptinezumab for the preventive treatment of migraine in participants in whom ≥1 CGRP-targeted preventive therapy had previously failed
•
Switching to eptinezumab treatment was associated with reduced migraine burden and improvements in multiple participant-reported migraine outcomes, including headache frequency, disability, disease status, and brain fog, despite substantial baseline disease burden.
journals.sagepub.com/doi/10.1177/25158163261455673
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In this 11-country MENA study (n = 2904 students), 78.6% reported headache during or after screen exposure.
•
Screen use ≥7 h/day and continuous use >2 h without breaks independently increased headache odds.
•
Caffeine, poor hydration, variable sleep, and high stress were significantly associated with screen-related headache.
•
Female sex and family migraine history increased reporting likelihood.
•
Findings suggest modifiable behavioral and ergonomic targets for prevention in academic settings.
journals.sagepub.com/doi/10.1177/25158163261453877
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
For #migraineawarenessmonth, we are pleased to share this fantastic video message from Professor Aynur Özge.
Migraine is more than “just a headache.” Greater awareness, understanding, and education are essential to improving care and reducing the burden for people living with migraine worldwide.
@ozge.aynur @IHS_Official
#migraine #migraineawareness #migraineawarenessmonth #headachemedicine -
International Headache Society
@ihs_official
New in Cephalalgia!
Misdiagnosis is common in migraine—28% were wrongly diagnosed with conditions like sinusitis or cervical issues. Resistant/refractory cases had more testing, but not more misdiagnoses. Timely and accurate diagnosis is needed.
journals.sagepub.com/doi/10.1177/03331024261443712
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study is the first to test the diagnostic performance of the most commonly used diagnostic criteria for Burning mouth syndrome and provides the first data-driven set of diagnostic criteria for the condition.
journals.sagepub.com/doi/10.1177/03331024261455835
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are delighted to announce that Cephalalgia’s impact factor has increased to 5.8.
The journal has remained in Q1 for decades and continues to rank strongly at 29 out of 296 in Clinical Neurology and 55 out of 330 in Neuroscience.
This milestone reflects the dedication of our authors, reviewers, and editorial community. Thank you to everyone contributing to the ongoing success of the journal.
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Happening tomorrow!
Cluster headache remains one of the most disabling and under-recognised neurological disorders, yet research in the field is advancing rapidly.
Join the upcoming International Headache Society (IHS) Cluster Headache Webinar: Updates in Cluster Headache, featuring experts from the IHS Cluster Headache Special Interest Group discussing the latest developments in:
🔹 Pathogenesis of cluster headache
🔹 Preventive treatment updates
🔹 Acute treatment advances
🔹 The emerging role of gepants as a potential preventive option
A fantastic opportunity for clinicians, researchers, trainees, and anyone interested in headache medicine to hear from leading international experts and engage in discussion during the live Q&A session.
📅 Thursday 18 June
🕐 13:00 BST | 14:00 CEST | 08:00 EST
Speakers:
• Dr Mona Nada (Chair)
• Dr Rolf Fronczek
• Dr Nunu Lund
• Dr Mark Burish
• Dr Soo-Jin Cho
Looking forward to an exciting discussion on the future of cluster headache research and care.
Link to register:
ihs-headache.org/en/learning-centre/resources/categories/…
#clusterheadache #headachemedicine #neurology #headacheresearch #ihsheadache #migraineandheadache #clinicalresearch #neurologyeducation -
International Headache Society
@ihs_official
New in Cephalalgia!
A ≥50% reduction in monthly migraine days (MMDs) does not always reflect meaningful clinical benefit, as most patients who met this threshold did not achieve IHS-aspired optimal migraine control with <4 MMDs.
journals.sagepub.com/doi/10.1177/03331024261456247
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Severity of dependence on analgesics in patients with medication-overuse headache (MOH) is strongly associated with headache burden, nicotine dependence, psychological distress, and addiction-related personality traits.
journals.sagepub.com/doi/10.1177/03331024261453544
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Specific subgroups of individuals with migraine may respond better to biofeedback (i.e., improvements in Migraine-Specific Quality of Life Role Function Restrictive (MSQv2.1-RFR)) based on baseline characteristics (i.e.,mindfulness traits and interest in physical exercise).
journals.sagepub.com/doi/10.1177/03331024261441579
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In real-world practice, CGRP monoclonal antibodies substantially reduce migraine frequency, but achieving optimal migraine control remains challenging, particularly in patients with higher baseline migraine burden.
journals.sagepub.com/doi/10.1177/03331024261453284
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Omega-3 supplements reduce migraine frequency and disability in adults. Optimal effects occur with moderate doses (≈2–2.5 g/day) in episodic migraine, while structured diet in chronic migraine.
journals.sagepub.com/doi/10.1177/25158163261454627
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This systematic review and meta-analysis provide robust evidence on the effect of angiotensin II receptor blockers (ARBs), particularly candesartan, in the prevention of episodic migraine, supporting the rationale for reconsidering its position in international guidelines.
journals.sagepub.com/doi/10.1177/03331024261451481
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
International Headache Society
@ihs_official
📢 Welcoming our new Associate Editor!
We are delighted to welcome Prof. Zhao Dong as the newest Associate Editor for *Cephalalgia* and *Cephalalgia Reports*.
Prof. Dong's expertise and contributions to headache medicine will be a valuable addition to our editorial team. We look forward to working together to advance high-quality research and support the global headache community.
Please join us in welcoming Prof. Dong to the editorial board.
#cephalalgia #cephalalgiareports #headacheresearch #migraineresearch #neurology #scientificpublishing #headachemedicine -
International Headache Society
@ihs_official
Cluster headache remains one of the most disabling and under-recognised neurological disorders, yet research in the field is advancing rapidly.
Join the upcoming International Headache Society (IHS) Cluster Headache Webinar: **Updates in Cluster Headache**, featuring experts from the IHS Cluster Headache Special Interest Group discussing the latest developments in:
🔹 Pathogenesis of cluster headache
🔹 Preventive treatment updates
🔹 Acute treatment advances
🔹 The emerging role of gepants as a potential preventive option
A fantastic opportunity for clinicians, researchers, trainees, and anyone interested in headache medicine to hear from leading international experts and engage in discussion during the live Q&A session.
📅 Thursday 18 June
🕐 13:00 BST | 14:00 CEST | 08:00 EST
Speakers:
• Dr Mona Nada (Chair)
• Dr Rolf Fronczek
• Dr Nunu Lund
• Dr Mark Burish
• Dr Soo-Jin Cho
Looking forward to an exciting discussion on the future of cluster headache research and care.
Link to register:
ihs-headache.org/en/learning-centre/resources/categories/…
#clusterheadache #headachemedicine #neurology #headacheresearch #ihsheadache #migraineandheadache #clinicalresearch #neurologyeducation -
International Headache Society reposted
Cephalalgia
@JCephalalgia
A message from Prof. Simona Sacco, Editor-in-Chief of Cephalalgia and Cephalalgia Reports, for Migraine Awareness Month.
It is time for action.
#migraineawareness #migraine #headachedisorders #cephalalgia #migraineresearchThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
International Headache Society
@ihs_official
#migraine Awareness Month #inspirational Interview with Spectacular @HeadacheMD Dr. Tesha Monteith @JCephalalgia @IHS_Official @NinaRiggins
www.veed.io/view/f0e9ec79-a5c8-4483-a5ef-1653699a6e38?sou… -
International Headache Society
@ihs_official
Answer to #sundayquiz
E. All of the above
Remember, invisible does not mean imaginary.
Let’s help everyone understand migraine better this #migraineawarenessmonth -
International Headache Society
@ihs_official
Which of the following everyday comments shows why migraine needs greater awareness?
A. Migraine is just stress, push through it
B. Take painkillers and move on
C. Everyone gets headaches, it is all in your head
D. You should be used to it by now
E. All of the above -
International Headache Society
@ihs_official
New in Cephalalgia!
Conceptual perspective proposing the Oral Dysaesthetic and Perceptual Disorder (ODPD) construct to better capture the broader spectrum of chronic idiopathic oral dysaesthetic conditions beyond burning-centered diagnostic frameworks.
journals.sagepub.com/doi/10.1177/03331024261452682
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study reports 48-month real-world eptinezumab outcomes in a highly refractory cohort.
•
Multiple exposure-defined cohorts (all-initiator, on-treatment, continuation, discontinuation) were used to address the complexity of long-term real-world treatment trajectories.
•
Symptom improvement was modest and most apparent among patients who remained on eptinezumab, while overall treatment persistence declined over time.
•
Post-discontinuation pathways were heterogeneous, with frequent switching and re-engagement with anti-CGRP therapy, reflecting iterative preventive management in chronic migraine.
journals.sagepub.com/doi/10.1177/03331024261451427
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Environmental and psychological risk factors for migraine chronification in China: A multicenter prospective cohort study” which has been selected as the Editor’s Choice for the May issue of Cephalalgia.
..................................
Prospective study of 1,642 patients reveals Anxiety and Analgesic Overuse as key drivers of Migraine Chronification in China, while Exercise offers protection.
journals.sagepub.com/doi/10.1177/03331024261446614
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
International Headache Society
@ihs_official
New in Cephalalgia!
When added to patient education, eptinezumab was associated with more favorable improvements than placebo in patient-reported outcomes related to disease burden, work productivity, and quality of life at Week 4 and Week 12 in adults with chronic migraine and medication-overuse headache.
journals.sagepub.com/doi/10.1177/03331024261449814
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Consistent with prior work, this study indicates that the transition from non-continuous to continuous headaches in children occurs more quickly than adults.
•
There were no significant differences in headache-related disability for children who had a sudden-onset headache compared to children who had a rapid or gradual evolution of headache to continuous.
•
Headache-related disability was greater if the onset of continuous headache was associated with a trigger.
journals.sagepub.com/doi/10.1177/03331024261446961
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to help develop the next generation of expert peer reviewers in headache research.
In this video, Dr Nina Riggins interviews Dr Jason Ray, who successfully completed the 2025–2026 Cephalalgia Reviewer Academy. He shares his experience, what he learned through the programme, and why reviewer training is important for improving the quality of peer review in headache research.
You can find the video on our YouTube channel.
www.youtube.com/watch?v=G57v5pesOIY
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/ -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
Do you know that ICHD 3 also includes Typical Aura without Headache?
It is characterised by typical aura symptoms that are not accompanied or followed by headache within 60 minutes.
These visual, sensory, or language symptoms can be frightening, disabling, and hard for many patients to describe.
So yes, migraine is #notjustaheadache
It deserves awareness.
It deserves recognition.
It deserves a month dedicated to understanding it better.
Happy #migraineawarenessmonth !
Let’s spread the word 📣
#migraineawarenessmonth #ichd3matters #ihs #headache #notjustaheadache -
International Headache Society
@ihs_official
The answer to the Sunday Quiz is C: June is Migraine and Headache Awareness Month.
Migraine is a debilitating neurological disorder that affects over 1 billion people worldwide. The International Headache Society is devoted to spreading knowledge about headache disorders and fostering headache research globally.
This June, let’s raise awareness of migraine and headache disorders, support people living with these conditions, and work together toward better understanding, care, and research.
#migraineawarenessmonth -
International Headache Society
@ihs_official
IHS Sunday Quiz | Hello June
June is coming. What headache awareness activity is coming this June?
A. Cluster headache
B. Trigeminal neuralgia
C. Migraine
D. Tension-type headache
Drop your answer below!
#sundayquiz #headacheawareness -
International Headache Society
@ihs_official
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
International Headache Society
@ihs_official
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to help develop the next generation of expert peer reviewers in headache research.
In this video, Dr Nina Riggins interviews Dr Nina Vaschenko, who successfully completed the 2025–2026 Cephalalgia Reviewer Academy. She shares her experience, what she learned through the programme, and why reviewer training is important for improving the quality of peer review in headache research.
You can find the video on our YouTube channel.
youtu.be/gdZSQBuc4uU
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
What is it like to be part of the Cephalalgia Reviewer Academy?
In this video, Dr Nina Riggins interviews Dr Omid Kohandel, who successfully completed the 2025–2026 Academy.
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to support the next generation of expert peer reviewers in headache research.
Dr Kohandel shares his experience, what he learned, and why peer review training matters for the future of headache science.
You can find the video on our YouTube channel.
youtu.be/7zePEL494cw
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
In this video, Dr Nina Riggins interviews Dr Zixuan Alice Zhang and Professor Messoud Ashina about their publication in Cephalalgia, selected as the Editor’s Choice for the April issue.
The study examined whether blocking hyperpolarisation-activated cyclic nucleotide-gated channels with ivabradine could modify KATP-induced migraine in humans or hypersensitivity in mice.
The main finding: ivabradine failed to modify KATP-induced migraine in humans or hypersensitivity in mice.
This suggests that hyperpolarisation-activated cyclic nucleotide-gated channels are unlikely to be key downstream mediators, while vascular-to-neuronal signalling may be important in migraine initiation.
You can find the video on our YouTube channel.
youtu.be/rVbElkcVhAg
Link to the paper:
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
International Headache Society
@ihs_official
#sunday Quiz
The correct answer is C. Hypnic headache syndrome or “alarm clock” headache is a frequently-recurring headache attacks developing only during sleep, causing wakening and lasting for up to 4 hours, without cranial autonomic symptoms or restlessness.
According to #ichd-3, the diagnostic criteria includes:
Recurrent headache attacks developing only during sleep, and causing wakening, occurring on ≥10 days/month for >3 months, lasting from 15 minutes up to 4 hours after waking
No cranial autonomic symptoms or restlessness
Not better accounted for by another ICHD-3 diagnosis.
Did you get it right?
Let us know in the comments! 👇
#sundayquiz #neurology #headaches -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine mechanisms remain unclear. Magnetic resonance spectroscopy (MRS) non-invasively measures brain neurochemical changes across diffrent region, but ictal findings across brain regions are inconsistent. More research is needed.
journals.sagepub.com/doi/10.1177/03331024261441576
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study aimed to compare nortriptyline monotherapy and combination therapy in the treatment of recurrent migraine of moderate frequency.
Combination prophylaxis may offer superior frequency reduction in moderate-frequency episodic migraine.
•
Improved efficacy may enhance adherence and persistence.
•
Lower-dose polytherapy may preserve tolerability.
journals.sagepub.com/doi/10.1177/25158163261453610
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz
Which of the following is NOT correct regarding Hypnic Headache according to the International Classification of Headache Disorders?
A. It occurs exclusively during sleep and causes awakening
B. It is more common after the age of 50 years
C. Cranial autonomic symptoms are typically prominent
D. Caffeine may be used as a treatment option
Share your answer in the comments 👇 #ichd3 -
International Headache Society
@ihs_official
New in Cephalalgia!
Prospective study of 1,642 patients reveals Anxiety and Analgesic Overuse as key drivers of Migraine Chronification in China, while Exercise offers protection.
journals.sagepub.com/doi/10.1177/03331024261446614
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHS Webinar: Headache Management in Pregnancy and Lactation
Join the IHS webinar on Thursday, 28 May, focusing on Headache Management in Pregnancy and Lactation.
Hosted by the IHS Education Committee, this open-access webinar will feature presentations by Dr Francesca Puledda, Dr Shazia Afridi, and Dr Anne MacGregor, who will discuss practical approaches to managing migraine during and after pregnancy.
Register today: us02web.zoom.us/webinar/register/WN_wiyGxz9fQhOsgybw9LVtig -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study examined associations between IL-6R gene polymorphisms and migraine in a Japanese population. Our results suggest a possible link between IL-6R variants and migraine, supporting a role for inflammatory pathways in migraine.
journals.sagepub.com/doi/10.1177/25158163261447417
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study reports an 84-year-old with Acute Confusional Migraine mimicking stroke. This case highlights acute confusional migraine as a critical differential in the elderly, challenging its pediatric exclusivity.
journals.sagepub.com/doi/10.1177/25158163261447291
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHS News | iHEAD Academy and China Headache Congress 2026
The iHEAD Academy will take place on 14–15 May 2026, followed by the China Headache Congress on 16–17 May 2026, in the historical city of Xi’an, China.
This activity highlights IHS’s continued commitment to strengthening headache education, fostering academic exchange, and supporting future collaboration in headache medicine across the region.
#ihs #iheadacademy #chinaheadachecongress -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A Delphi study assessed how non-factual impressions aid headache diagnosis. Only two statements reached consensus: a “familiar” headache suggests a primary cause, while an “unfamiliar” one may indicate a secondary headache.
journals.sagepub.com/doi/10.1177/25158163261420753
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
First case of interstitial pneumonia linked to galcanezumab for migraine. Key finding: inverted CD4/CD8 ratio on BAL. Full recovery after stopping treatment. Anti-CGRP antibodies may rarely cause pulmonary adverse events
journals.sagepub.com/doi/10.1177/25158163261437991
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#icdh3matters
Not all neuralgias are trigeminal!
13.2.1 Glossopharyngeal neuralgia is a rare type of neuralgias characterized by sudden, severe, and brief episodes of stabbing or electric-shock-like pain.
According to ICHD-3, the diagnosis requires recurring paroxysmal attacks of unilateral pain in the distribution of the glossopharyngeal nerve. Pain has all of the following characteristics: lasting from a few seconds to 2 minutes
severe intensity, electric shock-like, shooting, stabbing or sharp in quality and precipitated by swallowing, coughing, talking or yawning
To learn more, please visit: ichd-3.org/13-painful-cranial-neuropathies-and-other-faci… -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A Delphi round with 19 headache experts helped achieve consensus on: treatment response assessment criteria and timepoint, defining non-response to therapy, triptan usage, tolerability, and comorbidities within the Indian clinical context.
journals.sagepub.com/doi/10.1177/25158163261444610
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In this study, migraine patients showed no increased video head impulse testing (vHIT) asymmetry vs controls, supporting preserved Vestibulo-ocular reflex (VOR). Yet, higher asymmetry—even within normal range—was associated with greater dizziness-related disability. 🧠🌀
journals.sagepub.com/doi/10.1177/25158163261443698
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Flow cytometry reveals a link between T-cell immunoglobulin and mucin-domain containing-3 (TIM3) expression on cytotoxic T cells and headache frequency. TIM3, a potential biomarker of migraine chronification? Further studies are needed!
journals.sagepub.com/doi/10.1177/25158163261444000
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Some individuals without headache consider headaches a trivial problem, with females being more empathetic toward peopl with headache. Headache-related stigma appears to be a real problem, even among administrative body employees.
journals.sagepub.com/doi/10.1177/03331024261444665
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 New learning opportunity from the IHS Learning Institute!
The CSF Pressure and Volume Disorders course is now available — a collaboration between the IHS Education Committee and Dr. Marcio Nattan Souza. This 6-module course covers the full clinical spectrum of:
• Spontaneous Intracranial Hypotension (SIH)
• Idiopathic Intracranial Hypertension (IIH)
Topics include clinical presentation, imaging, CSF leaks, blood patch therapy, surgical options, neuro-ophthalmological evaluation, and more — all delivered by world-leading experts in pressure headache medicine.
Each module includes lectures + a multiple-choice quiz to assess your understanding.
🔗 Access the course: ihs-headache.org/courses/ihs-learning-institute-sih-iih/
🌐 Not yet an IHS member? Join the world's leading headache medicine organization and unlock exclusive resources, journals, and events:
👉 ihs-headache.org/en/membership-signup/
#neurology #headache #medicaleducation #cme #iih #sih #ihslearning -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study shows that people with migraine may face driving risks similar to those with epilepsy. Individualized assessment—considering aura, cognitive fog, vestibular symptoms, and patients’ own perceptions—could help improve driving safety.
journals.sagepub.com/doi/10.1177/25158163261443991
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The estimated disability weight (DW) of 0.432 indicates a substantial patient-reported health loss specific to Spontaneous intracranial hypotension (SIH) prior to definitive treatment.
journals.sagepub.com/doi/10.1177/03331024261444662
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This systematic review summarizes the evidence on pharmacologic treatments for post-traumatic headache. Some therapies show potential benefit, but the overall evidence base remains limited and higher-quality trials are needed.
Given the limited high-quality evidence overall, no specific clinical recommendations can be made at this time.
journals.sagepub.com/doi/10.1177/03331024261441563
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Across 21 trials with 7,032 patients, CGRP-targeted therapies may reduce migraine days and improve response in those with prior preventive treatment failure. Findings rely on limited evidence and longer independent studies are still needed
journals.sagepub.com/doi/10.1177/03331024261441287
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Domain-specific machine-learning models currently provide more reliable diagnostic performance compared to large language models (LLMs).
A supervised machine learning model trained on real-world clinical data showed better agreement with a specialist-confirmed diagnosis than a general-purpose, zero-shot, non-domain-adapted LLM.
journals.sagepub.com/doi/10.1177/03331024261441574
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Minimal physical activity was associated with lower migraine-related disability and better life satisfaction.
The identification of an activity engagement threshold and distinct patient clusters suggests a staged care model where pharmacologic stabilization enables physical activity, which may itself serve as a marker of recovery.
journals.sagepub.com/doi/10.1177/03331024261426569
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!.
Green-enriched white light is the most visually comfortable and causes the least physiological sensitivity compared to blue- and cyan-enriched white lights.
journals.sagepub.com/doi/epdf/10.1177/03331024261439257
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Improving 'sinus headache' diagnosis to stop mismanaged #migraine. New proposal aligns #sinusitis pain definition in #ichd / #icop with #epos 2020 & #icar-RS: adds negative predictors (no nausea/photophobia) & removes pressure tenderness.
journals.sagepub.com/doi/10.1177/03331024261439265
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study is the first large-scale retrospective cohort analysis to systematically evaluate spinal trigeminal nucleus (STN) lesions as a potential imaging biomarker for Trigeminal zoster-associated neuralgia (TZAN).
....
STN lesions are highly specific for TZAN and may serve as an auxiliary diagnostic indicator.
journals.sagepub.com/doi/10.1177/03331024261435927
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Visually-induced hemodynamic response did not differ between middle-aged women with ischemic stroke, migraine with aura, and patients with neither condition.
journals.sagepub.com/doi/10.1177/03331024261439256
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Genetic markers in BMAL1 and NPAS2 were found to be associated with an increased risk for cluster headache
•
The combinations of risk alleles carried by individuals with cluster headache are enriched in the positive feedback arm of the transcription-translation feedback loops (TTFL)
•
The analysis of risk associated with combination of non-pathogenic genetic markers can be used for identifying new treatment targets
journals.sagepub.com/doi/10.1177/03331024261440136
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 ICHD-3 Matters: Headache attributed to aeroplane travel (10.1.2)
Upcoming summer holiday season = more air travel... and for some, headache! Did you know that headache triggered by flying is actually recognized in the International Classification of Headache Disorders (ICHD-3) as:
Headache attributed to aeroplane travel
Typical features include:
🔹 Pain during take-off or landing
🔹 Usually short-lasting and improves after descent/ascent ends
🔹 Most occur during landing
A Scandinavian survey suggested that up to 8.3% of air travellers may experience this type of headache. Rapid pressure changes may play a role.
To learn more, visit here: ichd-3.org/10-headache-attributed-to-disorder-of-homoeost…
#ichd3matters #headache -
International Headache Society
@ihs_official
The International Headache Society offers a range of grants and awards each year to support headache research and career development.
Two important grant deadlines are coming up next week:
🔹 IHS Junior Research Grants
🔹 IHS Research into Headache in Children and Adolescents – Seed Funding Grant
📅 Deadline: 15 May 2026
Learn more about these funding opportunities and other IHS grants, awards, and training programmes here: ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Women with menstrual-related migraine (MRM) had higher rates of recent changes in frequency, consistent attack sites, and family history of headaches. MRM participants reported more prodromal symptoms and better response to triptans.
journals.sagepub.com/doi/10.1177/25158163261437831
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In the overall study cohort and those with migraine with aura, the rapid number naming task was significantly slower during all phases compared to the interictal phase.
journals.sagepub.com/doi/10.1177/25158163261436784
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Work has been underway for some time developing the new version of the International Classification of Headache Disorders, ICHD-4, and consideration should be given to broadening the system to include factors other than diagnosis.
journals.sagepub.com/doi/epdf/10.1177/03331024261439266
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The Cephalalgia Reviewer Academy has officially concluded its 2026 program, celebrating the successful graduation of an outstanding cohort. Congratulations to the 2025/2026 Cephalalgia Reviewer Academy graduates 🎓✨
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The April 2026 (Issue 4) table of contents for Cephalalgia, the International Headache Society’s journal, is now live.
Explore the full issue here: journals.sagepub.com/toc/cepa/46/4 -
International Headache Society
@ihs_official
#ichd3matters
1.2.2 Migraine with brainstem aura was formerly known as basilar migraine. It describes migraine aura symptoms that clearly originate from the brainstem, but occur without motor weakness.
According to ICHD-3, the diagnosis requires at least two fully reversible brainstem symptoms, such as dysarthria, vertigo, tinnitus, hypacusis, diplopia, ataxia, or decreased level of consciousness (GCS ≤13). Of note, bilateral paraesthesias were included in ICHD-2, but are no longer listed among the brainstem aura symptoms in ICHD-3.
Motor or retinal aura symptoms exclude this diagnosis.
To learn more, please visit: ichd-3.org/1-migraine/1-2-migraine-with-aura/1-2-2-migrai…
#ichd3 #migraine #headachemedicine -
International Headache Society
@ihs_official
New in Cephalalgia!
Using daily e-diaries and LH-validated ovulation, this study found no rise in migraine attacks during the ovulatory window. Only the perimenstrual period showed increased incidence, supporting menstruation as a trigger for migraine.
journals.sagepub.com/doi/10.1177/03331024261436415
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Digital information use is widespread among migraine patients in the Middle East and North Africa (MENA) region, with over 80% searching online and 72% using AI tools.
journals.sagepub.com/doi/10.1177/03331024261435594
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We’re delighted to share that the paper “Efficacy and effectiveness of anti-CGRP monoclonal antibodies treatment in the prevention of cluster headache attacks: A systematic review and meta-analysis”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution, which suggests that anti-CGRP monoclonal antibody treatment may be beneficial for episodic cluster headache but not for chronic cluster headache.
journals.sagepub.com/doi/full/10.1177/03331024261434209
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
#sundayquiz of the week!
Which of the following is NOT correct regarding 1.2.2 Migraine with brainstem aura?
A. Edwin Bickerstaff first described this phenomenon
B. Bilateral paraesthesias were included in ICHD-2, but not in ICHD-3
C. Altered level of consciousness can be a core diagnostic feature
D. Motor aura can also occur in brainstem aura
Share your answer in the comments 👇 #ichd3 -
International Headache Society
@ihs_official
New in Cephalalgia!
This systematic review and meta-analysis suggest that anti-CGRP monoclonal antibody treatment may be beneficial for episodic cluster headache but not for chronic cluster headache.
journals.sagepub.com/doi/full/10.1177/03331024261434209
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Migraine induced by vascular KATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation” which has been selected as the Editor’s Choice for the April issue of Cephalalgia.
..................................
Blocking hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels with ivabradine failed to modify KATP induced migraine in humans or hypersensitivity in mice.
HCN channels are unlikely to be key downstream mediators.
Vascular-to-neuronal signalling may drive migraine initiation.
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#throwbackthursday
Looking back at IHC 2025 in São Paulo, a truly global gathering of the headache community. With 130 invited speakers from 38 countries across 6 continents, this remarkable diversity highlights how international collaboration continues to shape and strengthen the field of headache medicine.
If you missed any sessions or would like to revisit key insights, a selection of presentations is available on the IHS YouTube channel.
🎥 youtube.com/playlist?list=PLwh0UqS-bULOdEhUWOmnE5pIlM1KSGA4h
#ihc2025 #headache #tbt #brazil -
International Headache Society
@ihs_official
New in Cephalalgia!
In this study, combination preventive treatment for chronic migraine (CM) with onabotulinumtoxinA and atogepant was safe and generally well-tolerated. Furthermore, the addition of atogepant to those stable on onabotulinumtoxinA resulted in clinically meaningful reductions in migraine days and improvement in responder rates, suggesting a benefit of combining treatments with distinct and complementary mechanisms of action for suppression of CM.
journals.sagepub.com/doi/10.1177/03331024261429118
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 ICHD-3 Matters: Primary Stabbing Headache (4.7)
Primary stabbing headache, previously referred to as “ice-pick headache,” is characterized by spontaneous head pain occurring as a single stab or a series of stabs, with each episode lasting only a few seconds. These stabs recur irregularly, ranging from one to many times per day, and occur without cranial autonomic symptoms.
To learn more, please visit: ichd-3.org/other-primary-headache-disorders/4-7-primary-s…
#ichd3matters #headache #icepick -
International Headache Society
@ihs_official
New in Cephalalgia!
In migraine of children and adolescents, brain networks play different roles by sex: males show altered sensory–affective circuits, females altered cognitive–attentive ones—the instruments and conductors of pain processing.
journals.sagepub.com/doi/10.1177/03331024261416494
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Systematic review of 14 human pharmacological migraine aura provocation studies (7 agents) suggests CGRP signaling and KATP channel activation (levcromakalim) are leading candidates to trigger migraine aura.
journals.sagepub.com/doi/10.1177/03331024261429112
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Transcultural Headache Medicine is a framework that links culture, traditional therapies, and health systems to headache diagnosis, treatment, and policy, and proposes a global research agenda to improve equitable, person-centred care.
journals.sagepub.com/doi/10.1177/03331024261432929
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study reports a refractory case of chronic cluster headache successfully treated with morning ergotamine and bedtime lasmiditan. This day–night tailored combination reduced attack frequency and severity without adverse effects, suggesting a novel
journals.sagepub.com/doi/10.1177/25158163261435608
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Behind every published paper, there are dedicated reviewers who give their time, energy, and expertise.
Cephalalgia Reports sincerely thanks all individuals who reviewed one or more manuscripts during 2025. Your contributions are essential, appreciated, and never taken for granted.
See the full list of reviewers here:
journals.sagepub.com/doi/10.1177/25158163261428526
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHS Seed Grant for Headache Research in Children & Adolescents
Seed grants to kickstart impactful research on headache disorders in children and adolescents—with a focus on low- and middle-income countries (LMICs).
Project requirements:
- Focus on individuals <18 years (up to 21 with strong justification)
- Address diversity (gender, race, ethnicity) in project development
- Potential to secure future external funding (e.g., NIH or other agencies)
- Include a clear plan for future funding
Eligibility:
- Applicants from LMICs or researchers conducting studies in LMICs
- Address cultural differences on the impact of migraine, including those in LMICs
Grant value: GBP 15,000
Deadline: 15 May 2026
Click for full details and application form: ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
🌍 IHS News from Recent Meetings
Nina Riggins, Social Media Editor of Cephalalgia, and Teshamae Monteith, Chair of the IHS Membership Committee, are moderating the headache medicine session at the American Academy of Neurology Annual Meeting 2026 in Chicago.
Moments like this highlight how our global network continues to connect, support, and inspire the next generation to improve care for people with headache disorders.
#ihs #headache #aanam -
International Headache Society
@ihs_official
IHS Junior Research Grant
Are you a young investigator passionate about advancing headache research? This is your opportunity to turn innovative ideas into impactful science! 🧠
The IHS Junior Research Grant supports early-career researchers and aims to:
- Promote careers in headache research
- Fund innovative basic and/or clinical studies
- Expand knowledge on headache disorders
Who can apply?
- Junior members of IHS
- Must be the Primary Investigator (joint PIs allowed)
Project duration: Up to 2 years
Grant value: GBP 10,000
Deadline: 15 May 2026
Click for full details and application form: ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Mediation modeling indicated that approximately three-quarters of the effect of rimegepant on functioning is mediated through reductions in pain intensity during the acute migraine attack phase.
journals.sagepub.com/doi/10.1177/25158163261433912
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Blocking hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels with ivabradine failed to modify KATP induced migraine in humans or hypersensitivity in mice.
HCN channels are unlikely to be key downstream mediators.
Vascular-to-neuronal signalling may drive migraine initiation.
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In a real-world cohort of over 500 treatment-resistant migraine patients, atogepant achieved clinically meaningful reductions in headache days at 3 months, with further improvement at 6 months. Tolerability was good, and fewer prior failures
journals.sagepub.com/doi/10.1177/03331024261431337
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
New real-world data on CGRP antibodies in drug-resistant migraine: Among 252 patients, 74.6% stayed on treatment. Most stopped early due to lack of effectiveness, while many who continued reported noticeable qualitative improvements.
journals.sagepub.com/doi/10.1177/25158163261433966
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The Sunday Reveal! 🧠✨
The correct answer to our clinical challenge is B.
While many associate Alice in Wonderland Syndrome (AIWS) primarily with children and EBV infections, it is a well-documented phenomenon in the adult migraine population.
In adults, these metamorphopsias (like micropsia or teleopsia) are most frequently a manifestation of migraine aura.
Though they can also be linked to temporal lobe epilepsy or ischemic events.
Did you get it right?
Let us know in the comments! 👇
#sundayquiz #neurology #headaches -
International Headache Society
@ihs_official
#sundayquiz 🧠✨
A 45-year-old patient with a history of migraine reports unusual visual episodes:
her surroundings feel tilted, and objects appear much smaller than they actually are (micropsia).
👀 What’s going on?
Which of the following statements about Alice in Wonderland Syndrome is CORRECT?
A) It is exclusively a pediatric condition caused by Epstein-Barr virus
B) In adults, it is most commonly linked to migraine aura
C) It is classified as a primary psychiatric disorder in ICHD-3
D) It is caused by a primary frontal lobe lesion
👇 Drop your answer in the comments and test your neuro skills!
#sundayquiz #neurology #headaches #migraine -
International Headache Society
@ihs_official
New in Cephalalgia!
This study found that migraine is not increased in multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), or myasthenia gravis (MG), while tension-type headache is more common in MS and NMOSD. Headache severity was not linked to disease activity or treatment.
journals.sagepub.com/doi/10.1177/03331024261429158
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#throwbackthursday to where it all began! 🧠✨
In 1995, at the AHS Annual Scientific Meeting in Boston, a final-year medical student presented his research on the epidemiology of headaches in medical students.
That student was none other than our current IHS President, Mario Peres (@marioperes), pictured here with the legendary Richard Lipton.
This 📷 photo captures more than just a poster presentation;
It captures the spark of a lifelong dedication to headache science.
From student to global leader—proof that the next generation of researchers starts right here.
📍 Boston, MA (1995)
#ihs #headachescience #throwback #medicalhistory #ahs1995 #neurology -
International Headache Society
@ihs_official
New in Cephalalgia!
Atogepant reduces migraine frequency and disability regardless of dosing time or meals. Evening use showed greater disability improvement, and intake without food led to larger headache day reduction.
journals.sagepub.com/doi/10.1177/03331024261416490
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Joining the International Headache Society means more than a membership.
It's an open door to the latest breakthroughs in migraine and headache disorders.🧠
From exclusive webinars to global clinical resources,
stay at the forefront of your field.
Join a global community of experts today. 🌍
#ihs #headache #learnwithihs #migraineresearch -
International Headache Society
@ihs_official
New in Cephalalgia!
1278 patients visited the pediatric emergency department for acute headache, accounting for 3.6% of all Pediatric Emergency Department (PED) visits. Brain MRI was performed in 19.1% of cases. Red flag symptoms were significantly associated with abnormal brain MRI findings.
journals.sagepub.com/doi/10.1177/03331024261431339
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
In clinical settings, the focus, understandably, is normally on treating the more severe condition (typically complex regional pain syndrome [CRPS] in patients with comorbid CRPS and migraine). However, recognizing that migraine and chronic daily headaches frequently develop after the onset of CRPS is crucial for optimal management of these comorbid conditions.
journals.sagepub.com/doi/10.1177/03331024261430856
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
CGRP-targeted therapies work—but not for all pain.
This case illustrates a clear therapeutic dissociation between migraine and complex regional pain syndrome (CRPS) under CGRP blockade. While both a CGRP monoclonal antibody and a CGRP receptor antagonist were highly effective for migraine prevention and acute treatment, neither intervention altered the severity of chronic CRPS.
journals.sagepub.com/doi/10.1177/03331024261430857
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The Physiotherapy Special Interest Group of the International Headache Society invites you to an online meeting to explore the latest scientific developments in physiotherapy for headache disorders.
🗓 Date & Time:
• 16 April 2026 – 21:00 (CEST)
• 17 April 2026 – 05:00 (AEST)
🎤 Featured presentations:
• Manual Therapy as Prophylactic Treatment for Migraine – Andreas Amons
• Combined Physiotherapy Interventions for Migraine – Gabriella Tolentino
💬 Plus:
Discussion on future directions and upcoming initiatives of the Physiotherapy Special Interest Group.
✨ A great opportunity to stay updated, connect with peers, and contribute to the advancement of physiotherapy in headache care.
📩 Registration: please contact Kerstin Luedtke: kerstin.luedtke@uni-luebeck.de
#headache #migraine #physiotherapy #ihs2026 #medicaleducation -
International Headache Society
@ihs_official
New in Cephalalgia!
In this nationwide register-based study, more than one-third (35.7%) of migraine patients in Sweden in 2015-2023 had comorbid depression or anxiety. There was a higher risk of comorbidity in the most versus the least deprived areas within Sweden.
journals.sagepub.com/doi/10.1177/03331024261430855
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Neuroimaging-based subtyping of migraine identifies clinically distinct phenotypes” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.
@Simona_Sacco_
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Data-driven multimodal neuroimaging-based clustering identified two distinct migraine subgroups with different clinical characteristics.
•
One subgroup showed widespread increases in cortical–subcortical functional connectivity and diffuse cortical volume reductions and was associated with greater symptom burden.
•
Functional connectivity contributed most strongly to subgroup differentiation, while structural variation provided complementary, orthogonal information, highlighting heterogeneity in brain organization within migraine.
journals.sagepub.com/doi/10.1177/03331024261433982
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Behind every published paper, there are dedicated reviewers who give their time, energy, and expertise.
Cephalalgia sincerely thanks all individuals who reviewed one or more manuscripts during 2025. Your contributions are essential, appreciated, and never taken for granted.
See the full list of reviewers here:
journals.sagepub.com/doi/10.1177/03331024261420094
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
International Headache Society
@ihs_official
New in Cephalalgia!
Data-driven, multimodal imaging-based clustering of migraine reveals subgroups with distinct structural, functional, and symptom profiles, providing complementary evidence to support subgroup characterization.
journals.sagepub.com/doi/10.1177/03331024261433982
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Join IHS and expand your learning.
Discover the IHS Learning Centre, your hub for expert education in headache medicine.
▶️ Videos & Podcasts — Expert-led clinical and scientific insights
📖 Learning Institute — Structured courses on headache disorders
🧾 Core Curriculum — Essential knowledge for neurologists
🌐 Webinars — Live and on-demand sessions with global specialists
🔗 Learn more & become a member: ihs-headache.org/en/learning-centre/ -
International Headache Society
@ihs_official
New in Cephalalgia!
Virtual education is now a permanent part of headache training. When designed with quality, equity, and interactivity in mind, it can expand global access and strengthen competency-based learning.
Virtual education should not be an alternative to clinical apprenticeship, but an amplifier of it.
journals.sagepub.com/doi/10.1177/03331024261433598
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
WHO’s essential medicines list (EML) recent report emphasises that headache disorders remain neglected despite the ill health and disability they cause.
journals.sagepub.com/doi/10.1177/03331024261420835
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are delighted to share that the IHS Instagram community has reached 11,000 followers this April 🎉♥️
This milestone highlights the growing global awareness of headache disorders and the strength of our shared mission. We encourage healthcare professionals not only to follow us, but also to join IHS and contribute to improving patient care and advancing headache medicine.
👉 Join IHS:ihs-headache.org/en/membership-signup/register-options/
#ihs #migraine #headache #11kfollowers #instagram -
International Headache Society
@ihs_official
New in Cephalalgia!
This Norwegian registry-based matched cohort study found a substantial and increasing burden of comorbidities, and lower income and education in people with cluster headache compared to controls.
journals.sagepub.com/doi/10.1177/03331024261428583
#clusterheadache #migraine #headache #brain #pain -
International Headache Society
@ihs_official
New in Cephalalgia!
This cross-sectional study describes post-traumatic headache phenotypes and treatment patterns in adults with moderate to severe post-traumatic headache and a high post-concussion symptom burden 2-4 months after mild traumatic brain injury.
journals.sagepub.com/doi/10.1177/03331024261423477
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
ICHD-3 Matters 🧠
Medication-overuse headache (MOH) is defined as headache on ≥15 days/month in a patient with a pre-existing primary headache, caused by regular overuse of acute medications for >3 months (≥10 days/month for triptans, ergots, opioids, or combination analgesic; ≥15 days/month for NSAIDs or paracetamol ). It usually improves after withdrawal.
To learn more, please go to: ichd-3.org/8-headache-attributed-to-a-substance-or-its-wi…
#ichd3matters #headache #migraine -
International Headache Society
@ihs_official
🔔 IHS Shares a Funding Opportunity – Brain Health Challenge Call
We are pleased to share an exciting opportunity from the BioInnovation Institute (BII) in Denmark.
The Brain Health Challenge Call, part of BII’s Bio Studio Program, is now open and seeks innovative research addressing key translational gaps in neurological diseases.
🧠 Focus areas include:
• Causal biology-driven therapeutics
• Advanced predictive models
• Precision delivery strategies across CNS & PNS disorders
💡 What’s offered:
• Funding up to DKK 5.35M/year (~€720K) for up to 3 years
• Dedicated project team & incubation in Copenhagen
• Access to world-class facilities, investors (200+ VCs), and industry network
• Support for start-up creation (with Entrepreneur-in-Residence model)
• IP remains with the home institution
🎯 Ideal for: Entrepreneurial Principal Investigators with platform technologies and clear therapeutic applications
📅 Deadline: May 4, 2026
This is a unique opportunity to translate cutting-edge neuroscience into real-world impact and potentially launch an investment-ready start-up.
🔗 Learn more & apply:
bii.dk/community/brain-health-challenge/ -
International Headache Society
@ihs_official
🔔 IHS Shares a Funding Opportunity – Deadline Extended
Great news for migraine researchers!
The American Migraine Foundation is now accepting Letters of Intent for the Dodick Lighthouse Research Award, supporting innovative, patient-centered research with the potential for near-term impact on migraine care.
💡 What’s on offer:
• Up to $150,000 in funding
• Two-year research awards
• Focus on clinically meaningful, patient-centered outcomes
⏳ Deadline Extended: April 20, 2026
This is an excellent opportunity to advance impactful research in headache and migraine.
🔗 Learn more and apply:
americanmigrainefoundation.org/resource-library/the-ameri… -
International Headache Society
@ihs_official
Paroxysmal hemicrania shows dramatic, complete response to indomethacin, which is essentially diagnostic.
In an adult, oral indomethacin should be used initially in a dose of at least 150 mg daily and increased if necessary up to 225 mg daily. The dose by injection is 100-200 mg. Smaller maintenance doses are often employed.
#ihs #headache #sundayquiz -
International Headache Society
@ihs_official
#sundayquiz of the Week!
A patient presents with frequent, short-lasting unilateral headaches associated with tearing and nasal congestion. Attacks occur more than 5 times per day.
Which feature is most diagnostic of paroxysmal hemicrania?
A) Presence of aura
B) Nocturnal predominance
C) Absolute response to indomethacin
D) Bilateral pain
Share your answer in the comments 💬✨
#sundayquiz #ihs #headache #learnwithihs #exploreneuro #paroxysmalhemicrania #internationalheadacheawareness -
International Headache Society
@ihs_official
💙 Cluster Headache Awareness Day & International Headache Week 💙
In this short video, Dr. Sophie Bryde Laursen from the Danish Headache Center highlights the key symptoms of cluster headache, current gaps in care, and future directions.
🔔 Awareness shouldn’t stop after one day—follow IHS as we continue to share expert insights and advance understanding of cluster headache worldwide.
#klyngehovedpine #clusterheadache #internationalheadacheweek -
International Headache Society
@ihs_official
"The most severe pain condition in medicine." 💔 It’s time we talk more about Cluster Headache.
Current treatments are often ineffective or hard to access, but the community is ready for change. 75% of patients surveyed are willing to join clinical trials to help find better solutions.
Let's support the search for better treatments. 🤝
✨ Are you living with cluster headache? What research would you like to see in the future? Let us know in the comments!
#clusterheadacheawareness #chronicillness #painmanagement #neurology #healthsupportThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
March 21 is Cluster Headache Awareness Day
Did you know that cluster headache is not only about severe pain and cranial autonomic symptoms?
👉Many patients also experience intense #restlessness during attacks.
In this video, Dr. Jr-Wei Wu @Bohemian_Wu (Taipei Veterans General Hospital) shares insights from his recent research, uncovering the brain mechanisms behind this unique and often overlooked symptom.
Let’s go beyond pain, and better understand the brain.
Learn more: link.springer.com/article/10.1186/s10194-025-02209-7
#clusterheadache #headache #neuroimageThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
Cluster Headache Awareness Day 🌸
No one should suffer this pain in silence.
Severe pain. Silent struggle. Often underestimated.
With care and empathy, Dr. Sophie Yener (University Hospital Geelong, Australia) shares a message of support and hope for people living with cluster headache ♥️
#clusterheadache #internationalheadacheweek -
International Headache Society
@ihs_official
Not all headaches are the same…
Some strike in seconds, others last for hours—but all share one pathway.
Welcome to the world of Trigeminal Autonomic Cephalalgias (TACs).
Cluster Headache: 15–180 min | 1–8/day
Paroxysmal Hemicrania: 2–30 min | >5/day
SUNCT / SUNA: 1–600 sec | up to hundreds/day
Hemicrania Continua: Continuous pain with flare-ups
#headacheawareness #tacs #clusterheadache #neurology #ihs #headacheeducation #internationalawarenessweek -
International Headache Society
@ihs_official
Today is Cluster Headache Awareness Day 📷
What is cluster headache?
It is one of the most severe pain conditions known to humankind.
In this video, Dr. Yi Liu (Tri-Service General Hospital, Taiwan) explains the key symptoms, defining characteristics, and the striking circadian and seasonal patterns of this highly disabling disorder.
#clusterheadache #internationalheadacheweekThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
During International Headache Week, we are delighted to share that the IHS Facebook page has reached 16,000 followers, just one month after celebrating 15,000.
This growth reflects the increasing global awareness of headache disorders. We encourage healthcare professionals not only to follow us, but also to join IHS to help improve patient care and advance headache medicine.
👉 Join IHS:
ihs-headache.org/en/membership-signup/register-options/
Thank you for your continued support 💙
#ihs #internationalheadacheweek #clusterheadacheawarenessday -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study offers evidence of the efectiveness of Galcanezumab in real life for the preventive treatment of episodic and chronic migraine, including an impact on psychiatric variables, contributing to daily practice and treatment guidelines
journals.sagepub.com/doi/10.1177/25158163261418597
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
After market entry of CGRP mAbs, newly diagnosed patients with migraine initiated and cycled through preventative migraine medications more rapidly than those diagnosed in earlier years.
journals.sagepub.com/doi/10.1177/25158163261421617
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
“Headache disorders are among the most disabling conditions worldwide—but some remain deeply misunderstood".
On the International Headache Awareness Week, we shine a light on one of the most severe yet under-recognized conditions: cluster headache—often called the ‘suicide headache’ because of its extreme intensity.
Through this video, we aim to raise awareness, improve recognition, and support those living with this devastating condition.
Because understanding headache is the first step toward better care—and better lives.” #clusterheadache2026 #awarenessday #clusterheadache #ichd3matters #ihs -
International Headache Society
@ihs_official
Cluster Headache Awareness Day is tomorrow 💙
Let’s take a moment to learn how to recognize one of the most painful conditions in medicine, as its diagnosis may be delayed for years.
Earlier recognition means faster, more effective treatment.
Stay tuned and help raise awareness for cluster headache 💪
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster_kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
International Headache Society
@ihs_official
This week marks International Headache Week, and March 21, 2026, is Cluster Headache Awareness Day, dedicated to raising awareness of one of the most painful conditions known to humankind: cluster headache.
Let’s stand together with people living with cluster headache and other headache disorders. The IHS remains committed to deepening understanding and moving headache medicine forward.
👉 Stay tuned to the IHS page throughout the week for a series of videos, educational posts, and expert insights.
#clusterheadache #internationalheadacheweek -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
CT-guided Gasserian ganglion injection may be a minimally invasive option for elderly or medically refractory trigeminal neuralgia patients unsuitable for surgery, with preliminary evidence of symptomatic benefit and acceptable safety.
journals.sagepub.com/doi/10.1177/25158163261418598
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The clinical reasoning behind the interpretation of the findings of the assessment of migraine patients is described, using three migraine patients with different clinical presentation and individualised interventions
•
Individualized physiotherapy treatments can be safely delivered to patients with migraine.
•
The therapeutic benefit of physiotherapy interventions depends on the clinical reasoning and the individualization of the treatments, including education and lifestyle management.
•
Manual therapy and exercises can be used to either target cervical musculoskeletal impairments related to a CMD or improve cervical hypersensitivity through pain modulation.
journals.sagepub.com/doi/10.1177/25158163251414038
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#throwbackthursday 💙
In March 2024, the global headache community came together to raise awareness, reduce stigma, and improve care for people living with headache disorders.
As we mark this year’s International Headache Week, let’s continue working together to promote understanding, improve recognition, and support better care worldwide.
#headacheawareness #migraine #ihs #headache -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Many women with enlarged breast tissue have frequent headaches. After breast reduction, this study showed that most saw headaches, neck pain, and sleep apnea risk improve—but surgery isn’t a guaranteed treatment. More research is needed.
journals.sagepub.com/doi/10.1177/25158163261416853
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This week is International Headache Week
Let’s raise awareness of headache disorders ❤️
Millions suffer.
Many remain undiagnosed.
Together we can change that.
Share and Support headache sufferers.
#headache #migraine #cluster_headache #tth
#awarenessweek #ihs -
International Headache Society
@ihs_official
This week is International Headache Week
Let’s raise awareness of headache disorders ❤️
Better control and adequate treatment begin with proper identification of the problem.
In this figure, each of the three individuals presents with a primary headache disorder from the first three chapters of ICHD-3. Can you correctly identify the most likely diagnosis for each?
👇 Share your answers in the comments! -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In patients with chronic migraine and chronic insomnia, daridorexant improved sleep quality, but not headache frequency.
journals.sagepub.com/doi/10.1177/25158163251415344
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In daily practice, management of trigeminal traumatic neuropathic pain is a challenge.
•
The use of perineural botulinum toxin may be useful in the management of neuropathic pain.
•
This study presents the first report of perineural botulinum toxin injection with ultrasound guidance in the trigeminal innervation for the management of post-traumatic pain.
•
Traumatic craniofacial pain of trigeminal origin may improve with the application of botulinum toxin.
journals.sagepub.com/doi/10.1177/25158163251414012
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know that March 21 is Cluster Headache Awareness Day?
This is Cluster Headache — one of the most severe primary headache disorders.
🔹 Attacks last 15–180 minutes
🔹 Can occur up to 8 times per day
🔹 Often appear in clusters for weeks or months
During an attack, people often feel restless or unable to stay still, unlike migraine where patients prefer to lie quietly.
Check more about cluster headache on ICHD-3
ichd-3.org/3-trigeminal-autonomic-cephalalgias/3-1-cluste…
#ichd3matters #ihs #headache #learnwithihs #exploreneuro #notjustaheadache -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Specialist workforce shortage: The surveyed Caribbean islands reported very few practicing neurologists, with virtually none having fellowship training in migraine/headaches.
journals.sagepub.com/doi/10.1177/25158163251415565
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Migraine as a primary care-sensitive condition: Building pathways to accessible care” which has been selected as the Editor’s Choice for the February issue of Cephalalgia.
@Simona_Sacco_
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes.
•
The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models.
•
Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways.
journals.sagepub.com/doi/10.1177/03331024261418704
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The International Headache Society invites early-career clinicians and researchers to apply for the International Headache Academy 2026, a unique opportunity to learn from global experts and connect with the next generation of headache specialists.
⏳ Application deadline: next Friday (20 March 2026)
Learn more: ihs-headache.org/en/news/ihs-international-headache-acade… -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes.
•
The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models.
•
Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways.
journals.sagepub.com/doi/10.1177/03331024261418704
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#ichd3matters
Headache attributed to reversible cerebral vasoconstriction syndrome (RCVS) typically presents as recurrent thunderclap headaches, and the attacks are often triggered by sexual activity, exertion, Valsalva manoeuvres, or strong emotions.
⚠️ Headache may remain the only symptom, but it can also be a warning sign preceding haemorrhagic or ischaemic stroke.
To learn more, please go to: ichd-3.org/6-headache-attributed-to-cranial-or-cervical-v… -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Migraine is a leading cause of disability in Eastern Europe.
This regional study (Moldova, Ukraine, Romania, Serbia) shows big gaps in diagnosis, limited access to modern therapies, and low awareness.
journals.sagepub.com/doi/10.1177/25158163251414020
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This real-world matched control study (n=37,054) found that people with migraine had significantly higher rates of certain comorbidities and significantly higher healthcare resource utilization compared to controls.
journals.sagepub.com/doi/10.1177/25158163251414041
#migraine #headache #brain #pain #neurology #neuroscience
@MatanyaTirosh @ShVinker -
International Headache Society
@ihs_official
New in Cephalalgia!
While chronic dizziness has a wide differential diagnosis, three common neurologic etiologies need to be considered in an outpatient evaluation: vestibular migraine, persistent postural-perceptual dizziness and dysautonomia/Postural Orthostatic Tachycardia Syndrome.
Dysautonomia is a common cause of chronic dizziness.
journals.sagepub.com/doi/10.1177/03331024261420838
#migraine #headache #brain #pain #neurology #neuroscience
@dysclinic -
International Headache Society
@ihs_official
New in Cephalalgia!
There is a compelling argument for the inclusion of Solitary Pontine
Lesion–Related Trigeminal Neuralgia as a distinct subgroup within Secondary Trigeminal Neuralgia in ICHD-4
journals.sagepub.com/doi/10.1177/03331024261419766
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Today is #internationalwomensday.
We honor the dedication and leadership of women in clinical care, research, advocacy, and education who continue to shape the future of headache medicine.
Thank you for advancing care and improving the lives of patients worldwide.
#headache #migraine #medicine -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations:
In this IHS Insight Conversation, Dr. Wanakorn Rattanawong from King Mongkut's Institute of Technology, Ladkrabang, Thailand, shares his perspective on the realities of headache care across Asia.
Dr. Rattanawong highlights the patient-to-specialist ratios in many Southeast Asian countries and the challenges in accessing newer treatments such as CGRP-targeted therapies . He also emphasizes the importance of strengthening headache education in medical training while recognizing cultural and clinical differences across regions.
These reflections highlight both the progress being made and the ongoing challenges in improving headache care for patients throughout Asia.
🎤 Interviewer: Dr. Jr-Wei Wu
▶️ Watch the full conversation:
www.youtube.com/watch?v=F1Ruc29mWDM -
International Headache Society
@ihs_official
New in Cephalalgia!
Solitary pontine lesion–related trigeminal neuralgia may be a distinct condition. Emerging evidence calls for updating the ICHD to recognize this unique form of trigeminal neuralgia.
journals.sagepub.com/doi/10.1177/03331024261419757
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 #throwbackthursday
Nearly 2 millennia ago, the Greek physician Aretaeus of Cappadocia proposed one of the earliest classifications of headaches.
He described three types: heterocrania, resembling migraine with unilateral pain and symptoms such as nausea, vomiting, photophobia, phonophobia, and olfactory changes; cephalalgia, a milder headache; and cephalaea, a more persistent headache resembling tension-type headache.
These early descriptions highlight how careful clinical observation long preceded modern diagnostic tools.
#headache #migraine -
International Headache Society
@ihs_official
New in Cephalalgia!
Fractal dimension-based structural MRI analysis is more sensitive to cortical changes than cortical thickness, even in low-frequency migraine.
journals.sagepub.com/doi/10.1177/03331024251414616
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The current systematic review highlights areas of agreement and disagreement between existing guidelines on the management of childhood and adolescent migraine and emphasizes the current gaps and opportunities
journals.sagepub.com/doi/10.1177/03331024251413283
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Eptinezumab is effective in real-world practice, both evaluating the percentage of reduction and using the IHS novel criteria.
•
Treatment with eptinezumab showed consistent and clinically meaningful reductions in both monthly migraine and headache days across episodic and chronic migraine patients, demonstrating real-world effectiveness in a refractory cohort.
•
According to the International Headache Society (IHS) categories, about 15–20% of patients achieved optimal control and 20–26% modest control after 24 weeks of treatment.
journals.sagepub.com/doi/10.1177/03331024251414659
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
New in Cephalalgia!
Early physical, cognitive, and emotional symptoms after mild traumatic brain injury may help identify those at risk for persistent post-traumatic headache. Continued monitoring and support for sleep and emotional issues are key in delayed recovery.
journals.sagepub.com/doi/10.1177/03331024251414856
#migraine #headache #brain #pain #neurology #neuroscience
@schwedtt -
International Headache Society
@ihs_official
Do you clearly remember the exact day your headache began?
🧠 A hallmark feature of New Daily Persistent Headache (NDPH) is its distinct and clearly remembered onset. The headache begins on a specific day, becomes continuous within 24 hours, and persists daily thereafter. Many patients can recall the precise date it started.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-10-new-dail…
#ichd3matters #headache #ndph -
International Headache Society
@ihs_official
February 28 is #rarediseaseday
Familial hemiplegic migraine (FHM) is a rare subtype of migraine characterized by reversible motor weakness during the aura phase that lasts less than 72 hours.
FHM is caused by genetic changes. Known forms include FHM1 (CACNA1A, coding for a calcium channel), FHM2 (ATP1A2, coding for a Na⁺/K⁺-ATPase), and FHM3 (SCN1A, coding for a sodium channel). These genetic findings can help guide diagnosis. Symptoms can be frightening, but typically do not cause permanent damage.
If you want to know more, go to: ichd-3.org/1-migraine/1-2-migraine-with-aura/1-2-3-hemipl… -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations:
Hsiangkuo (Scott) Yuan, MD, PhD, FAHS from the Jefferson Headache Center (USA) shares his treatment strategy using middle meningeal artery embolisation as a preventive treatment for refractory chronic migraine. In this interview, Dr. Yuan discusses patient selection, procedural considerations, and real-world clinical experience with this innovative technique.
🎤 Interviewer: Jr-Wei Wu (Chair of IHS Communication Committee)
👉 Watch the full video here: www.youtube.com/watch?v=9X-IFPH14Cc -
International Headache Society
@ihs_official
New in Cephalalgia!
Novel advanced MRI reveals altered cortical microstructure in persistent post-traumatic headache, including signs of neuroinflammation and cellular swelling that are partially distinct from migraine.
journals.sagepub.com/doi/10.1177/03331024251409317
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Peer review is one of the most important — and often unseen — pillars of scientific progress.
Congratulations to Dr Gabriele Sebastianelli for being recognised as Outstanding Peer Reviewer for Cephalalgia in 2025.
Your thoughtful, rigorous, and constructive reviews help maintain the highest standards in headache research. Thank you for your dedication to strengthening our scientific community.
#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba -
International Headache Society
@ihs_official
Excellence in peer review deserves to be celebrated.
Congratulations to Prof Mona Nada for being named Outstanding Peer Reviewer for Cephalalgia Reports in 2025.
Your expertise, fairness, and commitment to quality make a meaningful impact on the advancement of headache science. Thank you for your invaluable contribution to the field.
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know that ICHD 3 also recognises Medication Overuse Headache?
It should be considered in any patient with a pre existing primary headache who develops headache on 15 or more days per month in the setting of regular medication overuse for more than 3 months.
Importantly, MOH can coexist with chronic migraine, and careful phenotyping remains essential.
✍️ Before the next preventive script, have we addressed overuse?
#ichd3matters #ihs #headache #learnwithihs #exploreneuro #notjustaheadache -
International Headache Society
@ihs_official
New in Cephalalgia!
Corneal confocal microscopy reveals reduced corneal nerve fibers in migraine patients, regardless of migraine type or visual sensitivity, pointing to a wider role of peripheral nerve dysfunction in migraine beyond just sensory symptoms.
journals.sagepub.com/doi/10.1177/03331024251414172
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in sex and gender differences in migraine
Irene de Boer and Caroline M. Kopruszinski
Sex and gender affect migraine risk, presentation, and treatment. This paper highlights 2025 clinical and preclinical studies that have contributed to understanding sex differences in migraine pathophysiology and therapeutic management.
journals.sagepub.com/doi/10.1177/03331024261417385
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Correct answer: C) NOTCH3 🧬
CADASIL results from pathogenic variants in the NOTCH3 gene (chromosome 19).
It is the most common hereditary small-vessel disease of the brain and a recognized genetic vasculopathy in ICHD-3 (6.8.1).
Early recognition is essential in patients with migraine with aura and suggestive MRI findings.
#sundayquiz #cadasil #notch3 #ihs -
International Headache Society
@ihs_official
#sundayquiz
CADASIL is caused by pathogenic variants in which gene?
A) CACNA1A
B) APP
C) NOTCH3
D) MTHFR
Comment your answer below 👇🧠 -
International Headache Society
@ihs_official
Happy Friday, everyone!
Imagine stepping into a time machine…
You can witness one defining moment in headache medicine.
What would you choose?
🧠 The discovery of triptans
🧬 The CGRP pathway
📖 The first ICHD classification
We’re curious — share your answer in the comments 👇
#fridayfun #ihs #headachecare -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations: A career in headache - experience as a headache researcher
Mi Ji Lee from Seoul National University College of Medicine, South Korea, discusses how she initiated headache research at her university while balancing it with her clinical work.
Interviewed by: Heba Bani-Hani
👉 Watch the full video here: www.youtube.com/watch?v=1_gfJA3wwps -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations
Mi Ji Lee from Seoul National University College of Medicine, South Korea, and Diogo Edelmuth from the University of São Paulo, Brazil, discuss the best ways to manage patients with spontaneous intracranial hypotension
Interviewer: Marcio Nattan
👉 Watch the full video here:
www.youtube.com/watch?v=BfTeG45SiuI -
International Headache Society
@ihs_official
The IHS Presidential Symposium, Brazil, 2025.
“To Dream Their Impossible Dream” is now available to watch.
This powerful session addresses Access to Headache Care in Low- and Middle-Income Countries, highlighting real-world challenges, barriers, and solutions from across the globe.
Chaired by Rami Burstein, with speakers representing the Philippines, Azerbaijan, Moldova, Egypt, Nepal, Mexico, Mongolia, and Kenya.
🌍 Advancing equitable headache care worldwide.
🍿Watch for free on our YouTube channel.
#ihsheadache #ihc2025 #globalhealth #headachecare -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Great news for researchers! The submission deadline has been extended — you now have until 📅 28 March 2026 to submit your original research papers for the Jes Olesen Awards in Basic Science and Clinical Science.
Cephalalgia is proud to honour outstanding early‑career researchers whose work drives innovation in headache medicine. Two awards — one in Basic Science and one in Clinical Science — will each grant €10,000 and an opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old
🔹 Submission type: Original research only
🔹 Limit: One submission per participant
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards empower the next generation of headache researchers worldwide.
🌍 Don’t miss this chance to elevate your work, gain international visibility, and contribute to the future of headache science!
#jesolesenawards #headacheresearch #cephalalgia #ihs #callforpapers #researchopportunity -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations:
What triggers migraine can vary widely across individuals and across cultures.
Keiko Ihara (Keio University School of Medicine, Japan; Mayo Clinic, USA) and Tsubasa Takizawa (Keio University School of Medicine, Japan) collaborated with 12 headache specialists from 10 countries to explore how migraine triggers differ around the world.
👉 Watch the full video here: www.youtube.com/watch?v=S9_Xl1N8NPI -
International Headache Society
@ihs_official
🧠 Tension-Type Headache (TTH) Awareness — Treatment
Effective management of TTH involves both non-pharmacological and pharmacological approaches tailored to the individual. Non-pharmacological strategies include cognitive behavioral therapy, regular exercise, and a healthy lifestyle, such as adequate sleep and moderation of alcohol and smoking.
When needed, pharmacological treatment can be used. Simple analgesics such as paracetamol or non-steroidal anti-inflammatory drugs are often effective for acute attacks, while preventive medication may be considered for frequent episodic TTH or chronic TTH.
#tth2026 -
International Headache Society
@ihs_official
Tension-Type Headache affects nearly 2 billion people worldwide.
Despite often being perceived as mild, its high prevalence translates into a substantial cumulative impact at the population level.
Greater awareness of its burden is essential for informed health policy and research prioritization.
#tensiontypeheadache #cefalea_tensional #ihs #tth2026 #globalburden -
International Headache Society
@ihs_official
🎉 Milestone Reached!
We are delighted to announce that the International Headache Society’s Facebook page has grown to 15,000 followers!
Thank you to our global community for your continued support. We remain committed to sharing the latest news in headache medicine, updates on the activities of headache societies around the world, and cutting-edge research in this field.
#ihs #migraine #headache #15kfollowers -
International Headache Society
@ihs_official
🎯Answer to the Sunday Quiz #tth2026
Correct answer: D "Not aggravated by routine physical activity."
According to the ICHD-3, tension-type headache (TTH) is typically not worsened by routine physical activity.
Other typical features of TTH include a bilateral location, mild to moderate intensity, a pressing or tightening quality (non-pulsating), absence of nausea or vomiting, and no more than one of photophobia or phonophobia.
#tensiontypeheadache #céphalée_de_tension #cefalea_tensional #cefaleia_de_tensão #spannungskopfschmerz #緊縮型頭痛 #緊張型頭痛 #긴장성두통 #spændingshovedpine -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations
Can we detect the warning signs before a cluster bout begins?
In this episode, Jr-Wei Wu from Taipei Veterans General Hospital (Taiwan) discusses his research on pre-cluster symptoms, the challenges encountered during the study, and the implications of these findings for understanding and managing cluster headache.
🎙️ Interviewed by Wanakorn Rattanawong
👉 Watch the full video here:
www.youtube.com/watch?v=b3Sj0xeNjkI -
International Headache Society
@ihs_official
#sundayquiz for #tth2026
According to the ICHD-3, which of the following is the characteristic of tension-type headache?
A. Moderate or severe intensity
B. Unilateral location with pulsating quality
C. Presence of both photophobia and phonophobia
D. Not aggravated by physical activity
#tensiontypeheadache #céphalée_de_tension #cefalea_tensional #cefaleia_de_tensão #spannungskopfschmerz #緊縮型頭痛 #緊張型頭痛 #긴장성두통 #spændingshovedpine -
International Headache Society
@ihs_official
♥️ February 14 is Tension-Type Headache Awareness Day ♥️
Tension-Type Headache (TTH) is the most common headache disorder worldwide, affecting an estimated 2 billion people globally. Increasing recognition is key to improving diagnosis and treatment for TTH.
#tth2026 #céphalée_de_tension #cefalea_tensional #cefaleia_de_tensão #spændingshovedpine #緊縮型頭痛 #긴장성두통 -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations
How does BMI relate to CSF opening pressure in idiopathic intracranial hypertension (IIH)?
In this episode, Hsiangkuo (Scott) Yuan from the Jefferson Headache Center (Philadelphia, USA), interviewed by Jr-Wei Wu, discusses his research on the relationship between BMI and CSF opening pressure in IIH, highlighting the complexity of this question and the importance of multivariate analysis.
▶️ To learn more, watch this video: www.youtube.com/watch?v=cI7G7NYtr64 -
International Headache Society
@ihs_official
🎥 IHS Insight Conversations
What can early-career clinicians and researchers gain from joining the International Headache Society?
In this episode, Irene de Boer, Chair of the IHS Juniors Group from Leiden University Medical School (Netherlands), shares how IHS supports juniors through scholarship, networking, and global collaboration opportunities.
👉 Watch the full video here: www.youtube.com/watch?v=7nKCDpdQyb8 -
International Headache Society
@ihs_official
🌟 Welcome to the Cephalalgia & Cephalalgia Reports Editorial Boards! 🌟
We are delighted to welcome our newly appointed Graphical Abstracts Editors, who will play a key role in advancing the visual communication and scientific impact of our journals.
🎨 Olivia Grech, MD
Graphical Abstracts Editor, Cephalalgia
University of Birmingham, College of Medical and Dental Sciences
United Kingdom
🎨 Wanakorn Rattanawong, MD, FRCP(T)
Graphical Abstracts Editor, Cephalalgia Reports
King Mongkut's Institute of Technology Ladkrabang
Thailand
Their expertise will strengthen the clarity, accessibility, and visual quality of the research we publish.
Please join us in warmly welcoming them to the Editorial Boards! 🙌✨
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Today, on the International Day of Women and Girls in Science, the International Headache Society celebrates the women advancing headache science, clinical care, education, and research worldwide.
We are committed to supporting women across our community—through visibility, opportunity, mentorship, and inclusive leadership—so that excellence can thrive at every career stage.
Thank you to all women in science for your work and impact.
#womeninscience #womeninstem #headache #migraine #neurology #clinicalresearch #inclusion -
International Headache Society
@ihs_official
🔔 IHS Shares a Funding Opportunity
The American Migraine Foundation, in partnership with the American Headache Society, is requesting applications for the Dodick Lighthouse Research Award.
This two-year award supports high-impact, patient-centered research in headache and migraine with near-term clinical implications.
Learn more and apply: americanmigrainefoundation.org/resource-library/the-ameri… -
International Headache Society
@ihs_official
🌟 Welcome to the Cephalalgia Editorial Board! 🌟
We are delighted to introduce our newest Associate Editors, bringing exceptional expertise and global leadership to our publications:
🧠 Debashish Chowdhury, MD
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, India
🧪 Debbie Hay, BSc(Hons), PhD
University of Otago, Pharmacology & Toxicology, New Zealand
🔬 Hsiangkuo (Scott) Yuan, MD, PhD
Thomas Jefferson University, USA
Their scientific excellence and dedication to advancing headache research will continue to elevate the impact and quality of our journals.
Please join us in giving them a warm welcome! 🙌✨
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
We had the pleasure of hearing from Dr. Greg Dussor (University of Texas at Dallas) in an enlightening interview with Dr. Alexandre Kaup.
In this IHS Insight Conversation, the discussion centers on the biological mechanisms behind why migraines disproportionately affect women. The conversation also explores the potential of the endocannabinoid system, suggesting that its ability to target multiple receptors may offer broader relief for complex cases compared to current single-target therapies.
📺 Watch here: www.youtube.com/watch?v=KXq1OLsfvGw&t=76s -
International Headache Society
@ihs_official
🎥 Migraine Awareness | IHS Insight Conversations
Last year’s theme for Migraine Awareness Week (September 2025) emphasized that migraine is more than “just a headache.” It is a complex neurological disease that causes a substantial burden across multiple aspects of life and affects millions of people worldwide.
Members of the IHS Communications Committee—Jr-Wei Wu, Faraidoon Haghdoost, Heba Bani-Hani, and Sophie Yener—invite you to learn more about migraine across all IHS social media platforms.
👉 Watch the full video here: www.youtube.com/watch?v=ImVm4ANzhMU -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Clinical and genetic characterization of non-optimal triptan response among migraine patients” which has been selected as the Editor’s Choice for the January issue of Cephalalgia.
..............................................................
Non-optimal triptan response was associated with several clinical risk factors such as fibromyalgia and the use of gastro-oesophageal reflux medications, oral cavity disorders, intestinal disorders, and gynecological diagnoses.
journals.sagepub.com/doi/10.1177/03331024251414621
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Throwback Thursday!
Do you remember the IHS & EHF Joint Congress in 2021?
Looking back, it was a unique moment in our history. Due to the COVID-19 pandemic, the 2021 International Headache Congress remains the only IHC to be held entirely virtually and the only one officially co-hosted with the European Headache Federation.
It was a milestone of global collaboration during a challenging time.
#tbt #ihc2021 -
International Headache Society
@ihs_official
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
International Headache Society
@ihs_official
In the International Classification of Headache Disorders, 3rd edition (ICHD-3), cold-stimulus headache is defined as a headache with at least two episodes triggered by a cold stimulus applied externally to the head, or by ingestion or inhalation of a cold substance.
It is further categorized into:
🔹 Headache attributed to external application of a cold stimulus
🔹 Headache attributed to ingestion or inhalation of a cold stimulus (e.g., “ice-cream headache”)
🔹 Probable cold-stimulus headache
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-5-cold-stim…
#ichd3matters #cold-stimulus -
International Headache Society
@ihs_official
✅ The answer to the Sunday Quiz is: B! 🎯
The goal of early preventive treatment is to prevent the transition from episodic to chronic migraine, reduce attack duration and severity, and avoid refractoriness to acute treatment.
A: CGRP-targeted therapies are recommended as first-line options, but they are not the only effective treatments; traditional oral preventives remain important.
C: The suggested threshold in this positional statement is 2–4 monthly headache days.
D: Acute medications remain essential; the goal is optimized use and prevention of medication-overuse headache, not elimination. -
International Headache Society
@ihs_official
#sundayquiz of the Week
According to the 2025 IHS position statement “Early treatment in migraine – A call to shift prevention from attacks to disease progression”, which of the following statements is CORRECT?
A. Only CGRP-targeted therapies are effective for early prevention
B. Early intervention aims to prevent the transition from episodic to chronic migraine
C. Preventive treatment should start only at 3–4 monthly migraine days
D. Acute medications should be eliminated in all patients with migraine -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in post-traumatic headache
Rune Häckert Christensen and Haidar M. Al-Khazali
• Persistent post-traumatic headache is emerging as a chronic pain disorder with symptom burden comparable to chronic migraine, reinforcing shared underlying mechanisms
• Neuroimaging studies reveal overlapping brain signatures between post-traumatic headache and migraine, particularly in pain-processing networks involved in photophobia and sensory integration
• Experimental models identify critical early therapeutic windows, where timely intervention may alter long-term headache outcomes
• New molecular insights highlight roles for CGRP, endocannabinoid signalling, and cGMP pathways in driving post-traumatic headache persistence
• Machine learning approaches are advancing prediction of headache chronification, helping classify recovery trajectories after brain injury
• Bottom line: 2025 research positions post-traumatic headache alongside migraine in both biology and disability, while opening doors to earlier intervention and personalised prognosis.
journals.sagepub.com/doi/10.1177/03331024251409706
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in resistant and refractory migraine
Jennifer Robblee
• 2025 brought clearer international definitions for resistant and refractory migraine, helping standardise research and clinical care
• New longitudinal data show migraine resistance is dynamic — many people move between responsive, resistant, and refractory states over time
• Growing evidence supports multimodal care, combining CGRP-based treatments with targeted neuromodulation approaches
• Real-world studies highlight atogepant and eptinezumab as effective options even after multiple preventive failures
• Emerging pathways beyond CGRP, including PACAP-targeted therapies, offer hope for people who have exhausted current options
• A shift is underway: from counting failed treatments to understanding biological mechanisms behind resistance
• Bottom line: 2025 reflects steady progress toward precision care for resistant migraine — while the most refractory cases remain the next frontier for discovery
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251401231
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in digital technology in headache
Anker Stubberud
• 2025 saw rapid growth in digital headache care, spanning internet platforms, mobile apps, social media, wearables, and artificial intelligence
• Online tools are expanding access to education and self-management — but also raise challenges around misinformation and lack of personalised guidance
• App-based and internet-delivered therapies show promise, yet rigorous trials reveal mixed results, highlighting the need for stronger evidence
• New concepts such as digital phenotyping and “digital twins” aim to personalise diagnosis, treatment selection, and attack forecasting using real-time data from smartphones and wearables
• Artificial intelligence is advancing the prediction of treatment response and uncovering migraine genetics, while underscoring the importance of standardised study design and validation
• Generative chatbots may support education and research — but must be balanced against risks of over-reliance on AI
• Bottom line: digital technology offers powerful opportunities in headache care, but clinical adoption must be guided by robust evidence and careful implementation
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251401232
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in migraine prevention
Editors: Raffaele Ornello and Roberto De Icco
• Our editorial brings together the most impactful migraine prevention studies published in 2025, spanning clinical trials, real-world data, and new international guidance
• The 2025 International Headache Society and Italian Society guidelines place CGRP-pathway therapies at the top for preventive efficacy, while traditional options like amitriptyline, propranolol, candesartan, lisinopril, and anti-seizure medicines remain important tools
• A landmark randomized trial confirmed candesartan as an effective, well-tolerated, and low-cost option for episodic migraine prevention
• OnabotulinumtoxinA continues to be a cornerstone for chronic migraine, with reassuring real-world data even during pregnancy, while it showed no benefit for episodic migraine
• Short-term prevention with rimegepant showed promise for fasting-triggered headache, opening doors to situational preventive strategies
• PACAP-targeted therapies remain an exciting frontier, although recent phase 2 results highlight the need for further studies
• Bottom line: 2025 strengthened evidence-based migraine prevention and reinforced a shift toward earlier, more ambitious, and more personalised preventive care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251411865
#migraine #headache #brain #pain #neurology #neuroscience
@RaffaeleOrnello -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in acute migraine treatment
Bianca Raffaelli and Marcio Nattan Portes Souza
• 2025 brought major advances in acute migraine care, supported by new international guidelines and a wave of controlled trials plus real-world evidence
• Ten key studies reviewed in this editorial highlight how gepants are becoming central to acute treatment, showing effectiveness even in people who did not respond to triptans
• Data confirm similar efficacy in men and women, reassuring safety in people with anxiety or depression, and compatibility with preventive CGRP therapies
• Early treatment matters: both trials and real-world studies show higher response rates when gepants are taken early in an attack
• Long-term and real-world data demonstrate higher treatment persistence with rimegepant compared with triptans, suggesting more durable benefit in everyday practice
• Bottom line: 2025 consolidates gepants as a cornerstone of acute migraine management, with evidence now spanning clinical trials, long-term follow-up, and real-world care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251405467
#migraine #headache #brain #pain #neurology #neuroscience
@drmarcionattan, @Raffaelli_B -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in new targets for migraine treatment
Kristian A. Haanes and Håkan Ashina
• 2025 expanded migraine therapeutics beyond CGRP, spotlighting several new biological pathways with translational promise
• PACAP emerged as the most advanced new target, confirmed as a CGRP-independent pathway with early preventive efficacy
• Substance P returned as a validated human headache trigger, reopening discussion around neurokinin-based treatments
• Vascular KATP channels appear to act as a convergence point for multiple migraine mediators, positioning them as a potential broad-spectrum target
• TRPM3 channels link trigeminal activation with sex hormone modulation, offering insight into sex differences in migraine biology
• PAR2 highlights neuro–immune crosstalk as a novel therapeutic direction, with preclinical antibody data showing migraine-like pain reduction
• Bottom line: migraine treatment is moving toward mechanism-based precision care, with multiple new targets now opening doors beyond CGRP
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251413488
#migraine #headache #brain #pain #neurology #neuroscience
@h_ashina -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in non-invasive neurostimulation and neuromodulation for headache management
Chai Ching Ng and Hsiangkuo Yuan
• Neuromodulation is rapidly reshaping headache care, backed by new International Headache Society guidelines and growing clinical evidence
• Early use of remote electrical neuromodulation improves pain freedom and relief in acute migraine — with promising results even in children
• Kinetic oscillation stimulation shows preventive benefit in chronic migraine, offering a new mechanism-based option
• Targeted brain stimulation (TMS and tDCS) advances precision approaches by modulating pain and emotion networks
• Applications are expanding beyond migraine to cluster headache (CH), cervicogenic headache (CGH), and post-dural puncture headache (PDPH)
• Real-world data support safety and long-term use, while highlighting the need for better trial design and adherence strategies
• Bottom line: neuromodulation is evolving into a versatile, mechanism-driven part of headache care — next steps are rigorous trials and real-world integration
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251405935
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
[IHS NEWS for Headache Medicine]
Recently, a phase 3 randomized, placebo-controlled trial published in The New England Journal of Medicine demonstrates that fremanezumab, a CGRP monoclonal antibody, is effective and well-tolerated for the prevention of episodic migraine in children and adolescents (6–17 years).
These findings provide important evidence supporting CGRP-targeted preventive therapy in pediatric migraine, an area with substantial unmet clinical need.
Read more here: www.nejm.org/doi/full/10.1056/NEJMoa2504546
#migraine #pediatricmigraine -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in cluster headache
Roemer B. Brandt and Rolf Fronczek
• Cluster headache remains one of the most severe headache disorders, with a major unmet need — especially in the chronic form
• 2025 trials of CGRP monoclonal antibodies in episodic and chronic cluster headache did not meet primary endpoints, highlighting limits of translating migraine therapies directly to cluster headache
• Attention is shifting beyond CGRP, with PACAP-38 and inflammatory biomarkers emerging as potential new therapeutic directions
• Neuromodulation approaches (including vagal nerve stimulation, occipital nerve stimulation, TENS, and TMS) continue to expand, though high-quality randomized data remain limited
• New work also deepens understanding of circadian biology, disease progression, premonitory symptoms, and medication overuse in cluster headache
• Bottom line: meaningful progress was made in 2025, but a true causal treatment is still not in sight — ongoing trials into psychedelics and neuromodulation offer hope for more effective options ahead
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251411870
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The International Headache Society is delighted to share that the 🇹🇭 Thai Headache Society has joined our growing family of Affiliate Member Societies.
We look forward to strengthening collaboration and advancing headache care and research together globally.
🔗 Explore the full list of IHS Affiliate Member Societies here:
ihs-headache.org/en/about-ihs/affiliate-member-societies/
#thailand #headache -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in central and peripheral interactions in migraine
Anders Hougaard and Gabriele Sebastianelli
• 2025 research moves beyond the “central versus peripheral” debate, showing migraine arises from dynamic interaction between brain networks and peripheral generators
• New imaging studies suggest migraine does not cause permanent white-matter damage, while cortical thickness changes appear reversible with effective preventive treatment
• Peripherally acting therapies, including CGRP monoclonal antibodies, can reshape central brain connectivity in responders — highlighting how peripheral treatments drive central recovery
• Experimental studies show that peripheral vascular and meningeal mechanisms can directly activate trigeminal pain pathways, linking vascular events to central signalling
• Evidence also supports a bidirectional link: central activation can trigger peripheral CGRP release, reinforcing migraine as an integrated system disorder
• Ongoing work continues to refine the role of cortical spreading depression, aura, and pain, pointing toward multiple parallel pathways rather than a single origin
• Bottom line: migraine is best understood as a complex disorder emerging from continuous crosstalk between central and peripheral processes — guiding future mechanism-based care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251406579
#migraine #headache #brain #pain #neurology #neuroscience
@drhougaard -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights from real world studies in migraine
Edoardo Caronna and Marta Torres-Ferrús
• 2025 marks a turning point in migraine real-world research with the release of the new International Headache Society guidelines for real-world evidence studies
• A surge of real-world data is reshaping clinical practice, especially for CGRP therapies and gepants
• Long-term studies confirm sustained benefit of CGRP monoclonal antibodies — but also show many people continue to live with residual disease burden
• Real-world findings challenge forced treatment interruptions, showing symptom worsening after stopping and incomplete recovery after restarting in some patients
• Growing evidence supports atogepant and rimegepant as effective options, even in people with prior CGRP treatment failure
• Real-world safety data remain reassuring, including cardiovascular outcomes
• Bottom line: real-world evidence is no longer just observing care — it is actively shaping guidelines, policy, and how we treat people with migraine
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251407207
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in headache in children and adolescents
Laura Papetti
• Migraine in young people is no longer seen as just a neurological condition — it’s a developing, biopsychosocial process shaped by brain, behaviour, and environment
• 2025 research highlights how psychological factors, resilience, and early life experiences strongly influence migraine severity and long-term outcomes
• Studies show that anxiety, depression, pain catastrophising, and multisite pain can all affect disability and treatment response
• Education matters: stigma often begins in adolescence, making awareness among parents, teachers, and caregivers a vital part of care
• Early psychological, educational, and biopsychosocial interventions can change the trajectory of migraine across the lifespan
• A key focus for the future: integrated care models and smoother transitions from paediatric to adult services
• Bottom line: supporting a child with migraine today helps shape a healthier adult tomorrow
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251407208
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights – progress towards discovery of molecular and neuroimaging biomarkers for migraine
Marina Romozzi and Roberta Messina
• 2025 marked major progress in migraine biomarker research, spanning both molecular and brain imaging discoveries
• New studies highlighted key molecular signals linked to migraine mechanisms, including neuropeptides and markers of neuroinflammation
• Neuroimaging continues to reshape our understanding of migraine as a brain network disorder, with growing evidence of widespread connectivity changes
• Advances in imaging revealed alterations in trigeminal pathways, brainstem activity, and large-scale pain and visual networks
• Emerging data also point to sleep, glymphatic function, and brain plasticity as important contributors to migraine biology
• Bottom line: combining molecular markers with advanced neuroimaging is bringing us closer to mechanism-based, personalised migraine care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251408766
#migraine #headache #brain #pain #neurology #neuroscience
@MRomozzi @_RobertaMessina -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in medication overuse and medication overuse headache
Wanakorn Rattanawong and Luigi Francesco Iannone
• Medication overuse headache is now recognised as a complex neurological and biobehavioral disorder — not simply “too much medication”
• New 2025 evidence suggests that with CGRP-targeted therapies, stopping acute medication may not always be necessary to achieve improvement
• Mindfulness-based approaches show promise, with brain connectivity changes linked to pain control, emotion regulation, and medication use
• The endocannabinoid system may play an important role, pointing to new biological pathways behind medication overuse
• Long-standing assumptions are being challenged — medication overuse may extend beyond migraine, with emerging data in cluster headache
• Bottom line: MOH is multidimensional, involving biology, behaviour, and psychology — and future care will need personalised, multidisciplinary strategies
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251409313
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
2025 Highlights in comorbidities and headache
Editors: Nina Riggins and Faraidoon Haghdoost
• Migraine and headache disorders rarely exist alone — they often overlap with conditions like endometriosis, fibromyalgia, temporomandibular disorders, epilepsy, and depression
• 2025 research highlights shared biological pathways, including calcitonin gene-related peptide signalling, stress mechanisms, and genetic overlap
• Key clinical insights:
– Prolactin may increase migraine vulnerability in endometriosis
– Higher migraine attack frequency is linked to fibromyalgia
– Nearly half of people with epilepsy experience headache
– Migraine is closely linked with depression
• Bottom line: recognising comorbidities matters — and multidisciplinary care plus precision medicine will be essential for improving outcomes
journals.sagepub.com/doi/10.1177/03331024251409779
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost
@NinaRiggins -
International Headache Society
@ihs_official
The International Headache Society (IHS) offers Short-Stay Scholarships to support young clinicians and researchers from World Bank–classified low-, lower-middle, or upper-middle income countries. The scholarships fund short visits to leading international headache centres, fostering skills development and research capacity building.
🔹 Who can apply: IHS members who are students, early-career researchers, or early-career clinicians meeting defined training or graduation timelines and living and working in eligible countries
🔹 Purpose: Short-term training at a leading headache centre
🔹 Deadline: 20 April 2026
👉 Click below for full eligibility details and the application form.
ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
🌍 iHEAD Academy: Empowering Headache Specialists Worldwide
Rashad Alghurabi (Alborz Alazhar University Hospitals, Egypt) shares his experience as a delegate of the IHS International Headache Academy (iHEAD) in São Paulo, September 2025 — an opportunity that also enabled attendance at the 22nd International Headache Congress.
🗣️ Testimonial in Arabic
🎥 Watch here:
www.youtube.com/watch?v=ZoRHJDWXx8I
#ihs #ihead #ihc2025 #globalneurology #headacheeducation -
International Headache Society
@ihs_official
🧬 Biomarkers in Migraine: Towards Precision Medicine
Can genetic markers help us better understand migraine — and even predict treatment response?
Gisela Terwindt (Leiden University Medical Center, Netherlands) explores the role of biomarkers in uncovering migraine pathophysiology and shaping future personalised care.
🎙️ Interviewed by Marcelo Calderaro
🎥 Watch here:
www.youtube.com/watch?v=9Tq3NVmVpUc
#migraine #biomarkers #precisionmedicine #ihs #headacheresearch -
International Headache Society
@ihs_official
The International Headache Society (IHS) offers the Headache Trainee Programme for early-career clinicians and researchers from World Bank–classified low-, lower-middle, or upper-middle income countries. The programme supports a funded visit of up to 12 weeks to an international headache centre, with the goal of strengthening local headache care through knowledge transfer.
🔹 Who can apply: IHS members training in neurology or within 7 years of completing neurology training, living and working in eligible countries
🔹 Duration: Up to 12 weeks at an international headache centre
🔹 Deadline: 20 April 2026
👉 See below for programme details and the application form.
ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
🌍 Supporting Global Headache Care through IHS Grants
Princess Kathryn Mensah (Korle Bu Teaching Hospital, Ghana) shares what it meant to receive an IHS travel grant to attend the 22nd International Headache Congress in São Paulo, September 2025 — and how this opportunity supports education, collaboration, and impact worldwide.
🎥 Watch here:
www.youtube.com/watch?v=8cDmcGZ4He8
#ihs #ihc2025 #globalhealth #headachemedicine #capacitybuilding -
International Headache Society
@ihs_official
IHS Clinical & Basic Science Headache Research Fellowship Award
The International Headache Society (IHS) invites applications from early-career investigators for its Clinical and Basic Science Headache Research Fellowship. The award supports innovative, high-impact basic and/or clinical research, fosters career development, and advances knowledge in headache disorders.
🔹 Who can apply: Researchers within 6 years of completing their most recent professional training (excluding non-professional periods)
🔹 Funding: £50,000
🔹 Deadline: 1 April 2026
👉 Click below for details and the application form.
ihs-headache.org/en/resources/grants-awards-and-training-… -
International Headache Society
@ihs_official
🔴 Cluster Headache: Genetics, Diagnosis & New Therapies
What drives cluster headache — and what’s next for treatment?
Andrea Carmine Belin (Karolinska Institutet, Sweden) discusses the genetics of cluster headache, key diagnostic features, and promising new therapies on the horizon.
🎙️ Interviewed by Amr Hassan
🎥 Watch here:
www.youtube.com/watch?v=_4WJdtifQKc
#clusterheadache #headachemedicine #ihs #neurology #genetics -
International Headache Society
@ihs_official
🧒 Paediatric Headache: Advances in Care
How is migraine treatment evolving for children and adolescents?
Ishaq Abu-Arafeh (Royal Hospital for Children, Glasgow) highlights promising advances in paediatric headache management, key IHS guidelines, and important differences between treating young patients and adults.
🎥 Watch here:
www.youtube.com/watch?v=b9qBW0plsg4
#paediatricheadache #migraine #ihs #childneurology #headachemedicine -
International Headache Society
@ihs_official
🧪 Translational Impact of Animal Models in Migraine Research
Can animals experience headache? And how do researchers study migraine beyond human trials?
Philip Holland (King’s College London) and Greg Dussor (University of Texas at Dallas) explore the role of animal models in understanding migraine mechanisms and translating discoveries into clinical impact.
🎙️ Interviewed by Eloisa Rubio Beltran
🎥 Watch here:
www.youtube.com/watch?v=CQIE30QfAKY
#migraineresearch #translationalscience #animalmodels #ihs #neurology -
International Headache Society
@ihs_official
📣 Stay Connected with the International Headache Society!
Members of the IHS Communications Committee — Jr-wei Wu, Faraidoon Haghdoost, Heba Bani-Hani, and Sophie Yener — invite you to engage with IHS across social media platforms.
Follow, connect, and stay updated on the latest in headache science and education.
🎥 Watch here:
www.youtube.com/watch?v=aQs0KWNIxj8
#internationalheadachesociety #ihs #headacheresearch #neurology #stayconnected -
International Headache Society
@ihs_official
New in Cephalalgia!
This subgroup analysis demonstrates effectiveness of fremanezumab in preventing migraine following failure of previous preventive treatments, including onabotulinumtoxinA.
journals.sagepub.com/doi/10.1177/03331024251395029
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia and Headache!
A strong example of international collaboration in the headache research community.
Professor Simona Sacco, Editor-in-Chief of Cephalalgia, has published an editorial in Headache highlighting selected high-impact papers from 2025 in Cephalalgia, the official journal of the International Headache Society.
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/…
At the same time, Professor Amy Gelfand, Editor-in-Chief of Headache, has published an editorial in Cephalalgia to share important 2025 research from the journal of the American Headache Society.
journals.sagepub.com/doi/10.1177/03331024251403509
This cross-journal exchange helps ensure that impactful research reaches a broader global audience.
An excellent initiative that supports knowledge sharing and advances the field of headache research.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@aagelfand -
International Headache Society
@ihs_official
🧠 New Research Focus: PACAP Signaling in Migraine Management
Dive into the latest migraine science with Dr Rune Haeckert Christensen from the Danish Headache Center! He breaks down how PACAP signaling works in migraine and explains key differences between PACAP and CGRP therapies — a must-watch for clinicians and researchers.
🎥 Watch here: www.youtube.com/watch?v=RDWonOrjNAY
🔬 Presented by the International Headache Society
#migraine #pacap #cgrp #headacheresearch #ihs #neurology -
International Headache Society
@ihs_official
New in Cephalalgia!
What drives the burden of migraine? This study found that self-reported migraine days explained the disease burden. This should be considered when revising the definition of chronic migraine in the future ICHD-4.
journals.sagepub.com/doi/10.1177/03331024251406103
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Cephalalgia’s Editor’s Choice Episode 25 dives into the fascinating links between complex regional pain syndrome and migraine, with Drs Peter Drummond and Philip Finch.
🎥 Watch: www.youtube.com/watch?v=q-SfEEvq4NM
📖 Read: doi.org/10.1177/03331024251404910
#migraine #crps #painscience #cephalalgia -
International Headache Society
@ihs_official
New in Cephalalgia!
This real-world large-scale study, including >27k patients with migrain,e showed estrogen-containing combined hormonal contraceptive exposure was not associated with increased vascular risks in young women with migraine, regardless of subtypes.
journals.sagepub.com/doi/10.1177/03331024251404924
#migraine #headache #brain #pain #neurology #neuroscience
@ChiaChunChiang @KIharaMD -
International Headache Society
@ihs_official
Answer to #sundayquiz
B. James (Jim) Lance ✨
To learn more about Prof Lance and other great past presidents of the International Headache Society, visit the link below:
ihs-headache.org/en/about-ihs/meet-the-president/past-pre… -
International Headache Society
@ihs_official
New in Cephalalgia!
The authors created the composite 4D migraine scale, which includes four parameters: monthly migraine days, monthly acute medications, pain intensity, and MIDAS. This scale proved more sensitive than single measures in fully quantifying the migraine burden.
journals.sagepub.com/doi/10.1177/03331024251398020
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Which former IHS president had the perfect one liner
“The names get longer as the attacks get shorter!”
when the term “short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing” was first proposed?
A) Dieter Soyka
B) James Lance
C) Eero Hokkanen
D) Marcia Wilkinson -
International Headache Society
@ihs_official
New in Cephalalgia!
CGRP sensitizes Piezo1 channels in human induced pluripotent stem cell derived endothelial cells, boosting calcium signaling and cellular remodeling, relevant to migraine.
journals.sagepub.com/doi/10.1177/03331024251404478
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This exploratory prospective study of 100 consecutive patients at a tertiary headache clinic found associations between certain patient-reported migraine triggers and premonitory symptoms.
journals.sagepub.com/doi/10.1177/25158163251404485
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHC Posters Now Available Online 🎉
Posters from the IHC 2025 are now available in our online poster library, covering a broad range of topics in headache research.
Take a look, revisit the great science shared at IHC 2025, and explore the full collection below:👇
ihs-headache.org/en/resources/international-headache-cong…
#ihs #ihc2025 #cephalalgia2025 #migraine #headache #congress -
International Headache Society
@ihs_official
New in Cephalalgia!
Photophobia and forehead hyperalgesia are more intense ipsilateral than contralateral to complex regional pain syndrome in patients with comorbid migraine.
journals.sagepub.com/doi/10.1177/03331024251404910
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Atogepant demonstrated significantly greater reduction in mean monthly acute medication use days and significant improvement in MSQ v2.1 Role Function-Restrictive domain score compared with rimegepant in Japanese participants with episodic migraine.
journals.sagepub.com/doi/10.1177/25158163251399924
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This systematic review shows a bidirectional link between migraine and endometriosis, each raising the risk of the other and increasing disease burden. The migraine-polycystic ovarian syndrome connection remains unclear.
journals.sagepub.com/doi/10.1177/03331024251386776
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
There is a high risk of medication overuse headache in post-traumatic headache. Early and effective preventive strategies are required, including patient and clinician education.
journals.sagepub.com/doi/10.1177/03331024251404912
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
New in Cephalalgia!
This systematic review analyzes evoked potential studies in migraine, revealing distinct neurophysiological patterns and habituation deficits across migraine subtypes, especially between migraine with and without aura.
journals.sagepub.com/doi/10.1177/03331024251398792
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Complex regional pain syndrome and migraine: Clinical relationships and possible common aetiology” which has been selected as the Editor’s Choice for the December issue of Cephalalgia.
@Simona_Sacco_
....................................................
Photophobia and forehead hyperalgesia are more intense ipsilateral than contralateral to complex regional pain syndrome in patients with co-morbid migraine
journals.sagepub.com/doi/10.1177/03331024251404910
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
✨ Happy New Year 2026! ✨
As we step into 2026, the International Headache Society sends our warmest wishes for a joyful and healthy New Year.
Together, let’s celebrate progress in headache medicine and continue advancing care and improving quality of life for patients around the world. -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
Answer for #sundayquiz
A. Moderate headache on 7 days/month → Insufficient control (>6 days), not modest ❌
B. Severe headache on 5 days/month → Modest control (4–6 days), not insufficient ❌
C. Severe headache on 2 days/month → Optimal control (<4 days with moderate-to-severe headache) ✔️
D. Moderate headache on 4 days/month → Modest control (4-6 days), not optimal ❌
Correct answer is C.
To learn more, please go to: journals.sagepub.com/doi/10.1177/03331024251320608 -
International Headache Society
@ihs_official
#sundayquiz of the week
According to the 2025 IHS position statement “Setting Higher Standards for Migraine Prevention,” which headache frequency and level of control are CORRECTLY matched?
A. Moderate headache on 7 days/month — modest control
B. Severe headache on 5 days/month — insufficient control
C. Severe headache on 2 days/month — optimal control
D. Moderate headache on 4 days/month — optimal control -
International Headache Society
@ihs_official
Ready to take the next step in your career? 🚀
The International Headache Society has officially opened its 2026 Grants, Awards & Training Programmes - an exciting opportunity to advance your research, strengthen your clinical expertise, and connect with the global headache community.
To learn more, please go to: ihs-headache.org/en/resources/grants-awards-and-training-…
#grant #award #headache -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This paper highlights headache education in the sub-Saharan Africa region, barriers to migraine care, availability of migraine medications across the region and contributes suggestions to improving migraine education and management.
journals.sagepub.com/doi/10.1177/25158163251402983
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Migraine is a prevalent and disabling neurological disorder requiring effective acute treatment. However, access to optimal therapies varies significantly across healthcare systems in Mexico.
journals.sagepub.com/doi/10.1177/25158163251399923
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎄✨ Happy Holidays from the International Headache Society!
We extend our warmest wishes to all who are dedicated to headache medicine, as well as to everyone living with #headache disorders. We wish you a healthy and joyful holiday season. -
International Headache Society
@ihs_official
New in Cephalalgia!
Medication overuse headache hospitalisation rates, and length of stay have declined over time in Australia. Females and individuals aged over 60 were consistently overrepresented in admissions.
journals.sagepub.com/doi/10.1177/03331024251404451
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
There is limited RCT evidence supporting Greater occipital nerve block (GONB) for the treatment of migraine. Existing systematic reviews should be interpreted with caution. RCTs with homogenous methodologies are required to evaluate GONB in the management of migraine.
journals.sagepub.com/doi/10.1177/03331024251398390
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Corticosteroids increase CGRP expression in cell lines as well as in rodent. The present study suggests that the interplay among endogenous CGRP signaling, corticosteroids and migraine is more complex than previously envisaged.
journals.sagepub.com/doi/10.1177/03331024251367043
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to share the invitation to the 6th Master of Headache Disorders at the University of Copenhagen (2026–2028).
Since its launch, the programme has graduated 88 students from 36 countries, with 26 additional graduates expected in June 2025. Most graduates are now actively working in the headache field through clinical practice, teaching, and scientific research, contributing to the advancement of headache activities worldwide.
To learn more, please go to: continuing-education.ku.dk/master-of-headache-disorders/ -
International Headache Society
@ihs_official
New in Cephalalgia!
miR-34a and miR-382-5p show higher expression in peripheral blood mononuclear cells compared to monocytes, with this difference being largely driven by chronic migraine-medication overuse-related alterations, emphasizing the need for cell-specific analyses.
journals.sagepub.com/doi/10.1177/03331024251386769
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The present Delphi study has established internationally derived consensus guidelines and recommendations for the evaluation and comprehensive management of patients with persistent idiopathic facial pain.
journals.sagepub.com/doi/10.1177/03331024251399927
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
While AI has demonstrated success in predicting migraine treatment responses, future research incorporating novel AI techniques and diverse data sources could pave the way to advance personalized migraine treatment.
journals.sagepub.com/doi/10.1177/03331024251395541
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Ready to take the next step in your career? 🚀
The International Headache Society has officially opened its 2026 Grants, Awards & Training Programmes - an exciting opportunity to advance your research, strengthen your clinical expertise, and connect with the global headache community.
To learn more, please go to: ihs-headache.org/en/resources/grants-awards-and-training-…
#grant #award #headache -
International Headache Society
@ihs_official
New in Cephalalgia!
The addition of atogepant to OnabotulinumtoxinA is effective and well tolerated in real-world patients with Chronic migraine, including those previously exposed to multiple preventives.
journals.sagepub.com/doi/10.1177/03331024251398011
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study provides evidence that gepants reach the mouse brain, suggesting that they can exert antimigraine effects through a central action.
journals.sagepub.com/doi/10.1177/03331024251378713
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This review summarizes the management of migraine in pregnancy, when planning pregnancy, and when breastfeeding.
journals.sagepub.com/doi/10.1177/03331024251393945
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
✅ The answer to the Sunday Quiz is: C! 🎯
According to ICHD-3, 4.3 Primary headache associated with sexual activity requires at least two episodes. The headache may last from 1 minute up to 24 hours with severe intensity, or up to 72 hours with mild intensity.
In ICHD-I and ICHD-II, this disorder was subdivided into pre-orgasmic and orgasmic headache types. However, this distinction is no longer applied in ICHD-3.
#headacheknowledge #ichd3 #sundayquiz -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This review highlights the urgent challenges in delivering effective migraine care across North African countries—where access, diagnosis, and treatment remain limited, especially for women and rural populations.
journals.sagepub.com/doi/10.1177/25158163251403011
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Headache care in Africa: The IHS Regional Outreach Program trains non-physician clinicians to diagnose & manage headaches in Malawi. A scalable model supporting WHO IGAP goals & health equity through global-local partnerships. #globalhealth
journals.sagepub.com/doi/10.1177/03331024251404465
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Bridging headache neurology and orofacial pain: this invited commentary highlights diagnostic nuance and pragmatic treatment in persistent idiopathic facial pain.
journals.sagepub.com/doi/10.1177/03331024251399929
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz of the Week 🧠
In ICHD-3, which of the following statements is CORRECT regarding 4.3 Primary headache associated with sexual activity?
A. A single episode is sufficient for diagnosis
B. Headache lasts from 10 minutes to 24 hours with severe intensity.
C. The headache can last up to 72 hours with mild intensity
D. In ICHD-3, the pre-orgasmic & orgasmic types are classified separately
#ichd3matters #sexinducedheadache #headachemedicine -
International Headache Society
@ihs_official
🌟 Calling all researchers, clinicians, and trainees in headache medicine!
The International Headache Society has opened the 2026 Grants, Awards & Training Programmes, a fantastic opportunity to grow your career, expand your research, and deepen your clinical expertise in headache science and care! 🚀🚀🚀
To learn more, please go to: ihs-headache.org/en/resources/grants-awards-and-training-…
#grant #award #headache -
International Headache Society
@ihs_official
🎥 New video series now live!
We’re excited to introduce our new YouTube video series, featuring expert conversations and insights from the global headache community. From cutting-edge research to clinical perspectives, these videos bring key topics in headache medicine closer to you.
👉 Watch the full playlist here: www.youtube.com/playlist?list=PLwh0UqS-bULOEIOfkkf_sgY7i2…
#ihs #headache #migraine -
International Headache Society
@ihs_official
We’re delighted to announce that the International Headache Society’s Facebook page has grown to 14,000 followers!
This year, we not only continued to share updated knowledge in headache medicine and provide reliable information for patients, but also brought real-time news from #ihc2025 and headache conferences around the world.
Thank you all for being part of our growing community ❤️
#ihs #migraine #headache #14kfollowers #thankyou -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
[IHS News from Recent Meetings]
The final day of the 2025 Scottsdale Headache Symposium highlighted post-traumatic headache, with Dr. Catherine Chong and Prof. Peter Goadsby serving as moderators.
The session included an overview of how pathophysiology informs clinical management by Dr. Todd Schwedt; a discussion of cognitive, autonomic, and vestibular symptoms following head injury by Dr. Josh Kamins; practical strategies for return-to-life planning from Dr. Nina Riggins; and important considerations for contact sports and pediatric patients presented by Dr. Carlyn Patterson Gentile.
#ahsaz #headache #pth -
International Headache Society
@ihs_official
During the 2025 Scottsdale Headache Symposium in Scottsdale, Arizona, Prof. Peter Goadsby and Prof. Andrew Charles delivered an insightful debate on the practical question: “Should gepants be used as first-line treatment before triptans?”
#ahsaz #neurology -
International Headache Society
@ihs_official
[IHS News from Recent Meetings]
The European Headache Congress 2025, themed “Transforming Challenges into Solutions,” was held in the vibrant and historic city of #lisbon. The congress featured presentations on new treatment strategies and highlighted emerging directions in headache research.
#ehc2025 #headache #congress -
International Headache Society
@ihs_official
New in Cephalalgia!
Altered brain network connectivity found in both mnstrually-related migraine (MRM) and non-menstrual migraine (NMM) patients; MRM shows stronger connectivity in the left frontoparietal network vs. NMM; Weaker dorsal attention–default mode connectivity unique to MRM
journals.sagepub.com/doi/10.1177/03331024251396102
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
New Austrian Network for Idiopathic Intracranial Hypertension (AN4IH) consensus sets the standard for interdisciplinary care in idiopathic intracranial hypertension (IIH) in Austria defining structure, diagnostics, treatment, and monitoring for specialized centers. A major step toward optimized care
journals.sagepub.com/doi/10.1177/03331024251391374
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This trial rigorously demonstrated the efficacy of rimegepant for the preventive treatment of episodic migraine in participants with a documented history of inadequate response to prior oral preventive medications.
journals.sagepub.com/doi/10.1177/03331024251391378
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Abnormal neurovascular coupling (NVC) in the precuneus was involved in migraine chronification, with depression serving as a mediator in this process. NVC metric may serve as a biomarker for migraine chronification in the future
journals.sagepub.com/doi/10.1177/03331024251396031
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This is the first randomized study to demonstrate efficacy of a gepant for acute treatment of migraine in individuals unsuitable to triptans and provides evidence that rimegepant may be an appropriate therapeutic option in this population.
journals.sagepub.com/doi/10.1177/03331024251395298
#migraine #headache #brain #pain #neurology #neuroscience
@hmru_cph, @Janu_MD_, @MessoudAshina -
International Headache Society
@ihs_official
New in Cephalalgia!
A substantial variety exists in definitions used for a migraine day, even in recent large robust clinical trials. There is a pressing need for a standardized accepted definition of a migraine day, both from a clinical and research perspective.
journals.sagepub.com/doi/10.1177/03331024251393986
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
[IHS News from Recent Meetings]
The 2025 Taiwan Headache Society Annual Meeting featured a series of sessions highlighting the latest advances in headache medicine. Topics ranged from new scientific insights, discussions on vertigo and migraine, and emerging therapeutic targets, to updates on the ongoing development of ICHD-4 and the 2025 IHS standard and statement on early treatment.
To emphasize the importance of holistic patient care, the meeting also included key scientific sessions on fibromyalgia, migraine comorbidities, and neuromodulation, offering perspectives for both clinical practice and future research.
#headache #migraine #congress -
International Headache Society
@ihs_official
Happening now at the 2025 Taiwan Headache Society Annual Meeting.
Prof. Sait Ashina is delivering an insightful lecture on 'The CGRP-Targeted Therapy Era and Emerging Targeted Treatments for Migraine.' #headache #migraine #ths #congresss -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
New in Cephalalgia!
The results show that cannabidiol (CBD) and tetrahydrocannabinol (THC) can prevent both photophobia (light aversion) and pain (squint) caused by a centrally acting migraine trigger in mice. This further supports the likelihood that cannabinoids could be effective therapeutics.
journals.sagepub.com/doi/10.1177/03331024251392103
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study of 100 consecutive patients who attended a tertiary headache clinic in Australia found significant delays between time of migraine symptom onset and receiving a formal diagnosis of migraine as well as preventive treatment.
journals.sagepub.com/doi/10.1177/25158163251398869
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Existing results show the potential to predict migraine attacks and improve the quality of life of those with migraine.
journals.sagepub.com/doi/10.1177/03331024251391207
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Vestibular migraine is a frequent cause of vertigo with limited acute treatment options. This study reports a patient who experienced relief from lasmiditan, highlighting its potential as a novel therapeutic approach.
journals.sagepub.com/doi/10.1177/25158163251397366
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Headache care in Africa: The IHS Regional Outreach Program trains non-physician clinicians to diagnose & manage headaches in Malawi. A scalable model supporting WHO IGAP goals & health equity through global-local partnerships. #globalhealth
journals.sagepub.com/doi/10.1177/25158163251396915
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The Committee plans to consider further whether the terms “medication overuse” and “medication-overuse headache” are pejorative and if there are better terms to be used in the ICHD-4.
journals.sagepub.com/doi/10.1177/03331024251391371
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
This study embedded a neurology clinic offering headache services within a primary care clinic treating an underserved populations. The study reports on access, diagnoses and prescriptions of migraine-specific medications over three years.
journals.sagepub.com/doi/10.1177/25158163251391825
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
An estimated 4.9-5.9% of all time in Pakistan is spent with headache leading to substantial productivity loss. According to this data almost one third of the Pakistani would be expected to benefit from professional headache care.
journals.sagepub.com/doi/10.1177/03331024251386101
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In 100 patients with refractory migraine, 66% remained on anti-CGRP monoclonal antibodies after 3 years. Switching or temporary discontinuation improved persistence, supporting individualized treatment strategies.
journals.sagepub.com/doi/10.1177/25158163251388920
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
A correction to International guidelines on the pharmacological treatment of migraine will soon come thanks to the report of drs. Tfelt-Hansen and Hougaard.
journals.sagepub.com/doi/10.1177/03331024251393936
#migraine #headache #brain #pain #neurology #neuroscience
@RaffaeleOrnello
@Simona_Sacco -
International Headache Society
@ihs_official
New in Cephalalgia!
Suggested implementation: When the full evidence is included and accurately tabulated, the recommendation for nasal zolmitriptan 5 mg warrants a change from “suggest against” to “recommend for” acute treatment of migraine attacks, with “high quality of evidence” and “strong strength of the recommendation”.
journals.sagepub.com/doi/10.1177/03331024251393937
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
✨ Missed our latest webinar? Don’t worry — you can catch up anytime! ✨
All of our recent and past IHS webinars are available for viewing, so you never have to miss out on expert insights.
Our live webinars bring together leading global specialists to discuss the latest clinical and scientific topics in headache medicine — with real-time Q&A so you can engage directly with the experts.
If you can’t join live, remember: every session is recorded and available to watch afterward.
Don’t miss the opportunity to learn, revisit, and stay up to date! 🎥💡
ihs-headache.org/en/learning-centre/resources/categories/… -
International Headache Society
@ihs_official
The International Headache Society’s Core Curriculum is an essential resource defining the minimum knowledge neurologists need for specialist qualification in headache medicine.
💬 And great news: The Core Curriculum is available in multiple translations, making it more accessible to clinicians and trainees globally.
🔗 Explore and download the curriculum in the language that suits you best! ihs-headache.org/en/learning-centre/ihs-core-curriculum/ -
International Headache Society
@ihs_official
New in Cephalalgia!
The latest estimates of the Global Burden of Disease (GBD) study are now
published. Headache disorders once again rank among the top causes of healthloss quantified as years lived with disability (YLDs).
journals.sagepub.com/doi/10.1177/03331024251392884
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
New IHS practice guidelines: First evidence-based recommendations for non-invasive neuromodulation devices in migraine! #migraine #neuromodulation
journals.sagepub.com/doi/10.1177/03331024251388377 -
International Headache Society
@ihs_official
New in Cephalalgia!
Cannabinoid compounds may represent safe and effective alternatives for the treatment of episodic and chronic #migraine.
journals.sagepub.com/doi/10.1177/03331024251386794
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
International Classification of Orofacial Pain (ICOP) – Towards version 2.0: Update of the comprehensive classification system for orofacial pain
journals.sagepub.com/doi/10.1177/03331024251393111
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Higher Selenium levels are associated with a lower risk of migraine. Sex-specific effects showed reduced risk of migraine without aura in men and chronic migraine in female. #elsa_brasil @usponline
journals.sagepub.com/doi/10.1177/03331024251386768
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Men showed a later headache onset with a higher risk of secondary headaches, were less likely to be diagnosed or treated, and had a higher prevalence of trigeminal autonomic cephalalgias.
journals.sagepub.com/doi/10.1177/25158163251390417
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This review explores how monogenic disorders contribute to our understanding of migraine mechanisms. By analyzing key genes and clinical phenotypes, this study highlights potential therapeutic targets and new directions for precision medicine.
journals.sagepub.com/doi/10.1177/03331024251389241
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
For millions of people with migraine, new hope may be on the horizon. This study uncovered an association between the herpes simplex virus and migraine headaches. This research might open a door to developing innovative new treatments.
journals.sagepub.com/doi/10.1177/25158163251391285
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Dr Faraidoon Haghdoost, Social Media Editor for Cephalalgia and Cephalalgia Reports, talks about the new paper titled “International Headache Society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine”. The guidelines summarise evidence from 15 randomised controlled trials on devices such as SAVI Dual, Cefaly, Relivion, Nerivio, and gammaCore Sapphire, highlighting their safety, tolerability, and growing role as alternatives or additions to traditional drug treatments. The authors note that while the results are promising, the quality of evidence varies and more research is needed.
journals.sagepub.com/doi/10.1177/03331024251388377
#migraine #headache #neurologyThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Regular patient education every two weeks by a trained medical doctor using a WHO-recommended educational material, along with the standard of care, improved quality of life, disability, and headache impact in chronic migraine patients.
journals.sagepub.com/doi/10.1177/25158163251391185
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
IHS proposes a new #migraine preventive strategy based on the early initiation of effective and tolerable preventive therapies. According to current clinical data, early treatment improves patient outcomes.
journals.sagepub.com/doi/10.1177/03331024251387721
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Neck pain can be a trigger, symptom, or comorbidity in #migraine and is frequently misdiagnosed. This review outlines a framework for accurate assessment and treatment using both pharmacological and non-pharmacological approaches.
journals.sagepub.com/doi/10.1177/03331024251387449
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Study on 100 pediatric primary headache patients: 17% had obsessive-compulsive symptoms, more frequent in females and with neurovegetative symptoms. Routine screening is recommended.
journals.sagepub.com/doi/10.1177/25158163251391144
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This video, presented by Dr Faraidoon Haghdoost, Social Media Editor of Cephalalgia, discusses the paper titled: Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society.
The message is clear: migraine prevention should begin early, long before disability becomes severe. By shifting from reacting to attacks toward protecting long-term brain health, early preventive treatment can improve quality of life and potentially change the natural course of migraine.
Paper link: journals.sagepub.com/doi/10.1177/03331024251387721
#migraine #headache #brainhealth #cephalalgia #internationalheadachesociety #earlyintervention #neurologyThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in Cephalalgia!
This letter proposes specific and actionable recommendations for the forthcoming ICHD-4 to better align it with ICOP criteria for orofacial trigeminal autonomic cephalalgias and migraine.
journals.sagepub.com/doi/10.1177/03331024251391751
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
All late-breaking abstracts from the 22nd International Headache Congress (IHC 2025) have been published in Cephalalgia.
Check the link below to access. the abstracts
journals.sagepub.com/toc/cepa/45/1_suppl
#ihc2025 #cephalalgia2025 #migraine #headache #conference -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
New IHS Webinar: The Latest Research on Headaches in Children and Adolescents
What’s new in headache research for children and teens? Join leading researchers funded by the IHS Child and Adolescent Committee as they reveal the latest discoveries and discuss what’s next in understanding headaches in the young.
For more info and registration click the link below:
ihs-headache.org/en/news/ihs-webinar-on-headache-research…
#ihs #webinar #child #adolescence #headache_research -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Introducing a risk score for predicting ischemic stroke in migraine with or without visual aura” which has been selected as the Editor’s Choice for the October issue of Cephalalgia.
..................................................
New migraine associated risk of stroke score (MARS+) predicts stroke risk in migraine patients! Study of 1,485 people found that those with a score ≥5 have 4x higher stroke risk. The first tool made specifically for patients with migraine.
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/03331024251388094 -
International Headache Society
@ihs_official
New In Cephalalgia!
New migraine associated risk of stroke score (MARS+) predicts stroke risk in migraine patients! Study of 1,485 people found that those with a score ≥5 have 4x higher stroke risk. The first tool made specifically for patients with migraine.
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/03331024251388094 -
International Headache Society
@ihs_official
New in Cephalalgia!
This study evaluates ChatGPT-4o's accuracy on migraine-related topics, comparing its responses to medical literature. While generally reliable, the AI showed conceptual errors and false citations, highlighting the need for expert oversight
journals.sagepub.com/doi/10.1177/03331024251387684
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Friday Fact 🧠
Did you know that headache attributed to idiopathic intracranial hypertension (7.1.1) can masquerade as migraine or tension-type headache?
It develops when CSF pressure rises above 250 mm H₂O and is often accompanied by papilledema or pulsatile tinnitus. 👁️🎧
Do you have patients diagnosed with this condition?
#fridayfact #funfact #ihsheadache #neurofact #headachedisorders #neurology -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
🔬 New study protocol: Investigating how cilostazol triggers migraine in men vs. women with migraine without aura. Exploring sex differences in cAMP pathways to improve personalized treatments.
journals.sagepub.com/doi/10.1177/25158163251388611
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Children and adolescents with migraine demonstrate cervical musculoskeletal impairments (neck pain, reduced cervical mobility—especially in lateral flexion and upper cervical rotation—and heightened sensitivity) in craniocervical muscles.
journals.sagepub.com/doi/10.1177/03331024251387033
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Whole-body resistance exercise was shown to reduce attack frequency and intensity of migraine, but there was little evidence. For patients seeking non-pharmacological approaches, this provides a potential complimentary option.
journals.sagepub.com/doi/10.1177/25158163251383149
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study showed a pattern of increasing migraine-related disability with rising headache frequency.
The results also suggest that high-frequency episodic migraine (8-14 monthly headache days) is a severely disabling migraine subtype.
journals.sagepub.com/doi/10.1177/03331024251385965
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In 328 new daily persistent headache patients, white matter hyperintensities were seen in ~20%. Acute and preventive treatments were largely ineffective. Desvenlafaxine (54.6%) and venlafaxine (25%) were the best preventives for migraine and tension-type phenotypes, respectively.
journals.sagepub.com/doi/10.1177/25158163251386409
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Imagine seeing constant static — like a TV 📺 that never turns off.
Visual Snow is characterized by continuous flickering dots across the visual field for more than 3 months, often accompanied by afterimages (palinopsia), photophobia, floaters, or difficulty seeing at night (nyctalopia).
🔗 Learn more: ichd-3.org/appendix/a1-migraine/a1-4-complications-of-mig…
#visualsnow #ichd3matters #headachesociety #ihs #neurology #brainhealth -
International Headache Society
@ihs_official
New in Cephalalgia!
This study confirms the gradual decrease of standard preventive treatments during anti-CGRP therapy. A comorbid condition maintained the concomitant standard preventive treatments after 1 year of treatment.
journals.sagepub.com/doi/10.1177/03331024251378776
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Collegiate student athletes with a history of migraine performed worse on visual-motor tasks than their peers without migraine history.
journals.sagepub.com/doi/10.1177/25158163251378621
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Greater occipital nerve block improved acute migraine pain and 30-day outcomes in a randomized trial conducted in emergency care.
journals.sagepub.com/doi/10.1177/03331024251381764
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study uses Magnetoencephalography (MEG) and graph theory to reveal frequency-specific network disruptions in Tension-type headache (TTH), highlighting altered connectivity and topology in pain-related brain regions, offering insights for diagnosis and therapeutic strategies.
journals.sagepub.com/doi/10.1177/03331024251386425
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We’re delighted to share that the paper “Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
journals.sagepub.com/doi/10.1177/03331024251387721
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz of the week!
According to the ICHD-3, which of the following statements regarding primary stabbing headache is CORRECT?
A. Stab could be accompanied by cranial autonomic symptoms
B. Stabs recur with irregular frequency, from one to many per day
#ichd3matters #primarystabbingheadache -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Have you ever wondered what ‘migraine’ is called in other languages, like Arabic? Interestingly, in Arabic, there are two common synonyms for migraine: al-shaqiqah and ṣudā‘ niṣfī. To learn more, check out this paper!
journals.sagepub.com/doi/10.1177/25158163251379885
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Rimegepant 75 mg administered PRN for up to 52 weeks demonstrated a favorable safety profile and was well-tolerated.
journals.sagepub.com/doi/10.1177/03331024251371686
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Greater occipital nerve injection in combination with standard verapamil treatment provides faster reduction in attack frequency than verapamil alone and decreases the adverse events over the first 4 weeks after injection.
journals.sagepub.com/doi/10.1177/03331024251370324
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We’re delighted to share that the paper “International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
journals.sagepub.com/doi/10.1177/03331024251388377
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The phase 3, randomized, double-blind, placebo-controlled SUNRISE trial evaluated eptinezumab 100 mg, 300 mg, or placebo for prevention of chronic migraine among a predominantly Asian population.
Eptinezumab demonstrated statistically significant greater reductions in monthly migraine days compared with placebo.
journals.sagepub.com/doi/10.1177/03331024251386095
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Real-world study shows that the external combined occipital and trigeminal neurostimulation (eCOT-NS) neurostimulation device reduces monthly headache days over three months, especially with higher adherence, but larger confirmatory studies are needed.
journals.sagepub.com/doi/10.1177/25158163251377996
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Classification research is emerging as an important avenue of headache research. It has a multitude of different designs available and many of them do not need advanced equipment.
The international headache classification ICHD has developed significantly from edition to edition. Even after ICHD-3 a lot remains, however, to be studied.
journals.sagepub.com/doi/10.1177/03331024251377753
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 Neurological conditions are now the leading cause of ill health and disability worldwide.
According to the new WHO Global Status Report on Neurology, over 3 billion people — that’s more than 40% of the global population — are affected by neurological conditions every year.
The report calls for urgent global action to strengthen brain health strategies and improve access to care across all countries.
🔗 Learn more in the new WHO report:
👉 www.who.int/publications/i/item/9789240116139
#brainhealth #neurology #globalhealth #oneneurology #headachesociety #ihs #neuroscience #publichealth -
International Headache Society
@ihs_official
New in Cephalalgia!
Headaches are disabling, overlooked, and untreated in the armed forces. This study of 900+ German soldiers shows an urgent need for structured headache care in military settings. #migrainecare #cephalalgia #headacheawareness
journals.sagepub.com/doi/10.1177/03331024251374310
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
The Chordate System S020 delivers kinetic oscillation to the nasal mucosa, which is supposed to modulate the parasympathetic outflow
Treatment with the Chordate System S020 had no statistically significant effect on acute migraine headache relief.
journals.sagepub.com/doi/10.1177/25158163251377699
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Transcranial magnetic stimulation of the dorsolateral prefrontal cortex could be a non-pharmacological treatment option for chronic migraine patients refractory to monoclonal antibodies against CGRP.
journals.sagepub.com/doi/10.1177/03331024251364843
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 The IHC 2025 Abstracts are published!
The abstracts from the International Headache Congress 2025 are now published in Cephalalgia.
Explore the latest research and advances in headache and migraine from around the world.
🔗 Read the full supplement here: journals.sagepub.com/toc/cepa/45/1_suppl
#ihc2025 #headachesociety #cephalalgia #headacheresearch #migraine #neurology #globalscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The importance of treating migraine attacks early – even in youth: A real-world argument for neuromodulation
journals.sagepub.com/doi/10.1177/03331024251370675
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The PRECLUDE trial demonstrated that onabotA was well tolerated but did not show significant efficacy compared to placebo for the endpoint reducing migraine days from baseline in patients with episodic migraine (EM).
The discrepancy in results between the PREEMPT chronic migraine (CM) trials and the PRECLUDE EM trial highlights the complexity and variability in migraine pathophysiology between CM and EM and the challenges in managing the different subtypes of migraine.
journals.sagepub.com/doi/10.1177/03331024251370769
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Qualitative interviews with uncontrolled headache patients offers valuable insights for systems-level care.
journals.sagepub.com/doi/10.1177/25158163251378644
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to cortical spreading depression and decreases their number in female mice. OnabotA may have a non-neuronal mechanism of action in migraine.
journals.sagepub.com/doi/10.1177/03331024251378730
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
An international consensus using the Delphi method led to the development of 4 proposed definitions of refractory migraine: refractory migraine, probable refractory migraine, resistant migraine, and treatment-responsive migraine.
journals.sagepub.com/doi/10.1177/03331024251367767
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Data from 55,261 patients and 586,981 treatments shows that treating within 1-hour of migraine onset with Remote Electrical Neuromodulation (REN) doubles pain-freedom rates, emphasizing the importance of “treat as early as possible”.
journals.sagepub.com/doi/10.1177/03331024251370696
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
✅ The answer to the Sunday Quiz is: A! 🎯
According to the ICHD-3, hypnic headache lasts 15 minutes up to 4 hours after waking and occurs on ≥10 days per month for > 3 months — not "Occurring on ≥15 days/month for >3 months."
#headacheknowledge #ichd3 #hypnicheadache #mededucation -
International Headache Society
@ihs_official
New in Cephalalgia!
Atogepant treatment demonstrated statistically significant and clinically meaningful reductions in mean monthly migraine days compared with placebo across the 12-week double-blind treatment period in Japanese participants with episodic migraine.
journals.sagepub.com/doi/10.1177/03331024251374569
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
OnaBTX-A offers a promising option for managing post-traumatic headaches, particularly in cases involving temporalis muscle hypertrophy.
journals.sagepub.com/doi/10.1177/25158163251376557
#migraine #headache #brain #pain #neurology #neuroscience
@HanySaeid9 -
International Headache Society
@ihs_official
New in Cephalalgia!
Visual Snow Syndrome represents a distinct neurological disorder, not just a migraine or aura variant. New review shows unique brain network changes and calls for targeted treatments.
journals.sagepub.com/doi/10.1177/03331024251365908
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
#sundayquiz of the week!
According to the ICHD-3, which of the following statements regarding hypnic headache is CORRECT?
A. Lasting from 15 minutes up to 4 hours after waking
B. Occurring on ≥15 days/month for >3 months.
#ichd3matters #headache #hypnicheadache -
International Headache Society
@ihs_official
New in Cephalalgia!
Neuroimaging evidence suggests that, although migraine with aura and migraine without aura share many characteristics, there are differences in functional connectivity, brain activity, and some structural parameters that may contribute to the different clinical manifestations.
journals.sagepub.com/doi/10.1177/03331024251365807
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Letter to the Editor
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials
journals.sagepub.com/doi/10.1177/03331024251381337
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Letter to the Editor
Complementary, but not equivalent: Clarifying the role of real-world evidence and randomized controlled trials in migraine research.
journals.sagepub.com/doi/10.1177/03331024251381333
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Looking both ways: understanding the future of cluster headache.
In this insightful Cephalalgia editorial, authors reflect on the new prospective study by Lee et al., which reveals that the disease activity of episodic cluster headache tends to rise after onset and later decline over time — offering patients and clinicians a clearer view of what lies ahead.
journals.sagepub.com/doi/10.1177/03331024251368258
#cephalalgia #clusterheadache #headacheresearch #ihs #editorial -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine is increasingly understood as a brain network dysfunction, where altered connectivity, cortical hyperexcitability, and sensory hypersensitivity contribute to its associated cognitive impairment.
journals.sagepub.com/doi/10.1177/03331024251368328
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know ICHD-3 also included “Headache attributed to external application of a cold stimulus”? 🧊
This headache results from external cooling of the head — such as exposure to very cold weather, diving into cold water, or receiving cryotherapy. It appears only during the application of the cold stimulus and usually resolves within 30 minutes once the cold is removed.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-5-cold-stim…
#ichd3matters #neurology #brainfreeze #headache -
International Headache Society
@ihs_official
New in Cephalalgia!
New data on the prognosis of cluster headache (CH) have been released, including subtype shift, incidence rate of primary chronic CH, and relapse rate of bouts, based on a prospective observation of 295 patients with CH.
journals.sagepub.com/doi/10.1177/03331024251368259
#clusterheadache #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The optimization of the management of migraine and temporomandibular disorders (TMDs) when they are comorbid requires the integrated care of medicine and dentistry, where the dental discipline and specialty of orofacial pain is the meeting point.
journals.sagepub.com/doi/10.1177/03331024251368882
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Generative AI chatbots can transform headache care by tackling major gaps in education and research. With targeted innovation and strong evaluation, they hold real promise to revolutionize how we understand and manage #headache #ai
journals.sagepub.com/doi/10.1177/03331024251372117
#migraine #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
The impact of psychiatric comorbidities in children and adolescents with headache disorders is better understood through a biopsychosocial perspective, underscoring the critical role of resilience and executive function.
journals.sagepub.com/doi/10.1177/03331024251364204
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Migraine burden in the Middle East is an emerging public health focus.
•
In Gulf Cooperation Council (GCC) countries, patients with migraine are managed by a network of healthcare professionals composed of three levels: primary care physicians, general neurology clinics, and headache clinics.
•
To improve the care of migraine patients, we should improve patient education and awareness of migraine, improve the education of general practitioners, increase the number of headache specialists and specialized headache clinics, and improve the role of nurses in caring for migraine patients.
•
Most GCC countries have access to a broad spectrum of migraine medications, including simple pain relief in addition to prescription drugs like triptans, BoNT-A injections, and monoclonal antibodies.
journals.sagepub.com/doi/10.1177/25158163251374141
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This review synthesizes the latest preclinical findings comparing PACAP and CGRP in migraine models, highlighting both shared and divergent pathways in their roles as neuropeptide modulators.
journals.sagepub.com/doi/10.1177/03331024251364242
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We’re delighted to share that the paper “Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care”, a position paper of the IHS Child and Adolescent Committee, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution, which highlights the need for coordinated, patient-centred models of care to support young people transitioning from paediatric to adult headache services.
journals.sagepub.com/doi/full/10.1177/03331024251374686
#cephalalgia #headacheresearch #ihs #childandadolescentcommittee #essentialreading -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
New in Cephalalgia!
How can we ensure young people with headache disorders don’t fall through the cracks as they grow? This new position paper by the IHS Child & Adolescent Committee explores models, gaps, and solutions in the transition of care.
doi.org/10.1177/03331024251374686
#migraine #headache #brain #pain #neurology #neuroscience
@aynurozge -
International Headache Society
@ihs_official
new in cephalalgia reports!
Despite strong empirical support and endorsement by professional practice organizations, behavioral interventions are not widely accessible to headache patients. Telemedicine-based cognitive behavioral therapy (TENACITY) tests a cognitive behavioral therapy for headache delivery model.
doi.org/10.1177/25158163251374156
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine auras are often followed by headache and sometimes not. Sometimes headaches occur shortly after the aura starts. How should we think about it, and what is going on in the brain?
doi.org/10.1177/03331024251370629
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Probable medication overuse headache was seen in 16% of Danish cluster headache sufferers. It was associated with concurrent migraine, chronic cluster headache, and a worse effect of acute and preventive treatment.
doi.org/10.1177/03331024251364241
#migraine #headache #brain #pain #neurology #neuroscience
@nunu.lund -
International Headache Society
@ihs_official
[IHS Member Alert]
Fake emails claiming to be from IHS President Prof. Mario Peres are in circulation. The fraudulent address is thepresidentboard2020@gmail.com
🚫 Please ignore such emails. Do not click any links, and do not reply. -
International Headache Society
@ihs_official
new in cephalalgia reports!
CGRP-mAbs are generally well tolerated for migraine prevention. However, this study reports a rare case of severe allergic reaction after switching agents. Further studies are needed to clarify the safety of switching CGRP-mAbs.
doi.org/10.1177/25158163251373091
#migraine #headache #brain #pain #neurology #neuroscience
@nagahakui @don_ikko19035 -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine is poorly understood with significant stigma that can lead to social isolation, reduced support, and increased psychological distress.
doi.org/10.1177/03331024251368251
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Atogepant 60 mg daily demonstrated meaningful clinical benefit and good tolerability in real-world patients with treatment-resistant chronic migraine over a 24-week period. These findings extend RCT data and previous real-world settings.
doi.org/10.1177/03331024251370608
#migraine #headache #brain #pain #neurology #neuroscience
@doctorsundal -
International Headache Society
@ihs_official
new in cephalalgia reports!
Migraine-related sensory hypersensitivity, such as hyperacusis, may be mediated by CGRP pathways, supporting a shared pathophysiological mechanism.
doi.org/10.1177/25158163251373059
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine aura symptoms are polyhedric with hundreds of scenarios. In this study, all their variables were collected and their spectrum of presentations was explored.
The findings of this review show that migraine auras present a wide and multi-faceted spectrum of symptoms, generating hundreds of possible scenarios. Therefore, a detailed aura diary to complete during attacks will be of utmost importance to move toward a precise phenotypic classification.
doi.org/10.1177/03331024251372621
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Transient receptor potential vanilloid 2 (TRPV2) promotes NLRP3 inflammasome activation and microglial M1 polarization in vestibular migraine. Blocking TRPV2 reduces neuroinflammation and central sensitization, highlighting it as a potential therapeutic target for VM.
journals.sagepub.com/doi/10.1177/03331024251364753
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
High migraine prevalence may not reflect the unchecked perpetuation of a flawed human genome but rather a feature of societies that evolved to prioritize inclusion, interdependence, and cognitive labor.
doi.org/10.1177/03331024251374315
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
new in cephalalgia reports!
A Systematic Review of Case Reports and Case Series" explores the effectiveness of Botulinum Toxin A (BoNT-A) in managing post-craniotomy headaches (PCH).
doi.org/10.1177/25158163251371150
#migraine #headache #brain #pain #neurology #neuroscience
@HanySaeid9 -
International Headache Society
@ihs_official
New in Cephalalgia!
Non-invasive stimulation of the vagus nerve is a well-tolerated and should be considered early in the preventive treatment of trigeminal autonomic cephalalgias.
doi.org/10.1177/03331024251370339
#cluster #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Non-invasive neuromodulation, especially vagus nerve stimulation, is a key therapeutic option in cluster headache and other TACs. Its role deserves greater recognition in clinical practice.doi.org/10.1177/03331024251370318
#cluster #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
A substantial overlap between commonly reported migraine triggers and premonitory symptom were found in this study. These finding suggests that some trigger factors might potentially be early warning signs or vice versa.
doi.org/10.1177/03331024251364234
@Janu_MD_ @MessoudAshina @h_ashina @hmru_cph -
International Headache Society
@ihs_official
New in Cephalalgia!
The current study demonstrates altered brain structure in persistent post-traumatic headache using MRI. Changes in pain-processing brain regions similar to migraine suggest shared neurobiological mechanisms.
journals.sagepub.com/doi/10.1177/03331024251362830
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
How safe and effective is atogepant as a preventive therapy for migraine? This new study reports long-term results showing consistent benefit and no alarming safety surprises — a major step forward in migraine care.
Long-term treatment with atogepant is safe, well-tolerated, and effective for the preventive treatment of migraine.
journals.sagepub.com/doi/10.1177/03331024251365206
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Exploring the role of EEG in diagnosing pediatric migraine, especially in children with a family history of migraine/epilepsy or those with aura. Learn how EEG supports diagnosis and treatment decisions for better care. #pediatricmigraine
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/25158163251371154 -
International Headache Society
@ihs_official
New in Cephalalgia!
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine
In both phase 1 and phase 2 testing, the incidence of treatment-emergent adverse events (TEAEs), as well as the mean changes in clinical laboratory values and vital signs, were similar between groups, with no treatment-related serious adverse events (SAEs).
journals.sagepub.com/doi/10.1177/03331024251368757
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Migraine is associated with higher Work–family conflict (WFC), especially in strain-based domains, with a stronger effect in men. These findings emphasize the need for workplace and clinical strategies to support migraine patients in managing work-life balance.
journals.sagepub.com/doi/10.1177/03331024251352533
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Neurological symptoms associated with migraine change over time with fewer migraine-associated symptoms, particularly resolution of nausea and vomiting, being associated with improvement, but did not predict improvement.
journals.sagepub.com/doi/10.1177/25158163251371152
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Nerve matters: Longitudinal microstructural change in the trigeminal nerve is associated with durable pain relief after surgery for trigeminal neuralgia” which has been selected as the Editor’s Choice for the September issue of Cephalalgia.
..................................................
High resolution MRI diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia shows that specific, early, and sustained microstructural changes need to be induced in the nerve for durable long-term pain relief.
journals.sagepub.com/doi/10.1177/03331024251369827
#migraine #headache #brain #pain #neurology #neuroscience
@DrTejasSankar -
International Headache Society
@ihs_official
New in Cephalalgia!
High resolution MRI diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia shows that specific, early, and sustained microstructural changes need to be induced in the nerve for durable long-term pain relief.
journals.sagepub.com/doi/10.1177/03331024251369827
#migraine #headache #brain #pain #neurology #neuroscience
@DrTejasSankar -
International Headache Society
@ihs_official
New in Cephalalgia!
Did you know cluster headache often strikes at the same time each day or season? ⏰ This new paper explores the fascinating link between our body’s circadian clock and cluster headache — opening doors to more targeted treatments and understanding. 🔍🧠
journals.sagepub.com/doi/10.1177/03331024251365858
#clusterheadache2023 #awarenessday #clusterheadache #ichd3matters #ihs -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
First report of eyebrow psoriasiform lesions linked to galcanezumab in migraine treatment, resolving after switch to fremanezumab. Highlights CGRP's role in skin immunity & need for dermatological monitoring. #cgrp #migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/25158163251371684 -
International Headache Society
@ihs_official
New in Cephalalgia!
Chronic cluster headache meets rare disease criteria but lacks recognition. Patients face 5.7-year diagnostic delays, €20K+ costs, and limited treatments. Formal designation could improve funding and care.
journals.sagepub.com/doi/10.1177/03331024251369752
#clusterheadache #awarenessday #clusterheadache #ichd3matters #ihs -
International Headache Society
@ihs_official
New in Cephalalgia!
The opening of KATP channels activates meningeal nociceptors underlying migraine pain. These findings reveal a mechanism for migraine induction and highlight KATP channels as promising therapeutic targets.
journals.sagepub.com/doi/10.1177/03331024251359237
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
In individuals with migraine and a hypothalamic blood-brain barrier sleep improvement with fremanezumab may be independent of headache relief.
journals.sagepub.com/doi/10.1177/25158163251359611
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Acute confusional migraine: Proposal for inclusion in the International Classification of Headache Disorders – 4th edition (ICHD-4)
journals.sagepub.com/doi/10.1177/03331024251370305
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 New study: No difference in plasma adrenomedullin (AM) between people with migraine (n=667) & healthy controls (n=147). 👉 Episodic migraine showed slightly lower AM vs controls (P=0.04). 👉 AM levels ↑ with BMI & monthly migraine days.
journals.sagepub.com/doi/10.1177/03331024251360234
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
Persistent idiopathic dentoalveolar pain (PIDAP) Insights: This study reveals reduced gray matter in the primary somatosensory cortex of PIDAP patients, linked to higher pain catastrophizing scores. This highlights central mechanisms and the need for holistic treatment approaches.
journals.sagepub.com/doi/10.1177/25158163251359643
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Reply to Wasserman et al.: Elucidating the “Triggers” versus “Maintenance” in burning mouth syndrome/oral dysaesthetic and perceptual disorder
journals.sagepub.com/doi/10.1177/03331024251369533
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
PACAP was found in numerous human brain regions, some of which have since been related to CNS disorders and migraine, and is related to the trigeminovascular and autonomic systems.
journals.sagepub.com/doi/10.1177/03331024251368748
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Prof. Yen-Feng Wang, Chief of the Division of General Neurology at the Neurological Institute, Taipei Veterans General Hospital, reminds us during Migraine Awareness Week 2025 that migraine is not just a headache—it can cause substantial disability and suffering, and may be associated with depression, anxiety, and medication overuse.
#migraineawarenessweek #migraine -
International Headache Society
@ihs_official
Congratulations to our Cephalalgia campaign winners at IHC2025 in São Paulo — Víctor García Ortiz and Tuğba Erdoğan! 🎉
Each winner will receive a free 1-year membership to the International Headache Society. Thank you for helping us raise visibility and strengthen our global community. 💙
#ihc2025 #cephalalgia2025 #headacheresearch -
International Headache Society
@ihs_official
Answer to the #sundayquiz
The answer is (C). Migraine Awareness Week.
Migraine means much more than ‘just a headache’. Together, let’s change perceptions of migraine this Migraine Awareness Week (22–28 September).
To learn more, please go to: migrainetrust.org/get-involved/campaign-with-us/migraine-… -
International Headache Society
@ihs_official
#sundayquiz
💡 What important awareness event in headache medicine starts next week (since Sept 22)?
(A) Cluster headache Awareness Day
(B) Migraine Awareness Month
(C) Migraine Awareness Week
(D) International Headache Week -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
The 25th WHO Expert Committee has updated the Essential Medicines List, adding new options for the acute treatment of migraine and for both acute and prophylactic treatment for cluster headache.
To learn more, please go to: iris.who.int/bitstream/handle/10665/382350/B09544-eng.pdf… -
International Headache Society
@ihs_official
IHS Education Committee Meeting during IHC2025 🎓🧠 #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
Cephalalgia Editorial Board Meeting during IHC2025 📚🧠
Reviewing past work and discussing exciting plans for the future. #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
IHS Soccer Match ⚽🌍 Americas vs World!
IHC2025 is not just a scientific conference — it’s also about meeting friends, connecting with colleagues, and having fun together 🎉🤝 #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
🏆 Best Poster — as voted by IHC2025 attendees!
Congratulations to Tiago Gomes de Paula for his paper:
Association between childhood motion sickness and dizziness symptoms in adults: a retrospective study in patients with chronic migraine 👏🎉
#ihc2025 #cephalalgia2025 #headache -
International Headache Society
@ihs_official
Child and Adolescent Committee of the IHS — meeting during IHC2025 👧🧠👦 #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
🏆 Best Poster — as voted by the IHS Juniors Group!
Congratulations to Clémence Deborgies for her outstanding work on Hormonal influence on cluster headache severity in females. 👏🎉
#ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Huge thanks to all who took part on our social platforms. You made IHC 2025 truly unforgettable.
-
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Visual snow vs. migraine aura: debate summary and novel insights into the syndrome
Visual Snow Syndrome (VSS) is a persistent visual disturbance that overlaps with migraine with aura in mechanisms like serotonergic involvement and cortical hyperexcitability — yet remains a distinct neurological disorder.
Neuroimaging and electrophysiological studies consistently reveal abnormalities in visual, salience, and attentional networks, along with glutamatergic dysregulation and impaired top-down control.
This review highlights the urgent need for research into VSS-specific network dysfunctions to guide targeted therapies.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251365908
👏 Congratulations to the authors for advancing our understanding of this fascinating syndrome!
#headacheresearch #visualsnow #migrainescience #aura #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Jes Olesen Award 2025 – Clinical Science 🏆
Congratulations to the authors of “Subtype shift, relapse rate, and risk factors of frequent relapse in cluster headache: a multicenter, prospective, longitudinal observation” for receiving this year’s award! 👏🎉
Key findings from this important study:
• The incidence of chronic cluster headache during prospective observation was 3.8% in patients with first-onset cluster headache (primary chronic) and 1.4% in those with a history of episodic cluster headache (secondary chronic).
• The average relapse rate of episodic cluster headache was 0.29 per person-year (95% CI = 0.27–0.32).
• In patients with episodic cluster headache, older age, longer disease duration, and first-onset cluster headache were associated with fewer relapses, while seasonal rhythmicity and increasing attack intensity across bouts were linked to more frequent relapse.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024251368259
#cephalalgia #headacheresearch #jesolesenaward2025 #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Jes Olesen Award 2025 – Basic Science 🏆
Congratulations to the authors of “Sex Differences in Photophobic Behaviors Following Cortical Spreading Depression in Rats” for receiving this year’s award! 👏🎉
This research highlights striking sex-related differences:
• Female rats showed a more intense and prolonged photophobic response to KCl injections compared to males.
• KCl injections triggered significant light-aversion in females, while males showed no meaningful change.
• No sex differences were observed in pupil-to-iris ratios after either KCl or aCSF injections.
• Females also exhibited greater eye closure and periorbital allodynia, indicating stronger pain-related responses.
These findings shed light on the biological basis of sex differences in headache-related symptoms.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024241310550
#cephalalgia #headacheresearch #jesolesenaward2025 #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Cephalalgia Award 2025 goes to Professor Arne May for the article “Functional brainstem representations of the human trigeminal cervical complex” 🏆✨
This important work reveals a functional inter-inhibitory network between the trigeminal branches and the greater occipital nerve in healthy humans. It also shows that functional trigeminal representations intermingle perioral and periauricular facial dermatomes with individual branches of the trigeminal nerve — arranged in an onion-shaped, overlapping somatotopic pattern.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024231174862
#cephalalgia #headacheresearch #cephalalgiaaward2025 #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
“There are not enough neurologists and headache specialists for everyone – and this must change.” – Prof. Rami Burstein, IHS President & IHC 2025 Congress Chair.
At IHC 2025, our mission is to expand access to trained professionals and ensure that headache care reaches every community worldwide. -
International Headache Society reposted
Cephalalgia
@JCephalalgia
🌍 Voices from around the world echo a shared passion: “I love Cephalalgia”, “I read Cephalalgia”, “I have published in Cephalalgia”, “I review for Cephalalgia”.
On this final day of the Congress, we invite you to stop by the Cephalalgia booth and join our social media contest.
📸 Post your experience using the hashtags #ihc2025 and #cephalalgia2025 for a chance to win one year of free IHS membership.
Let’s celebrate science, community, and the future of headache research together! -
International Headache Society
@ihs_official
Don’t miss this session 8 am tomorrow.
#ihc2025 -
International Headache Society
@ihs_official
New perspectives on migraine and the brain 🧠✨
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction
Presented today by Raquel Gil-Gouveia.
Migraine attacks involve reversible dysfunction of cognitive and pain-processing networks, leading to transient deficits in attention, processing speed, and executive function — independent of pain intensity.
Even between attacks, disrupted connectivity and reduced cortical inhibition may contribute to subtle but persistent cognitive changes, especially in those with frequent attacks. This raises important questions about the long-term impact of migraine on cognitive health.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368328
👏 Congratulations to the authors for advancing our understanding of this crucial aspect of migraine.
#headacheresearch #migrainescience #cognitivehealth #ihc2025 #cephalalgia2025 -
International Headache Society reposted
Cephalalgia
@JCephalalgia
🎥 Meet us at the IHS & Cephalalgia booth!
Prof. Simona Sacco, Editor-in-Chief of Cephalalgia and Cephalalgia Reports, invites all attendees to stop by the IHS booth during the Congress.
Join our social media initiative and help amplify the voice of the global headache community.
📸🎥 Take part in our posting contest: snap a photo or record a video at the booth, share it on your social media, tag the International Headache Society, and include the hashtags #ihc2025 and #cephalalgia2025.
You'll be in the running to win a free IHS membership – don’t miss this opportunity!
#ihc2025 #headachescience #cephalalgia #ihs #headachecareforall #sãoPaulo2025 #neurologycongress #globalheadachecommunity -
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Reviewing the complex relationship between circadian rhythms and cluster headache
Cluster headache shows striking circadian features — from its clock-like pattern of attacks to genetic variations in circadian genes found in some patients. Notably, at least six established cluster headache medications directly alter the core circadian molecular oscillator.
The authors propose key next steps: defining circadian attacks clinically, developing animal models to study circadian features of headache, and adapting genetic study designs to capture circadian influences.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251365858
👏 Congratulations to the authors for advancing our understanding of the intricate ties between circadian biology and cluster headache.
#headacheresearch #clusterheadache #circadianrhythms #migrainescience #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Prof. Rami Burstein delivered a comprehensive review of early prevention and preventing migraine progression in today's scientific session. Really inspiring!
#ihc2025 #migraine #prevention -
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review
Presented today by Marco Antonio Arruda.
Psychiatric comorbidities have a profound impact on children and adolescents with headache disorders — worsening severity, increasing risk of chronification, and affecting quality of life, cognitive performance, and academic achievement.
Reduced resilience, greater vulnerability, and impaired executive function appear central to this impact. This review highlights the importance of routinely assessing psychiatric symptoms, resilience, executive skills, and school functioning — and calls for early interventions that could improve both psychiatric and headache outcomes.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251364204
👏 Congratulations to the authors for shedding light on this critical area for child and adolescent health.
#headacheresearch #migrainescience #childhealth #adolescenthealth #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Optimising combined treatment for migraine and temporomandibular disorders (TMDs)
Presented today by Marcela Romero-Reyes.
Effective care for patients with comorbid migraine and TMDs requires true integration across disciplines. Collaboration with a dentist specialised in orofacial pain is essential, alongside identifying shared mechanisms of sensitisation and developing multidisciplinary management protocols.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368882
👏 Congratulations to the authors for highlighting the importance of collaborative, patient-centred approaches.
#headacheresearch #migrainescience #orofacialpain #tmd #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Dr Arão Belitardo de Oliveira highlights the importance of multidisciplinary care and the challenge of ensuring that different professionals are properly trained to treat headache disorders. Learn more at www.ihc2025.org
-
International Headache Society reposted
Cephalalgia
@JCephalalgia
Professor Simona Sacco (Editor-in-Chief, Cephalalgia and Cephalalgia Reports), Wendy Krank (Managing Editor), and Dr Faraidoon Haghdoost (Social Media Editor) are inviting all Congress participants to visit the IHS/Cephalalgia stand!
📸🎥 Join the posting contest: take a photo or video, share on your social media, tag the International Headache Society, and use #ihc2025 and #cephalalgia2025 for your chance to win a free IHS membership. Don’t miss it! -
International Headache Society
@ihs_official
📸🎥 Join the posting contest: take a photo or video, share on your social media, tag the International Headache Society, and use #ihc2025 and #cephalalgia2025 for your chance to win a free IHS membership. Don’t miss it!
-
International Headache Society
@ihs_official
New perspectives on migraine and the brain 🧠✨
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction
Presented today by Raquel Gil-Gouveia.
Migraine attacks involve reversible dysfunction of cognitive and pain-processing networks, leading to transient deficits in attention, processing speed, and executive function — independent of pain intensity.
Even between attacks, disrupted connectivity and reduced cortical inhibition may contribute to subtle but persistent cognitive changes, especially in those with frequent attacks. This raises important questions about the long-term impact of migraine on cognitive health.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368328
👏 Congratulations to the authors for advancing our understanding of this crucial aspect of migraine.
#headacheresearch #migrainescience #cognitivehealth #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
IHS Juniors Committee Meeting — during IHC2025 🌟👩🔬👨🔬
Discussing exciting topics such as travel grants, iHEAD selections, research grants, and more! #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
IHS Juniors Social Event 🎉💫
Learning is great — but making friends and building connections is what makes it unforgettable! 🤗🌍 #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
IHS Membership Meeting during the IHC2025 conference 🗣️🌍 #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
Visit the Cephalalgia stand at IHC 2025!
🎥📸 Take a photo or record a short video, tag the International Headache Society, and use both hashtags #ihc2025 and #cephalalgia2025.
By sharing on your social networks, you’ll have the chance to win an IHS membership. Don’t miss it! -
International Headache Society
@ihs_official
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
In today's plenary session, 'Unveiling PACAP's role in migraine: Evidence from human provocation studies,' Professor Messoud Ashina delivered an insightful overview of the role of PACAP in migraine pathophysiology and future treatment.
-
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Decoding PACAP signaling: Splice variants, pathways, and designer drugs
Presented today and published today — a milestone in migraine research! PACAP and VIP neuropeptides are key players in migraine, with exciting implications for receptor diversity, novel signaling pathways, and future drug design.
👏 Congratulations to the authors for advancing our understanding of these crucial mechanisms!
journals.sagepub.com/doi/10.1177/03331024251363560
#headacheresearch #migrainescience #pacap #vip #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
🚨 Hot off the press & hot off the stage!
Decoding PACAP signaling: Splice variants, pathways, and designer drugs
Presented today and published today — a milestone in migraine research! PACAP and VIP neuropeptides are key players in migraine, with exciting implications for receptor diversity, novel signaling pathways, and future drug design.
👏 Congratulations to the authors for advancing our understanding of these crucial mechanisms!
journals.sagepub.com/doi/10.1177/03331024251363560
#headacheresearch #migrainescience #pacap #vip #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
ICHD Classification Meeting — members’ workshop during IHC2025 🧠📚 #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
In this interview, Professor Mona Nada shares her perspective on how IHC 2025 contributes to raising global awareness about cluster headache.
Don’t miss the upcoming sessions – explore the full programme at www.ihc2025.org
#ihc2025 #headachecongress #neurology #clusterheadache #globalhealthThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
International Headache Society
@ihs_official
IHC2025 is not only about great talks — it’s also about meeting new people, making friends, and creating connections that last 🤗🌍🤝✨ #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
In today’s teaching course, Dr. Nina Riggins delivered a detailed review of 'Life-threatening headache: non-vascular aetiologies.'
#ihc2025 #headache -
International Headache Society
@ihs_official
Day 1 at IHC 2025 was filled with science, learning and connections! From inspiring sessions to the vibrant atmosphere in São Paulo, the first day set the tone for an unforgettable Congress. Explore the full programme at www.ihc2025.org
#ihc2025 #headachecongress #neurology #globalhealth #sãoPauloThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
IHS Communication Committee meeting during the conference 🗣️📢
Great discussions on welcoming new members, covering the conference, and shaping future plans for awareness weeks and beyond. #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
Latin America Migraine Policy Summit: Diverse Perspectives, Collective Impact 🌎💡 #ihc2025 #cephalalgia2025
-
International Headache Society
@ihs_official
Win a free IHS membership! 🎉 It’s simple:
📸 Take a photo with the Cephalalgia stand
📲 Post it on your social media
🏷️ Add both #ihc2025 #cephalalgia2025 -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The official IHC 2025 Congress App is now available for download!
Access everything you need to make the most of your experience at the 22nd International Headache Congress. With just a few taps, you can:
🔍 Now available on the App Store and Google Play. Search: “IHC 2025” -
International Headache Society reposted
Cephalalgia
@JCephalalgia
Win a free IHS membership! 🎉 It’s simple:
📸 Take a photo with the Cephalalgia stand
📲 Post it on your social media
🏷️ Add both #ihc2025 #cephalalgia2025
Two lucky winners will be selected after the conference! -
International Headache Society
@ihs_official
Getting ready for IHC 2025. São Paulo, here we come!
#ihc2025 #saopaulo #headaxche -
International Headache Society
@ihs_official
Letter to the Editor!
There is growing evidence of a strong comorbid relationship between fibromyalgia and chronic migraine, with fibromyalgia diagnosed in a considerable number of chronic migraine patients.
journals.sagepub.com/doi/10.1177/03331024251360223
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache” which has been selected as the Editor’s Choice for the August issue of Cephalalgia.
..................................................
Opening of ATP-sensitive potassium channels activated meningeal nociceptors implicated in migraine and other headache disorders
•
Similar activation rates were observed for Aδ and C-fibers, as well as between male and female animals.
.................................................
journals.sagepub.com/doi/full/10.1177/03331024251359237
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
#sundayquiz Countdown to IHC 2025 in São Paulo!
Can you guess the year and city of this throwback photo?
A. IHC 2023 in Seoul
B. IHS–EHF Joint Congress 2021 in Berlin
C. IHC 2019 in Dublin
D. IHC 2017 in Vancouver
💬 Comment your guess below and see if you get it right!
#ihc2025 #headache #congress #sunday -
International Headache Society
@ihs_official
Join the Brazilian Society of Temporomandibular Disorders and Orofacial Pain (SBDOF) for a dedicated scientific session exploring the intersection of headache and orofacial pain.
Wednesday, 10 September 2025
Room 11 – WTC Events Center, São Paulo
View the full IHC 2025 programme at: www.ihc2025.org -
International Headache Society
@ihs_official
New in Cephalalgia!
✨ New Real-World Evidence
CGRP monoclonal antibodies show sustained effectiveness over 3 years of treatment.
🧑🤝🧑 The Study
179 people with migraine
Majority had chronic migraine and medication overuse
Followed across 3 consecutive one-year treatment cycles
📉 The Results
Average reduction of 12.7 monthly migraine days
Residual migraine days remained high (>8 days/month)
38.5% achieved a 50% response after 3 years
💡 What This Means
CGRP mAbs work long term
But migraine burden is still significant
More treatment options and new pathways need to be explored
journals.sagepub.com/doi/10.1177/03331024251353421
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Headaches are common in chiropractic patients, mainly tension-type and having more than one type of headache. Headache was the primary reason for consulting the chiropractor in two out of five headache consultations.
journals.sagepub.com/doi/10.1177/03331024251362126
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Analysis of 1,418 migraine patients confirms the validated e-headache diary has excellent psychometric properties for identifying migraine days, with all but one item showing outstanding discrimination.
journals.sagepub.com/doi/10.1177/03331024251359222
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know, ICHD-3 also included External-compression headache? 🤕
It is triggered within an hour of sustained pressure on the forehead or scalp, with pain peaking right at the site of compression, and it usually disappears within an hour once the pressure is relieved.
To learn more, please go to:
ichd-3.org/other-primary-headache-disorders/4-6-external-…
#ichd3matters #headache #compression -
International Headache Society
@ihs_official
🚨 Last chance! 🚨
1 September is the FINAL day to secure your IHC 2025 registration at a discounted rate. ⏳
👉 Register now: ihc2025.org -
International Headache Society reposted
Cephalalgia
@JCephalalgia
Cephalalgia Editor-in-Chief, Prof. Simona Sacco, shares insights on “What Makes a Great Research Manuscript” at ANZHS 2025 in Sydney, Australia.
A good manuscript is:
•Correct
•Structured
•Publishable
A great manuscript is:
•Compelling
•Impactful
•Memorable
#anzhs2025 #migraine #headache -
International Headache Society
@ihs_official
Temporomandibular disorders and orofacial pain are key comorbidities of primary headaches. At IHC 2025, we bring together dentists, neurologists, and pain specialists to explore this crucial intersection.
📍 Join us in São Paulo, 10–13 September 2025.
🔗 Register now atThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in Cephalalgia!
Substance P has recently been shown to trigger headache and arterial dilation in humans, reinforcing its role in migraine and its potential as a therapeutic target.
journals.sagepub.com/doi/10.1177/03331024251355944
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
Childhood trauma is common in migraine patients and linked to more complex clinical profiles, pointing to a distinct subtype with key treatment and prognostic implications.
journals.sagepub.com/doi/10.1177/03331024251358503
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
International Headache Society
@ihs_official
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
International Headache Society
@ihs_official
New in Cephalalgia!
Diffusion tensor imaging may not reliably predict outcomes of microvascular decompression in patients with classical trigeminal neuralgia due to arterial compression or deformation.
journals.sagepub.com/doi/10.1177/03331024251322505
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Did you hear about “ice cream headache”?
In the ICHD-3, it’s officially classified as “Headache attributed to ingestion or inhalation of a cold stimulus.”
It refers to a sudden, sharp pain in the forehead or temple triggered when something cold—such as ice cream, chilled drinks, or inhaled cold air—comes into contact with the palate or back of the throat. Although the pain can be intense, it typically resolves within 10 minutes after the cold stimulus is removed.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-5-cold-stim…
#ichd3matters #headache #icecream -
International Headache Society
@ihs_official
New in Cephalalgia!
Discover how digital phenotyping is transforming migraine research and management! This study shows how real-time data from wearables and smartphones unveils triggers, refines diagnosis, and enables personalized treatments.
journals.sagepub.com/doi/10.1177/03331024251363568
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Consistent and even long-term treatment with Onabotulinumtoxin A is crucial for initial responders as many real world open studies have shown a cumulative effect of repeated Onabotulinumtoxin A injections.
journals.sagepub.com/doi/10.1177/03331024251363268
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Did you know that migraine and epilepsy share common triggers and underlying mechanisms? Many effective anticonvulsants also serve as migraine preventives, demonstrating the intricate overlap between these conditions.
🔗 Explore the programme & register now: www.ihc2025.org -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
Letter to the editor!
Expanding the classification of burning mouth syndrome. It is important for the classifications to define the patients and not the other way around!
doi.org/10.1177/03331024251362822
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This randomized open-label study conducted during Ramadan demonstrates that once-daily rimegepant 75 mg orally disintegrating tablet may be effective and well tolerated for short-term prevention of fasting-related headache.
journals.sagepub.com/doi/10.1177/03331024251355947
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
This study examined the situation of visual snow syndrome in Japan. Patients with visual snow syndrome had a high prevalence of migraine, and a possible association with anisometropia.
journals.sagepub.com/doi/10.1177/03331024251360337
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know that the ICHD-3 also includes Primary thunderclap headache?
It’s defined as a sudden, explosive headache that peaks within 1 minute, lasts at least 5 minutes, and occurs without any underlying brain pathology.
To learn more, please go to:
ichd-3.org/other-primary-headache-disorders/4-4-primary-t…
#ichd3matters #headache #thunderclap -
International Headache Society
@ihs_official
@JCehalalgia Editor’s Choice @Simona_Sacco_ Video Program Episode with outstanding Dr Todd Schwedt. Longitudinal analysis of pain-induced brain activations in post-traumatic #headache. Cephalalgia 2025;45(5). doi:10.1177/03331024251345160 @schwedtt @ninariggins @ihs_official
-
International Headache Society
@ihs_official
New in Cephalalgia!
New rimegepant users are more likely to be persistent on acute treatment at one year versus new oral triptan users in a large US cohort of migraine patients.
journals.sagepub.com/doi/10.1177/03331024251352849
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
In this editorial from Cephalalgia, the Editor-in-Chief highlights a concerning trend: a growing number of manuscript submissions using the term “migraines”—a scientific inaccuracy likely fueled by unchecked generative AI tools
Migraine is a disease - singular, well-defined, and not to be pluralized or treated as a vague symptom.
journals.sagepub.com/doi/10.1177/03331024251365833
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society reposted
Cephalalgia
@JCephalalgia
Migraine Treatment Inequality: New Swedish Study Reveals Who Gets CGRP Access
🎥 In this video, Dr Faraidoon Haghdoost — one of our social media editors for Cephalalgia and Cephalalgia Reports — talks about a new Swedish study revealing persistent socioeconomic gaps in access to advanced migraine treatments.
📊 Out of nearly 53,000 people with migraine, only just over 3% received CGRP monoclonal antibodies — medications designed to prevent migraine attacks. Despite universal healthcare, people with higher income and education were far more likely to get these treatments, with high socioeconomic status patients being nearly 70% more likely to access them.
💡 The finding is clear: even when cost is covered, access gaps remain. We must ensure these life-changing treatments are available to everyone who needs them — not just the lucky few.
Read the full study here: journals.sagepub.com/doi/10.1177/03331024251348648
#migraine #headache #cgrp #healthcareequity #neurology #cephalalgia #publichealth
To share:
youtube.com/shorts/ji3yr-7I4jQThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
New in Cephalalgia!
Nearly half of patients with epilepsy have comorbid headache. Among patients with interictal headache, comorbid migraine has the most significant influence on their psychological state and daily life.
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know that the ICHD-3 also includes primary headache associated with sexual activity?
It required at least two episodes of head or neck pain occurring only during sexual activity, either gradually increasing with excitement or abrupt explosive intensity just before or with orgasm. Before making a diagnosis, it is mandatory to exclude subarachnoid haemorrhage, intra- and extracranial arterial dissection, and reversible cerebral vasoconstriction syndrome.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-3-primary-h…
#ichd3matters #sex #headache -
International Headache Society
@ihs_official
Why do some migraine patients experience tearing, nasal congestion, or facial flushing? This study at King’s College London found that women and those with aura are more likely to have these symptoms!
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
💡 Discover the IHS Learning Centre!
Explore a world of headache science with our latest videos, podcasts, and webinars — all in one place.
🧠 Whether you're brushing up on the basics or diving deep into #ichd3matters, we’ve got you covered.
👉 Visit now: ihs-headache.org/en/learning-centre/
#ihs_learning_centre #headacheeducation #neurology #medicallearning #ichd3matters -
International Headache Society
@ihs_official
New in Cephalalgia!
Interactive voice response delivery of Cognitive Behavioral Therapy for Veterans with Post Traumatic Headache is feasible, acceptable, and cost-effective.
Veterans experienced significant increases in self-efficacy from pre-to-post treatment.
journals.sagepub.com/doi/10.1177/03331024251351598
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Do you know ICHD-3 also includes primary exercise headache?
Before diagnosing primary exercise headache, it is mandatory to exclude intracranial disorders, including
subarachnoid haemorrhage, arterial dissection, and reversible cerebral vasoconstriction syndrome.
If you want to know more, go to: ichd-3.org/other-primary-headache-disorders/4-2-primary-e…
#ichd3matters #exercise #headache -
International Headache Society
@ihs_official
New in Cephalalgia
ADGRL3 gene was associated with both cephalic hypersensitivity in STA rats and an increased burden of rare variants in humans with migraine. The gene was expressed in the trigeminovascular system, a central pathophysiological component of cephalic pain. ADGRL3 provides novel insights into the pathophysiology of chronic cephalic pain in migraine.
journals.sagepub.com/doi/epub/10.1177/03331024251352844
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Post-stress modulation of the HPA and melanocortin systems alleviates migraine-like behaviors in mice” which has been selected as the Editor’s Choice for the July issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Migraine onset often follows stress resolution, but predicting its timing is difficult. This study suggests modulating hypothalamic-pituitary-adrenal (HPA) axis and melanocortin systems post-stress as a potential treatment, with possible sex differences in the mechanisms.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📍 Answer to the #sundayquiz
The International Headache Congress 2025 is heading to São Paulo, Brazil — taking place from September 10–13, 2025! 🇧🇷
Registration is now open. Be part of the global community advancing headache research and patient care: ihc2025.org
#saopaulo #headache #congress -
International Headache Society
@ihs_official
#sundayquiz of the Week 😊
Which city will host the upcoming International Headache Congress (IHC) 2025 from September 10 to 13?
#ihc2025 -
International Headache Society
@ihs_official
New in Cephalalgia 🧠🐭
Migraine onset often follows stress resolution, but predicting its timing is difficult. This study suggests modulating hypothalamic-pituitary-adrenal (HPA) axis and melanocortin systems post-stress as a potential treatment, with possible sex differences in the mechanisms.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
If you have not yet explored our e-learning certificate programme developed with WONCA (World Organisation of Family Doctors), now is the time.
👉 Learn more: ihc2025.org/ihc2025 -
International Headache Society
@ihs_official
At IHC 2025, gain in-depth knowledge on the therapeutic use of OnabotulinumtoxinA for headache relief. Learn to identify suitable patients, distinguish clinical from aesthetic applications, and integrate this effective treatment into your practice with confidence.
Register now: -
International Headache Society
@ihs_official
New in Cephalalgia
A post-hoc analysis of a phase 2/3, open-label study of rimegepant in the acute treatment of migraine according to current and historical triptan use.
Rimegepant 75 mg administered up to once per day as PRN (52 weeks) or EOD+PRN (12 weeks) was safe and well tolerated in participants with any triptan experience, including those with multiple discontinuations.
journals.sagepub.com/doi/10.1177/03331024251343309
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
International Headache Society
@ihs_official
Sumatriptan did not prevent KATP channel opener-induced migraine but reduced headache intensity. Highlights KATP channels as key migraine targets.
journals.sagepub.com/doi/10.1177/03331024251341464
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina @ZxZhAlice @Alkaragholi_MM @h_ashina @thienpdo -
International Headache Society
@ihs_official
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
International Headache Society
@ihs_official
Editorial for: Effect of Sumatriptan on ATP-Sensitive Potassium Channel Opening in Migraine: A randomised controlled trial [in press]
This new editorial in Cephalalgia explores the evolving science behind migraine triggering mechanisms.
journals.sagepub.com/doi/10.1177/03331024251342583
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s Choice for the June issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....................................
Socioeconomic disparities in access to migraine therapy persist—even in publicly funded healthcare systems.
In a population-based nested case-control study from Region Stockholm (N = 52,996), researchers examined the association between socioeconomic status (SES) and first-time dispensation of CGRP monoclonal antibodies for migraine prevention.
📉 Despite universal reimbursement policies:
Only 3.2% received CGRP inhibitors (CGRPi).
Patients with high SES had a 68% higher likelihood of CGRPi dispensation (aOR 1.68; 95% CI: 1.46–1.92).
Even middle SES conferred a significantly increased chance (aOR 1.41; 95% CI: 1.24–1.61).
➡️ Conclusion: Access to advanced migraine treatments remains unequal, with SES acting as a barrier - even where cost should not be.
journals.sagepub.com/doi/10.1177/03331024251348648
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New in Cephalalgia!
How does migraine with aura (MA) alter brain structure beyond the visual cortex?
🧠 ⚡Using structural MRI and network-based analysis, this study reveals altered grey-matter (GM) network topology in MA:
➡️ Right lingual gyrus: Increased nodal degree in MA vs. healthy controls (p < 0.001, FDR = 0.018) - Identified as a network hub in MA
➡️ Covariance with pain-related regions (right posterior insula, left ventral postcentral gyrus) negatively correlated with migraine duration
🔎 Conclusion: Migraine with aura is associated with localized structural reorganization in visual and pain-processing networks, possibly reflecting disease chronicity.
🔗 Read the full article: doi.org/10.1177/25158163251348665 -
International Headache Society
@ihs_official
How does stress trigger facial pain in mice—and how can we reverse it?
A recent study using a mouse model investigated the mechanisms behind stress-induced facial mechanical hypersensitivity, highlighting the role of the HPA axis and melanocortin signaling:
.Metyrapone (a glucocorticoid synthesis inhibitor) reversed stress-induced facial hypersensitivity in both male and female mice
.A low dose of CORT or ACTH after stress also alleviated hypersensitivity
.Metyrapone blocked the effect of ACTH, suggesting upstream modulation
.α-MSH and THIQ administration after stress further reduced hypersensitivity
These findings suggest that modulating neuroendocrine signaling may be a promising strategy for mitigating stress-related facial pain.
📄 Read the full study: journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #pain #research -
International Headache Society
@ihs_official
New in Cephalalgia!
Fibromyalgia (FM) is a common comorbidity in chronic migraine (CM), but how it affects treatment response has remained unclear.
📌 This prospective, proof-of-concept study compared treatment responsiveness to flunarizine in patients with:
- Chronic migraine alone (CM)
- Chronic migraine + fibromyalgia (CMFM)
📉 Key findings:
CMFM patients had worse baseline clinical profiles, including more monthly headache days (MHDs) and higher anxiety/depression scores.
Responder rate (≥50% MHD reduction):
▪ CM: 52%
▪ CMFM: 32% (p = 0.033)
FM comorbidity tripled the odds of not converting to episodic migraine (OR: 2.8 [1.1–7.1]).
🧠 Clinical implication: Comorbid FM in CM is associated with poorer preventive treatment outcomes, despite dual-targeted therapy. Early identification and tailored management strategies are essential.
Link to the article: doi.org/10.1177/03331024251353412 -
International Headache Society
@ihs_official
How is the endocannabinoid system involved in medication overuse headache (MOH)?
This study investigated alterations of AEA-related ECS components in PBMCs from patients with MOH. Results showed that:
.MOH patients exhibited lower FAAH gene expression but higher FAAH protein levels compared to those with episodic migraine.
.Across all clinical groups, FAAH gene expression was inversely correlated with FAAH protein levels
These findings suggest a dysregulation of the endocannabinoid system at both transcriptional and translational levels, which may play a role in the pathogenesis of MOH and its associated psychiatric comorbidities.
📖 Read more: journals.sagepub.com/doi/10.1177/03331024251314460
#moh #migraine #chronic_migraine -
International Headache Society
@ihs_official
Socioeconomic disparities in access to migraine therapy persist—even in publicly funded healthcare systems.
In a population-based nested case-control study from Region Stockholm (N = 52,996), researchers examined the association between socioeconomic status (SES) and first-time dispensation of CGRP monoclonal antibodies for migraine prevention.
📉 Despite universal reimbursement policies:
Only 3.2% received CGRP inhibitors (CGRPi).
Patients with high SES had a 68% higher likelihood of CGRPi dispensation (aOR 1.68; 95% CI: 1.46–1.92).
Even middle SES conferred a significantly increased chance (aOR 1.41; 95% CI: 1.24–1.61).
➡️ Conclusion: Access to advanced migraine treatments remains unequal, with SES acting as a barrier - even where cost should not be.
🔗 Read the full open-access article in Cephalalgia: doi.org/10.1177/03331024241260540 -
International Headache Society
@ihs_official
💥 What is PACAP — and why is it making waves in migraine research?
PACAP (pituitary adenylate cyclase-activating polypeptide) is emerging as a promising target for new migraine treatment. Curious how this neuropeptide could change the game?
🧠 Dive into the latest research here: www.nature.com/articles/s41582-024-01011-4 -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
New in Cephalalgia Reports!
A cross-sectional study examines real-world data from patients with cluster headache (CH) referred to a tertiary headache center.
Key findings:
✔️ 54% had chronic CH
❌ 34% lacked first-line acute therapy
❌ 55% had not received guideline-recommended preventives
🚬 Higher rates of smoking and illicit drug use vs. migraine/TTH
⏳ Faster referral compared to migraine, yet still delayed
🧠 Despite correct diagnosis in most cases, treatment remains inadequate before referral.
👉 Read the full open-access study -
International Headache Society
@ihs_official
The International Headache Congress (IHC 2025) is bringing together top global experts from 30+ countries to share the latest in headache diagnosis, treatment, and research.
www.ihc2025.org
📍 São Paulo, Brazil
📅 10–13 September 2025 -
International Headache Society
@ihs_official
#sundayquiz Answer: A is Incorrect.
This week’s question asked:
Which of the following statements about ICHD-3 criteria for Primary Cough Headache (4.1) is INCORRECT?
Let’s break it down:
❌ A) It lasts between 1 second and 1 hour
This is incorrect. According to ICHD-3, the duration of primary cough headache ranges from 1 second to 2 hours, not 1 hour.
✔️ B) A Valsalva manoeuvre can also be a trigger.
This is correct. Triggers include coughing and a Valsalva-like manoeuvre.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-1-primary-c…
Stay tuned for the next quiz!
#ichd3matters #headache -
International Headache Society
@ihs_official
New Research published in @Cephreports! Combined #spg and #gon blocks for patients with refractory #cluster headache @ihs_officialhttps://doi.org/10.1177/25158163251355554 @JCephalalgia @Simona_Sacco_
-
International Headache Society
@ihs_official
📢 We are delighted to officially welcome the 2025/2026 Cephalalgia Reviewer Academy Fellows! 🎉
These outstanding early-career researchers from around the world have been selected for their commitment to excellence in headache research and scientific publishing. Over the next year, they will be mentored by experienced editors to build their skills in peer review.
Welcome to the Cephalalgia community — we look forward to your contributions! -
International Headache Society
@ihs_official
#sundayquiz of the week
Regarding the ICHD-3 diagnostic criteria for primary cough headache, which of the following statements is INCORRECT?
A) It lasts between 1 second and 1 hour
B) A Valsalva manoeuvre can also be a trigger -
International Headache Society
@ihs_official
Throwback Thursday!
Do you remember iHEAD 2023 in Seoul? We welcomed 93 delegates from 30 countries to exchange ideas, foster friendships, and advance headache care together.
See you at IHC 2025 in São Paulo! 🌎✨
#tbt #ihc2025 #sãoPaulo -
International Headache Society
@ihs_official
The IHS Juniors Group is now accepting nominations for the 2025 elections! The deadline for nominations is 21 July 2025. Don’t miss this chance to represent your region and contribute to the future of headache medicine.
Nominations must be submitted using the official nomination form, available for download via the following link:ihs-headache.org/wp-content/uploads/2025/07/IHS-Juniors-G… -
International Headache Society
@ihs_official
Greetings from Dr Karina Vélez Jiménez, Board Member of the International Headache Society 🇲🇽.
For the first time, the International Headache Congress will be held in Latin America. Join us in São Paulo, Brazil, from 10 to 13 September 2025.
🌐 Register now:This media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
🧠 Psychedelics & Ketamine in Cluster Headache: A Case Series 🌈💊
📄 Cephalalgia Reports | doi.org/10.1177/25158163251345472
🔬 Leighton J, Lau C, Granata L, et al.
Can serotonergic psychedelics and ketamine offer relief where standard treatments fail?
This exploratory case series of 9 patients with treatment-resistant cluster headache examined compassionate-use treatment with:
✅ Psilocybin
✅ LSD
✅ Ketamine
📊 Key Findings:
▪️ All patients responded positively to at least one treatment
▪️ 8 out of 9 responded to psilocybin or LSD
▪️ Several patients experienced prolonged attack-free periods
💡 These findings add to the growing body of evidence suggesting a role for serotonergic psychedelics in CH management, and support further exploration—including controlled clinical trials—to validate efficacy and ensure safe access.
📌 Full article: doi.org/10.1177/25158163251345472
#clusterheadache #psychedelics #psilocybin #lsd #ketamine #cephalalgiareports #headachemedicine -
International Headache Society
@ihs_official
💥 New Insights on Oxygen Therapy in Cluster Headache 🧠💨
High Flow vs Ultra-High Flow (Demand Valve) Oxygen Delivery: A Patient Experience Survey
📄 Cephalalgia Reports doi.org/10.1177/25158163251339439))
🔬 Goadsby PJ, Bahra A, Hobbs V et al.
A unique patient-initiated, - funded and - conducted study by OUCH-UK compares standard high flow (15 L/min) with ultra-high flow (up to 250 L/min) demand valve (DV) oxygen in treating cluster headache attacks.
📊 Key Findings (from >1,400 attacks):
▪️ Mean time to abort:
→ High Flow: 36 min
→ Ultra-High Flow DV: 11 min
▪️ Complete relief achieved:
→ High Flow: 70%
→ DV: 89%
💡 Implications: preliminary evidence that ultra high flow DV oxygen may provide faster, more effective relief but randomized controlled trials are urgently needed.
📌 An example of how patient-driven research can generate actionable hypotheses for clinical care.
#clusterheadache #oxygentherapy #cephalalgiareports #patientledresearch -
International Headache Society
@ihs_official
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
International Headache Society
@ihs_official
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
International Headache Society
@ihs_official
Final call for late-breaking abstracts!
Submission closes: 30 June 2025 at 23:59 (Brasilia time)
Act now — share your latest discoveries with the global community at the 22nd International Headache Congress in São Paulo!
ihc2025.org/site/ihc2025/abstract-submission -
International Headache Society
@ihs_official
🎬 Episode 4 of the IHS documentary Headed for the Future is now live!
In “Rising Expectations,” we spotlight the urgent need for intensified research in migraine and other primary headache disorders. Leading scientists—including Professor Rami Burstein (USA), Professor Messoud Ashina (Denmark), and Professor Antoinette Maassen van den Brink (Netherlands)—highlight the vast unmet needs and the opportunities for major breakthroughs.
This episode also introduces the world’s foremost research centre for cluster headache at the Karolinska Institute, led by Andrea Carmine Belin. Their pioneering work aims to unravel the genetic and circadian factors behind cluster headache and develop better treatments for this devastating condition.
👉 Watch the teaser on our feeds, then stream the full episode here:www.youtube.com/watch?v=vyYzmJhduOE
#ihsdocumentary #headedforthefuture #migraineawarenessmonth -
International Headache Society
@ihs_official
🧠 New Case Report Alert 📄 in Cephalalgia Reports
Post-traumatic trigeminal injury leading to novel-onset orofacial migraine
📚 Cephalalgia Reports | doi.org/10.1177/25158163251345141
A compelling case of novel-onset orofacial migraine is described following surgical trauma to the trigeminal nerve during impacted tooth extraction. The patient, with no previous migraine history, initially diagnosed with post-traumatic trigeminal neuropathy—later evolving into migraine-like facial pain.
🔍 Why it matters
It highlights the clinical importance of differentiating post-traumatic neuropathy from emerging migraine in the orofacial region.
👉 Read the full case: doi.org/10.1177/25158163251345141
#migraine #orofacialpain #trigeminalnerve #posttraumaticpain #cephalalgiareports #headachemedicine -
International Headache Society
@ihs_official
#throwbackthursday
Discovered in 1983, CGRP (calcitonin gene-related peptide) has been proven to play a key role in migraine pathophysiology. From early clinical evidence to the development of CGRP-targeted therapies, this journey has transformed migraine care.
🔗 Learn more: journals.sagepub.com/doi/10.1177/0333102418779544
#migraineawarenessmonth #headache -
International Headache Society
@ihs_official
🔍 Redefining Burning Mouth Syndrome: Scientific Dialogue in Motion
We’re excited to share a dynamic scholarly exchange published in Cephalalgia Reports on the diagnostic framing of Burning Mouth Syndrome (BMS).
✉️ Suga et al. propose refining ICHD-3 criteria by broadening the sensory descriptors from strictly "burning" to include dysaesthetic qualities.
🔗 doi.org/10.1177/25158163251339141
🗣️ Reply by Musella et al.:
BMS criteria need expansion but caution against overgeneralization. They introduce the concept of Oral Dysaesthetic and Perceptual Disorder (ODPD)—a proposed nosological model distinguishing dysaesthetic from perceptual features.
🔗 doi.org/10.1177/25158163251346956
✅ Additional Reply: Need of a shared vision: better recognition of patients currently misclassified or undiagnosed under existing frameworks.
🔗 doi.org/10.1177/25158163251346957
🧠 Why this matters:
These letters tackle a critical issue in clinical orofacial pain: the risk of diagnostic exclusion due to overly narrow criteria. The proposed BMS–ODPD spectrum could lay the groundwork for future ICHD/ICOP revisions and more targeted care.
📚 Let’s keep the discussion going.
Your thoughts on including perceptual distortions in pain taxonomy?
#neurology #orofacialpain #bms #cephalalgiareports #ichd #paintaxonomy #clinicaldialogue #oralmedicine -
International Headache Society
@ihs_official
🧠 New Study Alert in Cephalalgia Reports!
What drives the fear of migraine attacks?
A recent cross-sectional study sheds light on the interictal burden in episodic migraine patients — particularly, the anticipatory anxiety of future attacks.
🔍 Key findings:
✔️ Allodynia symptoms and headache impact explained 35% of fear variance
✔️ High-attack-anxiety patients had worse scores on:
- Headache Impact Test
- Central Sensitization Inventory
- Allodynia Symptom Checklist
- Neck Disability Index
🎯 Takeaway: Fear of attacks is not just psychological — it’s linked to sensory processing and functional burden. Addressing these may ease the interictal suffering of migraine patients.
📖 Read the full study:
doi.org/10.1177/25158163251345140
#migraine #headachemedicine #neuroscience #chronicpain #allodynia #centralsensitization #patientcare #cephalalgiareports -
International Headache Society
@ihs_official
🚨 The call for applications to the 2025–2026 Cephalalgia Reviewer Academy is now closed!
72 applications for 6 available slots — a testament to the growing interest in contributing to high-quality peer review in the headache field. 🧠📚
The selection process is currently underway, and all applicants will be informed of the outcome soon.
A heartfelt thank you to everyone who applied — your enthusiasm and commitment to advancing science are truly inspiring!
💡🔬 #cephalalgia #revieweracademy #headacheresearch #peerreview #mentorship #scientificcommunity -
International Headache Society
@ihs_official
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
International Headache Society
@ihs_official
💊 Reevaluating Triptan Contraindications in LATAM Neurology Practice
📄 Cephalalgia Reports | doi.org/10.1177/25158163251347211
🧠 Bancalari E, Robblee J, Velez K, et al.
Are current triptan contraindications still relevant in clinical practice?
This LATAM-wide survey of 225 neurologists offers fresh insights into the real-world comfort level in prescribing triptans for migraine in the presence of commonly cited contraindications.
📊 Key findings:
Stroke: 54% never prescribe triptans
Dissection: 61% never
RCVS: 70% never
Venous thromboembolism: More varied – 27% sometimes
Hemiplegic migraine: 58% never
Prolonged aura: 25% sometimes, 40% never
Pregnancy: 57% never
Age >65: 36% sometimes, 22% never
SSRI co-use: Only 24% rarely avoid
🧠 Conclusion: Many contraindications are treated as absolute despite limited supporting evidence. There is a clear need for updated, evidence-based guidance to avoid unnecessary treatment gaps for patients with migraine.
🔗 Full text: doi.org/10.1177/25158163251347211 -
International Headache Society
@ihs_official
🧠 When trigeminal neuralgia isn't what it seems…
A rare case of lesional insular epilepsy masquerading as treatment-refractory trigeminal neuralgia for over a decade—resolved by epilepsy surgery.
This case report highlights the importance of considering ictal epileptic headache in patients with atypical or refractory neuralgiform pain.
📄 Read the full case:
“Lesional insular epilepsy mimicking treatment refractory trigeminal neuralgia effectively treated with epilepsy surgery”
🔗 doi.org/10.1177/25158163251342806
#epilepsy #headache #trigeminalneuralgia #neurosurgery #cephalalgiareports #neurodiagnostics #casereport -
International Headache Society
@ihs_official
We’re excited to share the results of the IHS Board elections!
The next IHS President-elect will be Patricia Pozo-Rosich (Spain). The newly elected Trustees are Piero Barbanti (Italy), Mo Levin (USA), and Derya Uluduz (Türkiye).
Congratulations to the elected members, and heartfelt thanks to all candidates who participated in the election.
To learn more, please go to: ihs-headache.org/en/news/ihs-board-election-results-annou…
#migraineawarenessmonth #headache -
International Headache Society
@ihs_official
🚨 New publication alert!
Sex matters in migraine – not just in prevalence but in pathophysiology and treatment response.
🧠🔍 In a compelling viewpoint, Porreca, Navratilova & Dodick explore sexual dimorphism in migraine mechanisms, including differences in CGRP and prolactin signaling.
📌 Most migraine data come from women, yet we rarely analyze outcomes by sex.
📌 Evidence suggests male and female nociceptors behave differently – opening the door to precision, sex-informed migraine therapy.
📌 The authors call for better inclusion of men in trials and mechanistic studies.
A must-read for anyone interested in pain research, clinical trial design, or migraine care.
📖 Full text: doi.org/10.1177/03331024251339466
#migraine #painresearch #sexdifferences #headache #cgrp #precisionmedicine -
International Headache Society
@ihs_official
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
International Headache Society
@ihs_official
🧠✨ Mindfulness meets neurobiology in CM-MOH!
New study: “Neurotransmitter-related functional connectivity changes in serotonin and dopamine systems after mindfulness in medication overuse headache”
Can mindfulness reshape the brain in chronic migraine with medication overuse? This fMRI study says yes. After one year of mindfulness training:
🔹 ↑ Serotonin-related connectivity in caudate & accumbens
🔹 ↑ Dopamine-related connectivity in the right insula
🔸 These areas are key in pain, emotion, and addiction pathways.
🧘♀️ Findings suggest mindfulness may modulate neurotransmitter systems—offering a promising non-pharmacological approach to chronic pain and medication overuse.
📖 Read more: doi.org/10.1177/03331024251332561
#migraine #cmmoh #mindfulness #neuroimaging #serotonin #dopamine #chronicpain #functionalconnectivity #cephalalgia -
International Headache Society
@ihs_official
🧠 Highly Interesting Review in Cephalalgia!
“Cortical thickness studies in migraine: Current evidence and future directions”
📅 Published June 6, 2025 | 🔓 Open Access
Cortical thickness is emerging as a key marker of migraine-related brain changes. This comprehensive review synthesizes current evidence from surface-based and voxel-based morphometry studies, highlighting:
🔹 Thickening in pain-processing regions (somatosensory cortex, insula, anterior cingulate) – possibly reflecting hyperexcitability.
🔹 Thinning in regions like the orbitofrontal and visual cortices – suggesting cortical integrity loss.
🔹 Differences between episodic vs chronic migraine, and preliminary signs of reversibility with CGRP-mAbs and botulinum toxin A in responders.
📌 The review underscores the potential of cortical thickness as a biomarker—but also the pressing need for standardized protocols and longitudinal data.
🔗 Read the full article: doi.org/10.1177/03331024251341204
#migraine #neuroimaging #corticalthickness #mri #cephalalgia #headacheresearch #neurology #cgrp #botox -
International Headache Society
@ihs_official
🎬 Episode 3 of the IHS documentary Headed for the Future is now live!
In “The Road Taken,” we explore the groundbreaking discovery that transformed migraine treatment: CGRP. Meet four internationally renowned neuroscientists—Professors Lars Edvinsson, Peter Goadsby @petergoadsby, Michael Moskowitz, and Professor Jes Olesen—who uncovered #cgrp’s critical role in migraine attacks, paving the way for a new generation of targeted therapies.
👉 Watch the teaser on our feeds, then stream the full episode here:
www.youtube.com/watch?v=4JBC0UT9qQo
#ihsdocumentary #headedforthefuture #migraineawarenessmonthThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy
#headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
International Headache Society
@ihs_official
🔍 Can atogepant offer relief for patients unresponsive to anti-CGRP mAbs?
The RESCUE study investigates the effectiveness of atogepant in individuals with episodic or chronic migraine who previously discontinued anti-CGRP monoclonal antibodies due to lack of efficacy.
🧠 Among 44 highly refractory cases:
✔️ 18.2% achieved ≥50% reduction in monthly headache days (MHDs)
✔️ Significant reductions were observed in MHDs, moderate-to-severe headache days, acute medication use, and HIT-6 scores
✔️ 59.1% reported some degree of global improvement
❗ Constipation was the most common adverse event (31.8%)
📌 These observational findings suggest that atogepant may be a viable preventive option for a difficult-to-treat population, meriting further prospective validation. RCTs are needed.
📖 Read the full article: doi.org/10.1177/03331024251346925
#migraine #cgrp #atogepant #realworldevidence #neurology #headachemedicine #rescuestudy -
International Headache Society
@ihs_official
Do you have new and exciting research that deserves to be shared at IHC 2025? The submission period for late-breaking abstracts is open.
More information: ihc2025.org/site/ihc2025/abstract-submission
• Submission closes on 30 June 2025 (23:59 Brasilia time). -
International Headache Society
@ihs_official
IHS Webinar On-Demand
"Headache: What to Look For and How to Treat" is now available on the IHS Learning Centre.
This webinar focused on the diagnosis of primary and secondary headaches, as well as the current evidence for migraine treatment.
Link below:
ihs-headache.org/en/news/reminder-headache-webinar-today-… -
International Headache Society
@ihs_official
🧠 New Insights from the OVERCOME (US) Study on CGRP Monoclonal Antibody Use in Migraine
In this large population-based analysis, Ashina et al. explore real-world patterns of CGRP mAb use among over 39,000 individuals with migraine.
Key findings:
✔️ Only 5% reported using CGRP mAbs; 46% continued use, 39% discontinued.
✔️ Use was more likely among those with triptan contraindications or current use of recommended acute treatments.
✔️ Continued use correlated strongly with concurrent botulinum toxin treatment.
📌 Despite their efficacy, CGRP mAbs remain underutilized - highlighting the need for improved access.
📖 Read the full paper here: doi.org/10.1177/03331024251341243
#migraine #cgrp #headachemedicine #neurology #overcomestudy -
International Headache Society
@ihs_official
New Article in Cephalalgia! Migraine: Beyond Biology
Migraine is more than a neurological disorder — it is a deeply personal, emotional, and existential experience.
This new review explores migraine through a philosophical lens, bridging neuroscience, clinical care, and patient narratives. What does it mean to suffer? How do we find meaning in pain? Drawing on reflections from Nietzsche, Sartre, and Camus, the work urges us to consider migraine not only as a dysfunction of the brain but as a lived human experience.
Understanding migraine requires more than science — it calls for empathy, reflection, and dialogue. A truly holistic, patient-centered approach must integrate the biological and the existential.
Check the full article here: doi.org/10.1177/03331024251343225 -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🗣️ A powerful patient voice in the migraine conversation
In response to "Setting Higher Standards for Migraine Prevention" by Sacco et al., Alleanza Cefalalgici (Al.Ce.), Italy’s national headache patient advocacy group, express strong support for this cultural shift in migraine care—from statistical thresholds to true well-being.
🔹 We welcome the call to aim beyond attack frequency reduction and toward migraine freedom—with minimal side effects.
🔹 We also call for broader access to innovative therapies—currently limited by restrictive reimbursement rules.
🔹 We advocate for an updated, patient-centered classification that reflects comorbidities, interictal disability, and psychosocial factors.
🔹 We urge collaboration between patient organizations and scientific societies to drive meaningful change.
📖 Read the patient perspective: doi.org/10.1177/03331024251343217
#migraine #headacheadvocacy #patientvoice #neurology #cephalalgia #ihs #disabilitymatters #migraineprevention -
International Headache Society
@ihs_official
📢 New publication alert!
“Intact white matter in adults with migraine: A REFORM MRI study”
🧠 Using advanced diffusion tensor imaging (DTI), this large case-control study of nearly 300 migraine patients found no significant differences in white matter integrity compared to healthy controls—across subtypes and even during attacks.
🔍 These findings challenge assumptions about microstructural brain changes in migraine and highlight the need to explore alternative imaging biomarkers and pathophysiologic pathways.
📖 Read the full article: doi.org/10.1177/03331024251339423
#migraine #mri #neurology #headacheresearch #dti #neuroimaging #cephalalgia -
International Headache Society
@ihs_official
🧠 New in Cephalalgia: Behavioral approaches to post-traumatic headache
Persistent post-traumatic headache (PPTH) is a common and disabling consequence of mild traumatic brain injury — yet treatment remains challenging.
🔍 This systematic review (n=12 studies; 2293 individuals) highlights:
✅ Cognitive behavioral therapy (CBT) as the most studied and promising approach
✅ The importance of integrated care models
✅ Strong link between PPTH and affective distress
📌 Key message: Effective PPTH management must address both pain and psychological comorbidity.
👉 Full open-access article: doi.org/10.1177/03331024251341237
#tbi #ppth #posttraumaticheadache #behavioraltherapy #cbt #headachemedicine #cephalalgia #neurorehabilitation -
International Headache Society
@ihs_official
🧪 New biomarker insights in migraine!
A cross-sectional study of over 750 adults reveals:
🔹 Serum GFAP levels are modestly but significantly higher (+6.8%) in people with migraine vs. healthy controls.
🔹 Serum NfL levels? No difference found.
🔹 Results were independent of migraine subtype or headache presence at sampling.
These findings open the door for further exploration of GFAP as a potential biomarker in migraine.
📖 Read the full study: doi.org/10.1177/03331024251338178
#migraine #biomarkers #gfap #nfl #neuroinflammation #neurology #cephalalgia #headacheresearch -
International Headache Society
@ihs_official
🧠 Post-Traumatic Headache: Tracking Brain Recovery
New article published in Cephalalgia: doi.org/10.1177/03331024251345160
Why do some patients recover from post-traumatic headache (PTH) after mild traumatic brain injury, while others continue to suffer for months or years?
This longitudinal fMRI study reveals key differences in how the brain responds to pain over time in people with PTH.
✅ Those who improved showed progressive normalization of pain-related brain activity.
❌ Those who did not improve had persistent abnormal activation in regions like the ventral striatum and olfactory cortex.
These patterns may represent biomarkers for persistent PTH, opening the door to earlier identification and more personalized interventions. -
International Headache Society
@ihs_official
Cephalalgia Editor's choice - May
We are pleased to announce and congratulate the authors for their paper:
Ku D, Mao L, Nikolova S, Dumkrieger GM, Ross KB, Huentelman M, Anderson T, Porreca F, Navratilova E, Starling A, Wu T, Li J, Chong CD, Schwedt TJ.
Longitudinal analysis of pain-induced brain activations in post-traumatic headache.
Cephalalgia. 2025 May;45(5):3331024251345160. doi: 10.1177/03331024251345160. Epub 2025 May 27. PMID: 40426297.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders. -
International Headache Society
@ihs_official
June is #migraineawarenessmonth!
Do you know there are clear criteria for diagnosing migraine?
The ICHD‑3 criteria, developed by the International Headache Society’s Classification Committee, give clinicians a clear guide for diagnosing headache disorders.
Swipe the infographic below for the essentials, then visit our website to read the detailed criteria: ichd-3.org/1-migraine/1-1-migraine-without-aura/
#migraine #headache #research -
International Headache Society
@ihs_official
🧠 New study alert!
Headache disorders are a major but underrecognized issue in the workplace.
🔍 In a palm plantation in Cameroon, 80% of workers reported headaches in the past year.
⚠️ Migraine was the most disabling—causing the highest rates of absenteeism, presenteeism, and poor quality of life.
📉 Female workers, palm field roles, and those aged 30–39 were most affected.
👉 Read the open access paper in Cephalalgia: doi.org/10.1177/03331024251343312
#globalhealth #neurology #headache #migraine #occupationalhealth #cephalalgia -
International Headache Society
@ihs_official
🧠 RCVS and unusual triggers: a case to reflect on
Reversible cerebral vasoconstriction syndrome (RCVS) is a rare cause of thunderclap headache, often linked to exertion, stress, or vasoactive exposures.
A new case highlights a previously undocumented trigger—underscoring the importance of thorough history-taking in evaluating sudden-onset headache.
🔍 This case raises awareness of potential underrecognized precipitating factors.
Read more in Cephalalgia: doi.org/10.1177/25158163251339404
#neurology #rcvs #headachemedicine #cephalalgia #thunderclapheadache #clinicalcases #vascularneurology -
International Headache Society
@ihs_official
🎬 Episode 2 of the IHS documentary Headed for the Future is here!
On 13 June, we premiere Episode 2: “Pain Without Gain” on the IHS YouTube channel. Migraine is a serious health condition with major workplace consequences, draining an estimated €50 billion from the European economy every year. Discover how migraine‑friendly workplaces protect employees and lift performance.
👉 Watch the teaser on our feeds, then stream the full episode here: youtu.be/0npY5baa3iE
#ihsdocumentary #headedforthefuture #migraineawarenessmonth -
International Headache Society
@ihs_official
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy
#headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
International Headache Society
@ihs_official
🔬 After the breakthrough of CGRP-targeted treatments, what’s next in migraine research?
📌 Emerging evidence suggests amylin—a peptide in the same family as CGRP—may play a role in migraine pathophysiology.
🧠 This new review explores:
✔️ Amylin’s link with CGRP signaling
✔️ Its ability to trigger migraine in provocation studies
✔️ Potential as a biomarker and therapeutic target
✔️ Early data on sex-specific mechanisms
🧩 Could amylin be the next frontier in migraine treatment—especially for those not responding to CGRP therapies?
👉 Read more and explore the evolving science behind amylin and migraine.
#migraine #headachemedicine #cgrp #amylin #neurology #biomarkers #precisionmedicine #futureofmigrainecare
doi.org/10.1177/03331024251331198 -
International Headache Society
@ihs_official
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience
@pul_fra @headacheMD @mariofpperes -
International Headache Society
@ihs_official
🚨 New Editorial in Cephalalgia 🚨
"Raising the bar in migraine prevention: Toward freedom and optimal control" by Antonio Russo & Uwe Reuter challenges us to rethink success in migraine care.
🔹 Moving beyond ≥50% MMD reduction
🔹 Emphasizing residual burden and quality of life
🔹 Advocating for ambitious goals: migraine freedom or optimal control
🔹 Highlighting the promise of pragmatic trials (like TACTIC) and multimodal strategies
It’s time for a mindset shift — from symptom reduction to patient-centered outcomes.
👉 Read the full editorial: doi.org/10.1177/03331024251331198 -
International Headache Society
@ihs_official
🧠 New study alert!
Headache disorders are a major but underrecognized issue in the workplace.
🔍 In a palm plantation in Cameroon, 80% of workers reported headaches in the past year.
⚠️ Migraine was the most disabling—causing the highest rates of absenteeism, presenteeism, and poor quality of life.
📉 Female workers, palm field roles, and those aged 30–39 were most affected.
👉 Read the open access paper in Cephalalgia: doi.org/10.1177/03331024251343312
#globalhealth #neurology #headache #migraine #occupationalhealth #cephalalgia -
International Headache Society
@ihs_official
🧬 New insights into abdominal migraine in adults
Abdominal migraine is rarely diagnosed in adults, leaving treatment options unclear. This case report suggests that CGRP-targeting therapies can lead to substantial symptom relief.
📉 The patient saw up to a 78% reduction in attack frequency after years of treatment failures.
This case underscores CGRP’s potential role in abdominal migraine pathophysiology and highlights the need for further research.
📖 Read more in Cephalalgia Reports: doi.org/10.1177/25158163251341303
#migraine #abdominalmigraine #cgrp #neurology #headache #cephalalgia -
International Headache Society
@ihs_official
🎉 Congratulations to the exceptional early-career researchers who have completed the 2024 - 2025 Cephalalgia Reviewer Academy! 👏
This inaugural cohort has demonstrated excellence, dedication, and a deep commitment.
👏 A heartfelt thank you to our outstanding mentors - Anna Andreou, Gianluca Coppola, Teshame Monteith, Kuan-Po Peng, Cristina Tassorelli, Marcelo Valença, and Simona Sacco - for sharing their expertise and guiding the next generation of reviewers.
🌍 From diverse backgrounds and across the globe, these eight talented individuals are now ready to contribute to elevate scientific publishing in the headache field.
🔎 We look forward to seeing their continued contributions to Cephalalgia and Cephalalgia Reports - and to welcoming new applicants to the 2025–2026 edition!
doi.org/10.1177/03331024251346916 -
International Headache Society
@ihs_official
June is #migraineawarenessmonth!
Did you know that #migraine with aura is associated with a higher risk of ischemic stroke? Migraine with aura accounts for 1/5 to 1/3 of migraine patients. The IHS Visual Aura Table helps clinicians and researchers identify and characterize visual aura in a standardized way.
To learn more, please go to: ihs-headache.org/en/resources/visual-aura-table/ -
International Headache Society
@ihs_official
Migraine is a debilitating neurological disorder affecting over 1 billion people, about 14–15% of the global population. Women are three times more likely to be affected, highlighting a major gender disparity.
In this Episode 1 'Pain & Prejudice', Anette shares her lifelong journey with severe migraine. The film features insights from leading experts: Prof. Cristina Tassorelli (Italy), Prof. Robert Shapiro (USA), Prof. Christian Lampl (Austria), and Asst. Prof. Jelena Pavlovic (USA).
It also includes perspectives from patient advocates Heather Phillips (American Migraine Foundation) and Elena Ruiz de La Torre (European Migraine and Headache Alliance), highlighting the importance of advocacy and improved access to care.
To see the full video: www.youtube.com/watch?v=EDHgYzFi9-k&t=1s
#mam2025 #migraineawareness -
International Headache Society
@ihs_official
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy #headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
International Headache Society
@ihs_official
June is Migraine Awareness Month.
On June 2, the International Headache Society proudly launches Headed for the Future — a compelling new documentary series highlighting the impact of migraine and cluster headache.
To learn more, please go to:
youtu.be/7NwkPsW9f38
#mam2025 #migraineawareness -
International Headache Society
@ihs_official
June is Migraine Awareness Month
Migraine is a debilitating neurological disorder that affects over 1 billion people worldwide, with 14–15% of the global population experiencing it. Women are two to three times more likely to be affected, often due to hormonal influences.
This June, let’s raise awareness and advocate for better care for those living with #migraine.
#mam2025 #migraineawareness -
International Headache Society
@ihs_official
This study proposes the inclusion of formal diagnostic criteria for painful nervus intermedius neuropathy attributed to Bell’s Palsy, which is an under-recognized yet clinically relevant feature of this condition.
journals.sagepub.com/doi/10.1177/03331024251340059
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Al-Khazali et al. showed that substance P induced headache and arterial dilation in healthy individuals, supporting its role in headache pathogenesis and warranting further research in migraine and other headache disorders.
journals.sagepub.com/doi/10.1177/03331024251336132
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
OnabotulinumtoxinA treatment for chronic migraine appears to be effective during pregnancy.
There is currently no evidence of pregnancy-related adverse effects associated with the use of OnabotulinumtoxinA for chronic migraine during pregnancy.
However, abrupt discontinuation of OnabotulinumtoxinA treatment in pregnancy has been linked to a high risk of migraine relapse.
journals.sagepub.com/doi/10.1177/03331024251327387
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This research explores combining transcranial direct current stimulation (tDCS) with CGRP-targeting monoclonal antibodies to improve migraine treatment.
tDCS as an adjunct: tDCS, applied alongside CGRP monoclonal antibodies, resulted in a significant reduction in migraine days during the 28-day follow-up compared to the sham group.
•
Neurophysiological effects: active tDCS induced a significant decrease in delta power in frontal regions, suggesting an impact on central migraine mechanisms.
•
Reduction in migraine days: participants receiving active tDCS reported fewer migraine days during the 28-day follow-up compared to the sham group.
•
Safety profile: tDCS was well tolerated, with no serious adverse events reported.
journals.sagepub.com/doi/10.1177/03331024251325567
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Burning Mouth Syndrome isn’t just “burning.” This paper proposes broader ICHD-4 criteria to include tingling and other dysaesthetic descriptors, ensuring more accurate diagnosis, better research, and improved care for oral pain sufferers.
journals.sagepub.com/doi/10.1177/25158163251339141
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This an editorial linked to the article, Serum GFAP and NfL Levels in Migraine: a Registry for Migraine (REFORM) Study ---which has not published yet.
journals.sagepub.com/doi/10.1177/03331024251338171
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Final Day to Save!
Register today – 26 May – to benefit from the early registration fee for IHC 2025.
Join global leaders in headache science this September in São Paulo and take part in the conversation shaping the future of headache care.
Register now: www.ihc2025.org -
International Headache Society
@ihs_official
We’re proud to share that Professor Fayyaz Ahmed, Trustee of the International Headache Society, was invited to the Royal Garden Party at Buckingham Palace—an honour recognising his outstanding dedication to headache and migraine care.
www.hey.nhs.uk/news/2025/05/21/hull-headache-specialist-a… -
International Headache Society
@ihs_official
Sphenopalatine neuralgia is a close differential of complex regional pain syndrome of face as both share clinical features and both respond to sphenopalatine ganglion block.
journals.sagepub.com/doi/10.1177/25158163251327173
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This is an editorial linked to the article, Intact White Matter in Adults with Migraine: A REFORM MRI Study --which has not published yet.
journals.sagepub.com/doi/10.1177/03331024251339431
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Register by 26 May to take part in the 22nd International Headache Congress, where leading experts, emerging voices, and dedicated healthcare professionals will gather to share cutting-edge advances in headache science and care.
www.ihc2025.org -
International Headache Society
@ihs_official
This case reports suggest chilblains can be associated with treatment with CGRP monoclonal antibodies but not during treatment with a CGRP oral antagonist.
journals.sagepub.com/doi/10.1177/25158163251329568
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine potentially impacts headache management including treatment prediction and early intervention.
journals.sagepub.com/doi/10.1177/03331024251331554
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Al-Khazali et al. reported that individuals with persistent post-traumatic headache (PTH) exhibit disability and headache profiles comparable to those with chronic migraine, emphasizing the necessity for targeted management strategies akin to chronic migraine care.
journals.sagepub.com/doi/10.1177/03331024251331605
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Join us for an IHS Education Committee Webinar
"Headache – what to look for and how to treat"
Join us on 29 May 2025 at 18:00 Uzbekistan / 15:00 CEST for a special session chaired by Marcio Nattan Souza, featuring expert talks on the diagnosis and management of headache disorders.
• Diagnosis of primary headaches – Marcio Nattan (Brazil)
• Diagnosis of secondary headaches – David García Azorín (Spain)
• Treatment of migraine – Roberta Messina (Italy)
🔗 Register now: us02web.zoom.us/webinar/register/WN_yW6aIZIS426vziTurrJeA -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
International Headache Society
@ihs_official
📢 Final Day – Last Chance – Deadline: 19 May!
This is your last opportunity to submit your abstract for IHC 2025 – the first International Headache Congress ever held in Latin America.
Share your research with the global headache community and be part of this landmark scientific Congress.
🔗 Submit now at ihc2025.org/ihc2025
#ihc2025 #neurology #neurologist #neuroscience #migraine #abstract #internationalheadachecongress #headachecongress #medicinecongress -
International Headache Society
@ihs_official
Throwback Thursday!
#ihc2017 in Vancouver marked a turning point in migraine therapy, as the congress featured pivotal studies on CGRP monoclonal antibodies—opening a new horizon for treatment.
Did you attend this congress? Share your favorite photo!
#tbt #migraine #headache -
International Headache Society
@ihs_official
🧠✨ New Evidence-Based Guidelines for Migraine Treatment!
The International Headache Society and Italian Society for the Study of Headache have released updated guidelines for the pharmacological management of migraine, covering both acute attacks and preventive strategies.
A major step toward standardizing care and improving outcomes for people with migraine worldwide.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Final Call for Abstract Submissions!
Showcase your research at the 22nd International Headache Congress – the first ever in Latin America.
🗓 Submission deadline: 19 May 2025 (Brasilia time)
🔗 Submit now via ihc2025.org/ihc2025 -
International Headache Society
@ihs_official
This study demonstrated the effectiveness of atogepant in preventing migraine after 12-week treatment in real life conditions. Only 3 out of 106 patients discontinued treatment for adverse events.
journals.sagepub.com/doi/10.1177/03331024251335927
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
There is a notable high prevalence of gastroesophageal reflux disease (GERD) in burning mouth syndrome (BMS) patients, highlighting a potential comorbid relationship between the two conditions.
.....
journals.sagepub.com/doi/10.1177/03331024251336139
#gerd #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🚀 Advancing Migraine Care: New Guidelines Released!
The International Headache Society and Italian Society for the Study of Headache present the latest evidence-based guidelines for acute and preventive migraine treatment.
Clear, rigorous, and practical—these guidelines are a major step toward improving migraine management worldwide. 🌍🧠
📖 Discover the full recommendations:
journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscienceThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
🚀 Advancing Migraine Care: New Guidelines Released!
The International Headache Society and Italian Society for the Study of Headache present the latest evidence-based guidelines for acute and preventive migraine treatment.
Clear, rigorous, and practical—these guidelines are a major step toward improving migraine management worldwide. 🌍🧠
📖 Discover the full recommendations:
journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
April's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Evidence-based guidelines for the pharmacological treatment of migraine” which has been selected as the Editor’s Choice for the April issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Abstract Submission Deadline Extended!
You now have until 19 May 2025 to submit your abstract for IHC 2025.
This is a unique opportunity to share your research with the global headache community at the first International Headache Congress ever held in Latin America.
Submit now at ihc2025.org/ihc2025 -
International Headache Society
@ihs_official
🚨 Final hours to submit your abstract to #ihc2025!
Make your mark on the global stage of headache science.
Submissions close tonight at 23:59 (Brasília time).
🔗 Don’t wait – submit now: ihc2025.org -
International Headache Society
@ihs_official
IHS ALERT!!!
Fake emails circulating...
Please be aware that there is a fake email circulating saying it is from the IHS President – the email address is rburstei@gmail.com.
Please DO NOT RESPOND to this email. It is NOT from IHS.
We remind members to be vigilant and carefully check incoming email addresses to make sure they are genuine. IHS and its Board members will never send requests for financial assistance.
#ihs #headache #ihc2025 -
International Headache Society
@ihs_official
Stroke-like migraine attacks after radiation therapy (SMART) syndrome remains underrecognized among non-radiologist specialists.
journals.sagepub.com/doi/10.1177/03331024251334355
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Throwback Thursday!
Remember the unforgettable moments at #ihc2019 in Dublin?
We can’t wait to reunite at #ihc2025 in São Paulo, Brazil, this September 10–13!
#tbt #dulin -
International Headache Society
@ihs_official
In a cross-sectional study in a large population of frequent flyers risk factors for airplane headache were identified with two multivariate logistic regression models. They align with established risk factors for other headache forms
journals.sagepub.com/doi/10.1177/03331024251329837
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
⏳ Final days to submit your abstract to #ihc2025!
Don’t miss your chance to share your research at the leading global Congress in headache medicine.
📅 Deadline: 5 May 2025 at 23:59 (Brasília time)
🔗 Submit now: ihc2025.org -
International Headache Society
@ihs_official
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This MR imaging study investigated validated signs intracranial hypotension in people with posttraumatic headache (PTH) compared to healthy controls. Based on this method, people with PTH do not show signs of intracranial hypotension!
journals.sagepub.com/doi/10.1177/03331024251325556
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
International Headache Society
@ihs_official
New in Cephalalgia: “Social Media’s Role in Migraine Education: Headache or Not Headache?” Social media offers access, support & awareness—but also spreads misinformation, unverified cures & triggers. Can we harness it for good?
journals.sagepub.com/doi/10.1177/03331024251336152
.....................
Special issue:
📢 Call for Papers: Digital Headache
⏳ Deadline for Submissions: December 31, 2025
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
📌 Manuscripts should be submitted electronically through the journal's online submission system. -
International Headache Society
@ihs_official
IHS webinar
A Physiotherapy Specialist Interest Group – Why is it needed?
Did you miss the latest IHS Webinar about Physiotherapy SIG?
Now you can watch it online on the IHS YouTube Channel.
Click the link below to learn more about the role of physiotherapy in headache disorders.
ihs-headache.org/en/news/watch-the-latest-ihs-webinar-a-p…
#ichd3matters #physiotherapy #sig #headache #ihs -
International Headache Society
@ihs_official
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
A multidisciplinary headache team effectively reduces headache frequency, sick leave, and psychological distress in patients with present or recurrent headache-related sick leave.
journals.sagepub.com/doi/10.1177/03331024251332572
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society reposted
Jr Wei Wu, MD, FAAN
@Bohemian_Wu
A warm welcome to Prof. Patricia Pozo-Rosich @ppozorosich to Taiwan!
Her inspiring talks on breakthrough on migraine research & biomarker-driven precision medicine at Taipei Veterans General Hospital & #amtns deeply resonated with all.
Thank you for sharing invaluable insights -
International Headache Society
@ihs_official
SISC-IHS guideline for pharmacological treatment of #migraine is now published @JCephalalgia @Simona_Sacco_
@Schwedtt @MessoudAshina @SaitAshina @Bohemian_Wu @Faradoost @ninariggins
doi.org/10.1177/03331024241305381 -
International Headache Society
@ihs_official
Are you a trainee with outstanding research? 🎯
Submit your abstract to #ihc2025 and opt in for the Trainees Excellence Tournament!
🏆 Top presentations voted by attendees – winner receives a cash prize!
📅 Deadline: 5 May 2025
🔗 ihc2025.org -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Submitting to #ihc2025 is simple:
📌 Follow the abstract guidelines
📝 Prepare your best work
📤 Submit online via the Congress website
📅 Deadline: 5 May 2025
🔗 ihc2025.org -
International Headache Society
@ihs_official
Preventive treatment with anti-CGRP mAbs and BTX-A effectively reduces non-perimenstrual headache and non-perimenstrual migraine days but appears to have limited efficacy in perimenstrual headache and migraine days.
journals.sagepub.com/doi/10.1177/03331024251332519
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Did you know that burning mouth syndrome is included in the ICHD-3? 🔥👄
According to the ICHD-3, burning mouth syndrome (BMS) is defined as a recurring daily burning or dysaesthetic sensation inside the mouth, lasting more than 2 hours per day, for over 3 months, and without any visible lesions.
👉 Want to learn more? Check it out here: ichd-3.org/13-painful-cranial-neuropathies-and-other-faci…
#ichd3matters #headache #bms #burning_mouth_syndrome -
International Headache Society
@ihs_official
📢 ICHD-4: Work in Progress!
The International Headache Society shares updates on the upcoming International Classification of Headache Disorders, 4th edition (ICHD-4).
Key issues under discussion include:
🔹 Overlapping features in primary vs secondary headaches
🔹 Revisions to tension-type headache criteria
🔹 Rethinking chronic vs episodic migraine classification
🔹 Updates on vestibular migraine and medication-overuse headache
🔹 Plans for open community feedback at IHC2025 in São Paulo
Get involved and help shape the future of headache diagnosis!
🧠 Read the full report: journals.sagepub.com/doi/10.1177/03331024251325550
#ichd4 #ihs #cephalalgia #neurology #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This letter is presented as a thought experiment—grounded in clinical observation and current literature—and aims to promote discussion around the limitations of the current duration-based status migrainosus definition.
journals.sagepub.com/doi/10.1177/03331024251334137
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Letter to the Editor:
Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure: The need for a broader perspective.
Link: journals.sagepub.com/doi/10.1177/03331024251329513
Reply: journals.sagepub.com/doi/10.1177/03331024251329506
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Showcase your research, gain global visibility, and contribute to advancing headache care worldwide. 🌍🧠
Submit your abstract to #ihc2025 – the most comprehensive Congress in headache medicine.
📅 Deadline: 5 May 2025
🔗 ihc2025.org -
International Headache Society
@ihs_official
Letter to the Editor
Reply to “What is the evolutionary disadvantage of migraine?”
doi.org/10.1177/03331024251327377
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧬🧠 Is Migraine an Evolutionary Mismatch?
A new article in Cephalalgia explores the idea of migraine as a dysevolutionary disorder—a trait once beneficial in ancestral environments but now maladaptive in modern life.
📉 Using global data, the study shows that stronger natural selection correlates with lower migraine prevalence, offering fresh insight into the evolutionary roots of migraine.
📖 Read more: journals.sagepub.com/doi/10.1177/03331024251327361
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This Editorial launches a new Topical Collection of Cephalalgia on Headache in Children and Adolescence. It will include original researches and review articles dealing with the main topics of headache in youth.
journals.sagepub.com/doi/10.1177/03331024251331217
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 Ready to present your research on a global stage?
Submit your abstract to IHC 2025 and join the leading global programme in headache medicine.
📅 Deadline: 5 May 2025 – 23:59 (Brasília time)
🔗 Submit now: ihc2025.org -
International Headache Society
@ihs_official
It was a wonderful reunion of those deeply dedicated to headache medicine—IHS members, the committee chair, and the @JCephalalgia social media editor—at #aanam. Great to see such strong engagement from the #headache community ❤️
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
With amazing @DawnBuse #aanam @AANmember @headacheMD @Bohemian_Wu @ChiaChunChiang @WNGtweets Great #headache session! @JCephalalgia @ihs_official @ahsheadache
-
International Headache Society
@ihs_official
Fremanezumab treatment was effective and safe for patients with refractory migraine and hereditary transthyretin amyloidosis.
Clinical implications
•
Safety: Fremanezumab was well-tolerated, with no significant safety concerns observed in the cases.
•
Potential therapeutic benefit: Given its effectiveness and safety profile, fremanezumab, or other anti-CGRP antibodies, may represent a promising treatment option for patients with refractory migraine and hereditary transthyretin amyloidosis.
doi.org/10.1177/25158163251327180
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
A case of refractory cluster headache presented, where there was a clear reduction of attacks after gender-affirming treatment.
This case contributes to a growing body of literature suggesting that hormonal factors may significantly impact the clinical course of primary headache disorders, including cluster headache.
journals.sagepub.com/doi/10.1177/25158163251322801
#migraine #headache #brain #pain #neurology #neuroscience #clusterheadache -
International Headache Society
@ihs_official
This paper found that genetic risk for migraine may not be a causal risk factor for Primary-Open Angle Glaucoma (POAG).
journals.sagepub.com/doi/10.1177/25158163251323245
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
A reminder from Dr Mario Peres, Local Organising Chair of IHC 2025:
Don’t forget — the abstract submission deadline is 5 May 2025.
Check the full guidelines here:
ihc2025.org/site/ihc2025/abstract-submission -
International Headache Society
@ihs_official
This letter emphasizes the significance of reassessing the definitions of "not responding" and "partial efficacy," advocating for a more precise categorization that distinguishes effective treatment, partial efficacy, and not responding.
journals.sagepub.com/doi/10.1177/03331024251325526
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
⏰ Only 1 month left!
Submit by 5 May 2025 to be part of IHC 2025 in São Paulo.
Showcase your research at the leading global event in headache medicine.
#ihc2025 #headache -
International Headache Society
@ihs_official
March's Editor's Choice
We are pleased to announce and congratulate the authors on their paper, “Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
....
doi.org/10.1177/03331024251329400
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
journals.sagepub.com/doi/10.1177/03331024251329400
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Throwback Thursday!
Do you remember the outstanding science and vibrant activities at #ihc2023 in Seoul?
Let’s look forward to #ihc2025 in São Paulo, Brazil — coming up on September 10–13, 2025!
#tbt #headache -
International Headache Society
@ihs_official
📬✨ Stay Ahead in Headache Research!
Never miss a breakthrough—sign up for Cephalalgia Table of Contents alerts and get the latest in headache and migraine research delivered straight to your inbox.
🔗 Stay informed. Stay inspired.
journals.sagepub.com/home/CEP
#cephalalgia #headacheresearch #neurology #stayupdated #migrainescience -
International Headache Society
@ihs_official
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
International Headache Society
@ihs_official
Meta-analysis of cervicogenic headache revealed a prevalence of 3.9% in the population and 3.1% in clinics, of which of 80.8% were female. The limited data stressed the need for standardization of research and clinical criteria.
journals.sagepub.com/doi/10.1177/03331024251322446
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Editor's Choice: An Interview with Drs Andrew Russo and Erik Zorrilla by Dr Nina Riggins.
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice.
Link to the video:
www.youtube.com/watch?v=pJOXHSHa210&ab_channel=Internatio…
Link to the paper:
journals.sagepub.com/doi/10.1177/03331024251314487
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Plasma and salivary CGRP levels in participants with vestibular migraine (VM) were not significantly different from those in healthy controls but significantly elevated in those with chronic migraine (CM).
journals.sagepub.com/doi/10.1177/03331024251322418
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world data (RWD) studies, and therefore the strength and reliability of their output.
journals.sagepub.com/doi/10.1177/03331024251318016
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia @ppozorosich -
International Headache Society
@ihs_official
A recent review on occipital neuralgia (ON), a severe and paroxysmal pain condition affecting the occipital nerves, analyzed data from 15 clinic-based studies involving 579 patients.
ON shows female predominance and links with migraine and neck trauma.
journals.sagepub.com/doi/10.1177/03331024251317595
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 New Neurology Podcast episode! 🎙️
In the @GreenJournal podcast from the American Academy of Neurology @AANmember Dr. Jessica Ailani interviews Dr. Francesca Puledda (@pul_fra) from @KingsCollegeLon on the @ihs_official practical recommendations for migraine, recently published in @JCephalgia !
Tune in here:
www.neurology.org/media/podcast/global-recommendations-mi…
📄 Read the full articles in Cephalalgia:
Acute:
journals.sagepub.com/doi/10.1177/03331024241252666
Preventive:
journals.sagepub.com/doi/10.1177/03331024241269735
A must-listen for anyone interested in evidence-based migraine management!
Kudos to Francesca and Jessica for this clinical useful podcast! 👏 #migraine #neurology #cephalalgia -
International Headache Society
@ihs_official
This study reviewed the methodological challenges in using depression screening questionnaires in patients with migraine, in order to investigate whether they are applied and interpreted correctly.
journals.sagepub.com/doi/10.1177/03331024251317635
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
www.youtube.com/watch?v=-KCPdrBbTRc
Cephalalgia Editor’s Choice Episode 14 – Interview with Dr Dwij Mehta
#headache #orthostatic @Simona_Sacco @JCephalalgia @NinaRiggins -
International Headache Society
@ihs_official
Reduction in cortical functional connectivity was observed in treatment responders after 3 months of treatment with galcanezumub.
journals.sagepub.com/doi/10.1177/03331024241313377
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Migraine aura is one of the most fascinating subjects.
@michele viana talks to @henrik schytz and @nattan Souza about phenotyping migraine aura in this webinar, now available here
ihs-headache.org/en/learning-centre/resources/phenotyping… -
International Headache Society
@ihs_official
The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world data (RWD) studies, and therefore the strength and reliability of their output.
journals.sagepub.com/doi/10.1177/03331024251318016
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia -
International Headache Society
@ihs_official
On Cluster Headache Awareness Day, Dr. Anja S. Petersen from the Danish Headache Center highlights the urgent needs of individuals living with cluster headache and emphasizes the importance of recognition and effective treatment of this devastating condition.
She also refers to a newly published article in @TheLancetNeuro outlining recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache:
🔗 doi.org/10.1016/s1474-4422(24)00143-1
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster_kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
International Headache Society
@ihs_official
An independent dose-response association between headache frequency and odds, severity, and impact of fibromyalgia in migraine patients.
journals.sagepub.com/doi/10.1177/03331024251317486
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia -
International Headache Society
@ihs_official
Today is Cluster Headache Awareness Day.
Did you know that before the bouts of cluster headache, there is often a brief pre-cluster phase?
Watch this short video by Dr. Jr-Wei Wu @Bohemian_Wu , Chair of the IHS Communication Committee, as he shares new research findings on pre-cluster symptoms and their potential role in the treatment of cluster headache.
To learn more, please go to: doi.org/10.1186/s10194-024-01862-8
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster_kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
International Headache Society
@ihs_official
🔴 How to Diagnose Cluster Headache? 🔴
Today is International Cluster Headache Awareness Day, a moment to highlight this debilitating condition and improve recognition.
🎥 Watch this short video by Dr. Faraidoon Haghdoost, One of the Social Media Editors of Cephalalgia, on how to diagnose cluster headache and ensure timely, accurate identification.
📢 Let’s raise awareness and support those affected!
@faradoost
#clusterheadache #neurology #migraine #painmanagement #clusterheadacheawareness
Cephalalgia
@JCephalalgia
🔴 How to Diagnose Cluster Headache? 🔴
Today is International Cluster Headache Awareness Day, a moment to highlight this debilitating condition and improve recognition.
🎥 Watch this short video by Dr. Faraidoon Haghdoost, One of the Social Media Editors of Cephalalgia, on how to diagnose cluster headache and ensure timely, accurate identification.
📢 Let’s raise awareness and support those affected!
@faradoost
#clusterheadache #neurology #migraine #painmanagement #clusterheadacheawarenessThis media couldn't be displayed. See it on the original post. -
International Headache Society
@ihs_official
Clinical data from 4 ubrogepant and 4 atogepant randomized, double-blind, placebo-controlled trials showed male participants experienced migraine symptom improvement.
journals.sagepub.com/doi/10.1177/03331024251320610
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia -
International Headache Society
@ihs_official
Tomorrow, March 21, is International Cluster Headache Awareness Day. Dr. Nina Riggins, Cephalalgia's Social Media Editor, invites everyone to help raise awareness of cluster headache.
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster-Kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
International Headache Society reposted
Cephalalgia
@JCephalalgia
What is Proper Migraine Management?
Watch this very short video by our Social Media Editor, Dr. Faraidoon Haghdoost @faradoost , on the recent position statement by the International Headache Society.
This statement calls for ambitious goals in migraine prevention, shifting the focus toward migraine freedom and optimal control—not just reducing attacks.
Link to the paper:
journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🧠 March 16th - 22nd, 2025, marks International Headache Week, a time to raise awareness about the burden of headache disorders and advocate for better care and research.
Furthermore, March 21st, 2025, is Cluster Headache Awareness Day, dedicated to highlighting one of the most painful conditions known to humankind- Cluster Headache.
Together, let’s stand with headache warriors, deepen understanding, and drive progress in headache medicine.
#headache #migraine #cluster_headache #tth -
International Headache Society
@ihs_official
🌍 Brain Awareness Week 2025: Shedding Light on Headache Disorders
Did you know that headache disorders are among the top three most common neurological conditions across most age groups? Let’s raise awareness and support research for better headache care!
#brainawarenessweek #headache #neurology -
International Headache Society
@ihs_official
Chilblains may be a spontaneous, monophasic reaction triggered by galcanezumab. Prescribers should be aware of this potential side effect in the post-marketing phase of this medication.
journals.sagepub.com/doi/10.1177/25158163251322967
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🕒 Super Early Bird Registration Ends Soon – Don’t Miss This Scientific Milestone!
The 22nd International Headache Congress (IHC 2025) will bring groundbreaking advancements in headache medicine, featuring:
✅ Latest research on pathophysiology & biomarkers
✅ Innovative treatment strategies & AI in headache medicine
✅ Breakthroughs in migraine prevention & patient care
Be part of the most comprehensive scientific programme in headache research!
🎟 Register before March 10 to secure the Super Early Bird rate!
🔗 www.ihc2025.org
📅September 10–13, 2025
📍 WTC São Paulo, Brazil
#ihc2025 #headacheresearch #medicalscience #neurology -
International Headache Society
@ihs_official
On #internationalwomensday, we express our gratitude for the dedication, expertise, and leadership of women in medicine—our IHS leadership and members, headache specialists, neurologists, and healthcare professionals—who are shaping the future of headache medicine.
Wishing you a Happy Women’s Day! -
International Headache Society
@ihs_official
🌍 Super Early Bird Registration Ends Soon – Don’t Miss This Global Gathering of Experts!
The 22nd International Headache Congress (IHC 2025) will bring together renowned speakers from 30+ countries, sharing the latest breakthroughs in headache medicine.
👩⚕️ World-leading specialists presenting cutting-edge research
🌎 A truly global event – Connect with experts from 30+ countries
🎤 Engaging sessions on innovations in diagnosis, treatment, and AI-driven solutions
Join top neurologists, researchers, and healthcare professionals shaping the future of headache medicine!
🎟 Register before March 10 to secure the Super Early Bird rate!
🔗 www.ihc2025.org
📅 September 10–13, 2025
📍 WTC São Paulo, Brazil
#ihc2025 #globalexperts #headachescience #neurology #medicalconference -
International Headache Society
@ihs_official
This study indicates that patients with MOH report a higher concurrence of psychopathological comorbidities. These can overburden people with migraine, which end up resorting to analgesic overuse, leading to poorer quality of life.
journals.sagepub.com/doi/10.1177/25158163251318713
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The 22nd International Headache Congress (IHC 2025) is the leading global event for headache specialists, bringing together top experts to advance the field. From September 10–13, 2025 in São Paulo, Brazil, dive into groundbreaking research, innovative treatments, and unparalleled networking opportunities.
Why You Can’t Miss It:
📍 Experience São Paulo – A dynamic city of culture, gastronomy, and innovation.
🤝 Expand Your Network – Connect with leading specialists from around the world.
🔬 Cutting-Edge Science – Stay at the forefront of headache medicine, from pathophysiology to AI-driven treatments.
📝 Super Early Bird Registration Ends Soon! Don’t miss the best rate—register today!
www.ihc2025.org
📅September 10–13, 2025
📍 WTC São Paulo, Brazil
#ihc2025 #headachescience #neurology #medicalconference -
International Headache Society
@ihs_official
In a mouse model of mild traumatic brain injury, early and continuous blockade of CGRP signaling blocked acute post-traimatic headache (PTH) and prevented PTH persistence, with greater analgesic effects in females than males.
journals.sagepub.com/doi/10.1177/03331024251321087
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Annoucment of the Jes Olesen Awards.
The International Headache Society (IHS) has announced the launch of the annual Jes Olesen Awards. Two awards will be granted each year, recognising outstanding original contributions in each of clinical and basic science research.
Read the paper:
journals.sagepub.com/doi/10.1177/03331024251318563
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Mice of both sexes become sensitized to CGRP with increasing migraine frequency consistent with clinical observations of efficacy of CGRP-targeting therapies for migraine prevention in both men and women frequent EM or CM.
journals.sagepub.com/doi/10.1177/03331024251317446
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Guidelines for the use of depression screening tools in patients with migraine are needed.
journals.sagepub.com/doi/10.1177/03331024251317606
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society reposted
Jr Wei Wu, MD, FAAN
@Bohemian_Wu
Honored to co-organize 4th Headache Master School as Secretary-General of the Taiwan Headache Society!
Over 2 days, we covered key topics in #headaches, and I presented on emerging migraine therapy & pressure-related headaches. Excited to keep advancing headache care in Taiwan! -
International Headache Society
@ihs_official
Phenotyping Migraine Aura: A complex common disorder
10 March 2025; Central European Time 18.00
Join the IHS Education Committee for an insightful webinar on Migraine Aura. Dr. Michele Viana will present the latest updates on this fascinating topic, providing expert insights into migraine with aura.
The session will conclude with a Q&A, offering attendees the opportunity to engage and ask questions.
Don’t miss this chance to deepen your understanding!
Register via this link: us02web.zoom.us/webinar/register/WN_rOU7z-eOTA6KH6uCXS0lEw -
International Headache Society
@ihs_official
A position statement by the International Headache Society calls for ambitious goals in migraine prevention, aiming for migraine freedom and optimal control.
doi.org/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Patients on long-term mexiletine were titrated to a median last daily dose of 600 mg, which may be a reasonable target dose for rCM patients.
•
The presence of dizziness as an adverse effect during lidocaine infusion was associated with early mexiletine discontinuation.
•
The most reported side effects of mexiletine were nausea, dizziness, and tremors.
journals.sagepub.com/doi/10.1177/25158163241313123
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
February's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice” which has been selected as the Editor’s Choice for the February issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
Using three mouse models, this study examined the impact of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on migraine-relevant behaviors triggered by (1) calcitonin gene-related peptide (CGRP), (2) sodium nitroprusside (SNP), and (3) cortical spreading depolarization (CSD).
....
journals.sagepub.com/doi/full/10.1177/03331024251314487
@AS_Wattz
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full paper: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHS Webinar: Physiotherapy for Headache
The next IHS webinar focuses on physiotherapy and will be led by the leaders of the recently formed IHS Physiotherapy Special Interest Group. Join us on 10 April at 14:00 GMT to learn more!
🔗 Register now: ihs-headache.org/en/news/ihs-webinar-on-physiotherapy-10-…
#headache #webinar -
International Headache Society
@ihs_official
📢 Symposium on Cluster Headache 📢
We’re pleased to share information about the Symposium on Recent Advances in Cluster Headache Research and Medicine, part of the Nobel Symposium, on May 16 in Stockholm.
🔗 Program & Registration: news.ki.se/calendar/symposium-on-the-recent-advances-in-c…
Feel free to share! #clusterheadache #neurology #ihs -
International Headache Society
@ihs_official
Cephalalgia Reports: Expanding Science & Bridging Global Gaps
Our latest editorial highlights the evolution of Cephalalgia Reports, reinforcing its mission to address regional disparities in headache research and care. From showcasing local insights to amplifying diverse voices, we’re committed to advancing headache science worldwide.
....
journals.sagepub.com/doi/10.1177/25158163251316840
....
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Exciting News: Graphical Abstracts Now in Cephalalgia Reports!
Following the success of graphical abstracts in Cephalalgia, we’re thrilled to announce that Cephalalgia Reports will now feature graphical abstracts to enhance the visibility and accessibility of headache research!
🎨 Why Graphical Abstracts?
✅ Concise, engaging visual summaries
✅ Improves knowledge dissemination
✅ Increases research impact & accessibility
To support this initiative, Esme Ekizoğlu and Rogelio Dominguez-Moreno have been appointed as Graphical Abstract Editors, bringing expertise to help authors craft high-quality visuals.
....
journals.sagepub.com/doi/10.1177/25158163251316843
....
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
February 14 is Tension-Type Headache Awareness Day! ♥️
Tension-type headache can be managed with simple analgesics like paracetamol, aspirin, and NSAIDs, but overuse of analgesics should be avoided. Non-pharmacological approaches, including stress relief, good sleep hygiene, hydration, and massage, also play a key role.
Let’s raise awareness and improve care!
#tth2025
#céphalée_de_tension #cefalea_tensional #cefaleia_de_tensão #spændingshovedpine
#緊縮型頭痛 #긴장성두통 #spanningshoofdpijn
#spannungskopfschmerz -
International Headache Society
@ihs_official
♥️ 2025 Tension-Type Headache (TTH) Awareness Day ♥️
In 2024, @JCephalalgia published a fascinating paper exploring the time features of TTH and other primary headaches. Learn more here: 🔗
journals.sagepub.com/doi/10.1177/03331024241297652
#tth2025 -
International Headache Society
@ihs_official
Today is Tension-Type Headache Awareness Day!
How can we distinguish tension-type headaches from migraine? Check out the infographics for a clear comparison of these two primary headache disorders!
#tth2025
#céphalée_de_tension #cefalea_tensional #cefaleia_de_tensão #spændingshovedpine
#緊縮型頭痛 #긴장성두통 #spanningshoofdpijn
#spannungskopfschmerz -
International Headache Society
@ihs_official
Approximately 1/3 of patients with NDPH responded to treatment with onabotulinumtoxinA.
Response rates in NDPH were similar to daily chronic migraine.
....
journals.sagepub.com/doi/10.1177/03331024251317448
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Tomorrow, February 14, is...
♥️ Tension-Type Headache Awareness Day! ♥️
Chronic TTH occurs more than 15 days per month and affects 1-3% of adults worldwide. It can be disabling and often requires treatment.
Raising awareness is key to improving diagnosis and management! Let’s spread the word.
#tth2025 #headache -
International Headache Society
@ihs_official
We are pleased to welcome Dr. Marcio Nattan Souza to join Dr. Henrik Schytz as co-chair of the IHS Education Committee.
Marcio is a consultant neurologist at Hospital das Clínicas of the University of São Paulo, where he works at the Headache Clinic. He is also a consultant neurologist at Hospital Israelita Albert Einstein in São Paulo, Brazil.
Instagram: @drmarcionattan
Linkedin: @marcionattanportessouza -
International Headache Society
@ihs_official
February 14 is TTH Awareness Day!
Episodic tension-type headache occurs <15 days/month, is typically bilateral, pressing or tightening, mild to moderate, and lasts 30 minutes to 7 days. It does not worsen with routine activity or cause nausea, though photophobia or phonophobia may occur.
#tthawareness #tth2025 -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Despite the demonstrated effectiveness and tolerability of anti-CGRP-mAbs in migraine prevention, this systematic review highlights the importance of closely monitoring the blood pressure of patients undergoing CGRP-targeted treatment
journals.sagepub.com/doi/10.1177/03331024241297673
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Did you know tension-type headache (TTH) is the most prevalent headache disorder, affecting over 2 billion people worldwide? Though often overlooked, its chronic form can be disabling.
Join us in raising awareness for TTH and supporting our patients!
#tthawareness #headachehealth #tth2025 -
International Headache Society
@ihs_official
In this retrospective observational study the effectiveness and safety of eptinezumab was confirmed also in people with migraine who had failed erenumab/galcanezumab, hinting at the possibility of a successful switch also in these patients.
journals.sagepub.com/doi/10.1177/25158163251316809
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The answer to yesterday's Sunday Quiz was A:
According to ICHD-3, The pain attack of #suna is strictly unilateral, located at the orbital, supraorbital, or temporal, with moderate or severe intensity, lasting for 1–600 seconds. The cranial autonomic symptoms of SUNA should have only one or neither of the following: conjunctival injection and lacrimation (tearing).
To learn more, please go to: ichd-3.org/3-trigeminal-autonomic-cephalalgias/3-3-short-… -
International Headache Society
@ihs_official
#sundayquiz of the week:
According to ICHD-3, which criterion is NOT included for diagnosing 3.3.2 SUNA?
A. Both of the following, ipsilateral to the pain:
conjunctival injection, lacrimation (tearing)
B. Lasting for 1–600 seconds -
International Headache Society
@ihs_official
#sundayquiz of the week:
According to ICHD-3, which criterion is NOT included for the diagnosis of 3.3.2 Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)?
#neurology #headache #suna -
International Headache Society
@ihs_official
Endometriosis is a risk factor for migraine. In a mouse endometriosis model, prolactin promoted vulnerability to migraine by sensitizing trigeminal neurons. Prolactin lowering medications may prevent migraine in women with endometriosis.
journals.sagepub.com/doi/10.1177/03331024241313378
@schwedtt
@daviddodick
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎯 Submit your abstract to #ihc2025!
Be part of a global discussion on headache care. Choose from 28+ topics & get published in Cephalalgia! 🚀 Funding available for young presenters.
📅 Submit now: www.ihc2025.org
#neurology #medicalconference #headachecare #abstractsubmission -
International Headache Society
@ihs_official
January's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Defining the Typical Characteristics of Orthostatic Headache in Patients with Spontaneous Intracranial Hypotension,” which has been selected as the Editor’s Choice for the January issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
......
Time to baseline headache severity on lying down is the most important factor when assessing for an orthostatic headache. In patients with chronic headaches, retrospective history of orthostatic headache at onset should be sought as this quality can be lost with time. Rhinorrhoea can be present in almost 14% of patients with spontaneous intracranial hypotension.
.........
journals.sagepub.com/doi/10.1177/03331024241308154
@Manjit_Matharu
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
New Editor's Choice Article Dr Sacco @Cephalalgia
Please see an exciting discussion with the great authors and @ninariggins youtu.be/P4NU4uXPPnk -
International Headache Society
@ihs_official
Do you know how to diagnose nummular headache?
According to the ICHD-3, nummular headache is characterized by pain localized to a small, circumscribed area of the scalp, with no underlying structural lesion. The pain is fixed in size and shape, typically round or elliptical, measuring 1–6 cm in diameter. While its duration varies widely, it often presents as a chronic condition.
To learn more, please go to: ichd-3.org/other-primary-headache-disorders/4-8-nummular-…
#headache #ichd3matters #nummularheadache -
International Headache Society
@ihs_official
People genetically predisposed to autism are more likely to experience migraine, including migraine with and without aura.
Sex does not affect, and personality trait neuroticism partly explains this relationship.
journals.sagepub.com/doi/10.1177/03331024241312666
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🚨 Scam Alert! 🚨
A fake email claiming to be from the IHS President. Please remain vigilant and double-check incoming email addresses to ensure their authenticity. IHS and its Board members will never request financial assistance or logistical support. -
International Headache Society
@ihs_official
Cephalalgia is pleased to announce the establishment of the Jes Olesen Awards, recognising outstanding contributions in headache medicine across both clinical and basic sciences.
The awards will be granted annually to the best original research papers submitted under a dedicated call.
Each year there will be two awards, one for a basic science paper, and one for a clinical paper.
Recipients will present their work at the bi-ennial International Headache Congress.
Award value: Eur 10,000 per award
Submission closes 28 February 2025.
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎉✨ Announcing the Top Peer Reviewer Award Winner for Cephalalgia!
We are thrilled to recognize Bianca Raffaelli as the recipient of the Top Peer Reviewer Award! Her exceptional contributions, insightful feedback, and unwavering dedication have been instrumental in upholding the high quality and rigor of Cephalalgia.
Additionally, we’re delighted to announce that Bianca has been appointed as an Associate Editor for the journal—a well-deserved recognition of her expertise and commitment to advancing headache research.
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
Please join us in congratulating Bianca on these remarkable achievements!
#cephalalgia #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎉✨ Celebrating Our Exceptional Peer Reviewers for Cephalalgia
On behalf of the entire Cephalalgia journal team, we extend our deepest gratitude and heartfelt congratulations to our exceptional peer reviewers for their invaluable contributions:
Gregory Dussor (U.S.A.)
David Garcia-Azorin (Spain)
Roberta Messina (Italy)
Raffaele Ornello (Italy)
Aynur Özge (Turkey)
Lanfranco Pellesi (Denmark)
Their dedication, expertise, and insightful feedback have been instrumental in ensuring the high quality and rigor of Cephalalgia.
✨ Exceptional reviewers were selected based on:
Number of reviews completed
Ratio of reviews accepted versus invitations sent
Timeliness in completing reviews
Quality of review reports
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
#cephalalgia #peerreview #academicexcellence #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
IHC 2025: Making History in Latin America!
Join us in São Paulo, 10–13 September 2025, for a groundbreaking event dedicated to the future of global headache care.
#savethedate #ihc2025 #headache -
International Headache Society
@ihs_official
New study by @ChrStaehr et al. uses a genotype-first strategy to study FHM-associated genes. Variants in CACNA1A and ATP1A2 are linked to migraine. Intriguingly, homozygous SCN1A variants increase migraine risk but reduce epilepsy risk!
journals.sagepub.com/doi/10.1177/03331024241306103
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Time to baseline headache severity on lying down is the most important factor when assessing for an orthostatic headache. In patients with chronic headaches, retrospective history of orthostatic headache at onset should be sought as this quality can be lost with time. Rhinorrhoea can be present in almost 14% of patients with spontaneous intracranial hypotension.
journals.sagepub.com/doi/10.1177/03331024241308154
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Female rats exhibited a more intense and prolonged photophobic response to potassium chloride (KCl) injections compared to males.
•
KCl injections caused significant light-aversion in females, while males showed no significant change in light-aversion across treatment groups.
•
No sex differences were observed in pupil-to-iris ratios following KCl or aCSF injections.
•
Females demonstrated greater eye closure and periorbital allodynia post-KCl injection compared to males, indicating stronger pain-related responses in females.
journals.sagepub.com/doi/10.1177/03331024241310550
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
One of the primary focuses of the Cephalalgia and Cephalalgia Reports social media editors has been to ensure that all papers published in the journals are highlighted across the IHS and the journals' social media channels.
journals.sagepub.com/doi/10.1177/03331024241310519
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🎉✨ Exciting News! Welcoming Our New Associate Editors
We’re thrilled to introduce our newest Associate Editors for Cephalalgia and Cephalalgia Reports:
Anna P. Andreou
Rolf Fronczek
Bronwyn Jenkins
Francesca Puledda
Marta Vila Pueyo
Their expertise and dedication will help shape the future of headache research publishing. Join us in giving them a warm welcome to the team!
#cephalalgia #cephalalgiareports #headache #neurology #migraine -
International Headache Society
@ihs_official
🎉✨ Welcome to Our New Graphical Abstract Editors!
We are thrilled to introduce Rogelio Dominguez-Moreno and Esme Ekizoğlu as the new Graphical Abstract Editors for Cephalalgia Reports! Their expertise will enhance the visual representation of cutting-edge headache research, making it more accessible and engaging for our readers.
Join us in giving them a warm welcome!
#graphicalabstracts #headache #neurology #medicalpublishing -
International Headache Society
@ihs_official
Complex regional pain syndrome (CRPS) can present as a syndrome of headache with facial pain.
CRPS can develop without any known mechanically related trauma.
These cases should be reviewed and classified according to the Budapest Criteria as early diagnosis and treatment may improve symptoms and quality of life.
journals.sagepub.com/doi/10.1177/25158163241307325
#headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
This study demonstrated that serum uric acid levels in patients with tension type headache were lower than in controls.
Uric acid is a substance that exhibits antioxidant properties by removing superoxide, a reactive oxygen species, from the cell, inhibiting the reaction between superoxide and nitric oxide, and reducing the production of peroxynitrite. Lower uric acid levels may indicate a role in tension type headache (TTH) pathophysiology by affecting oxidative stress mechanisms, inflammation and neuroprotection.
Modifying uric acid levels may lead to new therapeutic approaches in the treatment of TTH.
journals.sagepub.com/doi/10.1177/25158163241308795
#headache #brain #pain #neurology #ne -
International Headache Society
@ihs_official
Epicrania fugax triggered by head/neck movement or change in position may be due to subdural hepatoma, posterior fossa lesions or cervical vertebral lesions.
journals.sagepub.com/doi/10.1177/25158163241307328
#headache #neurology #pain -
International Headache Society
@ihs_official
December's Editor's Choice
@Simona_Sacco_
The methodology of drug trials in migraine has been described in multiple publications and is fragmented.
This paper synthesized this information and is an easy inroad to understanding the principles of drug trials.
journals.sagepub.com/doi/10.1177/03331024241298642
#migraine #headache #brain #pain #neurology #neuroscience
@d036218 -
International Headache Society
@ihs_official
🎉 Happy New Year 2025! 🎉
The International Headache Society wishes you health and happiness in 2025. Together, let’s continue advancing headache research and improving the lives of our patients worldwide. And don’t forget to join us at #ihc2025 in São Paulo!
#happynewyear #happynewyear2025 -
International Headache Society
@ihs_official
This is the protocol for a placebo-controlled crossover trial to explore how sildenafil (Viagra®) triggers migraine in men with migraine. While prior studies have focused on women, this study aims to uncover potential sex differences in mechanisms.
journals.sagepub.com/doi/10.1177/25158163241307329
#migraine #headache #brain #pain #neurology #neuroscience
@Lanfpelledoc -
International Headache Society
@ihs_official
Cephalalgia is introducing graphical abstracts to its publications. A graphical abstract is a visual summary, in a single representation, of the findings of a study.
It must represent concisely and accurately the scientific content of the article. The aim of the graphical abstract is to summarise the main results of the study.
journals.sagepub.com/doi/10.1177/03331024241300883
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The methodology of drug trials in migraine has been described in multiple publications and is fragmented.
This paper synthesized this information and It is an easy inroad to understanding the principles of drug trials.
journals.sagepub.com/doi/10.1177/03331024241298642
#migraine #headache #brain #pain #neurology #neuroscience
@d036218 -
International Headache Society
@ihs_official
The machine-learning based tool holds promise in the prediction of treatment outcomes for patients with migraine undergoing anti-CGRP/R mAbs.
journals.sagepub.com/doi/10.1177/03331024241262751
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
The International Headache Society wishes you and your loved ones a joyful holiday season filled with warmth, laughter, and cherished moments. Happy Holidays! 🎄✨
-
International Headache Society
@ihs_official
Data from five large clinical trials demonstrated that atogepant was associated with consistent and modest dose- and duration-dependent weight loss when used as a preventive treatment in people with episodic or chronic migraine.
•
Given the high rate of comorbid obesity in people with migraine, the impact of atogepant on weight is an important factor to inform clinical decision making.
journals.sagepub.com/doi/10.1177/03331024241299753
#migraine #headache #brain #pain #neurology #neuroscience #weight -
International Headache Society
@ihs_official
📢✨ Exciting News!
The Abstracts of the 20th Biennial Migraine Trust International Symposium (MTIS), held in London, UK, from 5th to 8th September 2024, are now available! Dive into the latest advancements and groundbreaking research in migraine and headache disorders.
🗂️ Explore the abstracts and stay updated on cutting-edge developments in the field.
journals.sagepub.com/doi/full/10.1177/03331024241280496
#mtis2024 #migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
These results demonstrate the value of preventive treatment with atogepant for reducing migraine-attributed impacts on multiple aspects of daily life, health, and well-being across the spectrum of people with migraine
journals.sagepub.com/doi/10.1177/03331024241300305
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Incremental burden was observed across migraine subgroups (1–3 MHDs, 4-7 MHDs, 8-14 MHDs, and ≥15 MHDs) irrespective of the use of prescription medication compared to the matched controls without migraine.
journals.sagepub.com/doi/10.1177/03331024241276415
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
-
International Headache Society
@ihs_official
The number needed to treat for atogepant 60 mg once daily vs placebo was comparable with CGRP mAbs.
Atogepant demonstrated a numerically lower number needed to treat compared with CGRP mAbs in the primary analysis.
doi.org/10.1177/03331024241299377
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌍 IHC 2025: In Latin America for the first time!
Join us in São Paulo from 10-13 September 2025 for a landmark event dedicated to advancing global headache care.
#savethedate #ihc2025 #headache -
International Headache Society
@ihs_official
November's Editor's Choice
@Simona_Sacco_
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society
This study aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache, which varied greatly across the world.
journals.sagepub.com/doi/10.1177/03331024241297688
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
Females with medication-overuse headache had repressed levels of Anti-Müllerian Hormone, a well-established biomarker for fertility, likely through disruption of granulosa cell proliferation.
journals.sagepub.com/doi/10.1177/03331024241290530
#migraine #headache #brain #pain #neurology #neuroscience
@rj_rigmor
@hmru_cph -
International Headache Society
@ihs_official
Going forward, physicians should consider the importance of informing patients of the risk of headache worsening as part of routine practice when starting verapamil.
journals.sagepub.com/doi/10.1177/25158163241295990
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
🌟 Highlight from Dr. Simona Sacco’s Inspiring Session 🌟
In a thought-provoking presentation at #ehc2024, Simona Sacco, Chief Editor of Cephalalgia, shared her insights on the transformative role of AI in scientific publishing.
Her powerful message resonates with all of us:
"Do not fear technology. Fear remaining unchanged in a world that evolves every day."
Let’s embrace innovation and adapt as the world of science and publishing moves forward. 🚀📚✨
#cephalalgia #aiinpublishing #scientificpublishing #innovation #adapttoevolve -
International Headache Society
@ihs_official
Save the date! Join us for the International Headache Congress 2025 in São Paulo, 10-13 September!
For the first time in Latin America, over 100 experts from 30+ countries will share groundbreaking advances in headache care. Don’t miss this unique scientific and cultural experience!
#headache #migraine #congress -
International Headache Society
@ihs_official
Dr. Mario Peres, President-Elect of the International Headache Society, delivered remarkable talks at #ehc2024 and warmly invited everyone to join #ihc2025 in São Paulo!
#headache #conferences -
International Headache Society
@ihs_official
"This comprehensive review underscores the significance of chronobiology in phenotyping primary headache disorders and unraveling their pathophysiological underpinnings.
Insights from chronobiological studies pave the way for enhanced efficacy and precision in headache management, marking a significant advancement in patient care.
journals.sagepub.com/doi/10.1177/03331024241297652
#migraine #headache #brain #pain #neurology #neuroscience -
International Headache Society
@ihs_official
3, 2, 1... HEADACHE! Enlightening speech by the Dr. Alexandre da Silva (right) @UMich @UMichDentistry, moderated by Dr. @MarcioNattan (left) from @hospitalHCFMUSP
#ihsrhc2022 #neurology #vr #headache #pain #neuroscience #brain














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































